var title_f36_50_37664="Electroconvulsive therapy (ECT)";
var content_f36_50_37664=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Electroconvulsive therapy (ECT) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?36/50/37664/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37664/contributors\" id=\"au3573\">",
"       Charles Kellner, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?36/50/37664/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37664/contributors\" id=\"se3327\">",
"       Peter P Roy-Byrne, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?36/50/37664/contributors\">",
"       Deputy Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37664/contributors\" id=\"de3194\">",
"       David Solomon, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37664/contributors\" id=\"de2799\">",
"       Constanza Villalba, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/50/37664?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      WHAT IS ECT?",
"     </span>",
"    </p>",
"    <p>",
"     Electroconvulsive therapy (ECT) is a safe and effective treatment for certain psychiatric disorders. ECT is most commonly used to treat severe depression (major depression). It is often the fastest and best treatment available for this illness. ECT is also sometimes used to treat other psychiatric disorders, such as:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Mania, a condition that makes you feel very happy or angry; sleep less; have lots of energy; and behave strangely; or",
"      </li>",
"      <li>",
"       Psychosis, a condition that can make you lose touch with reality; have false, fixed beliefs; or hear voices of people who are not there",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     During ECT, a small amount of electrical current is passed through the brain. This current causes a seizure that affects the entire brain, including the parts that control mood, appetite, and sleep.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HOW DOES ECT WORK?",
"     </span>",
"    </p>",
"    <p>",
"     ECT causes chemical changes in the brain that relieve severe depression. While scientists do not yet fully understand exactly how ECT does this, they know it causes helpful changes to the molecules and cells of the brains of people with depression. One thing that is clear is that the treatment works very well; more than 70 percent of depressed people who receive it respond favorably, making it the most effective treatment for severe depression. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=see_link\">",
"      \"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     If your doctor suggests that you be treated with ECT, it is because he or she believes that you have a disorder that will improve with ECT. Discuss this with your doctor.",
"    </p>",
"    <p>",
"     Before ECT begins, your doctor will carefully assess your medical condition to make sure that ECT is safe for you. He or she will examine you, ask you about your medical history, and run tests. For example, you will probably have blood tests and a test called an \"electrocardiogram\" (ECG) to check the condition of your heart. These tests will also help the doctor make sure that there is no other medical problem causing your psychiatric symptoms.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HOW MANY TIMES WILL I NEED TO BE TREATED?",
"     </span>",
"    </p>",
"    <p>",
"     People undergoing ECT need multiple treatments. The number needed to successfully treat severe depression can range from 4 to 20, but most people need a total of 6 to 12 treatments. The treatments are usually given three times a week &mdash; Monday, Wednesday, and Friday.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      WHAT SHOULD I DO TO PREPARE FOR EACH SESSION?",
"     </span>",
"    </p>",
"    <p>",
"     You must not eat or drink anything after midnight the night before your scheduled treatment. If you smoke, do not smoke the morning of your treatment. Smoking beforehand could cause problems during the treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      WHAT HAPPENS DURING THE ECT PROCEDURE?",
"     </span>",
"    </p>",
"    <p>",
"     Before you receive the treatment, a doctor or nurse will place a needle into a vein in your arm (IV). That way, the medical team can easily give you the medications you need before and during the procedure. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link\">",
"      \"Technique for performing electroconvulsive therapy (ECT) in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Although you will be asleep during the treatment, the medical team will need to start preparing you for the treatment while you are still awake. The team will:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Place sensors called electrodes on your head, so that they can measure the electrical activity in your brain. To do this, they will use a device called an EEG, or \"electroencephalogram.\"",
"      </li>",
"      <li>",
"       Place electrodes on your chest, so that they can measure the electrical activity in your heart. To do this, they will use a device called an ECG, or \"electrocardiogram.\"",
"      </li>",
"      <li>",
"       Wrap a blood pressure cuff around your arm, so that they can monitor your blood pressure during the procedure.",
"      </li>",
"      <li>",
"       Put a small sensor on one of your fingers called a \"pulse oximeter,\" which will allow them to measure the amount of oxygen in your blood. This will tell them if you are breathing normally.",
"      </li>",
"      <li>",
"       Give you oxygen through a mask or a tube that rests below your nose. You will get oxygen throughout the whole procedure, until you wake up.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     When everything is connected, the medical team will test the ECT machine to make sure that it is set properly for you. Next, a doctor or nurse will inject you with a medication (such as methohexital) that will make you go to sleep for 5 to 10 minutes. When you are asleep, you will get another injection, of a muscle relaxant (succinylcholine). This will keep you from moving about during the treatment. The muscle relaxant may cause mild muscle soreness after the treatment, but this soreness will pass.",
"    </p>",
"    <p>",
"     Once your medical team is sure that you are deeply asleep and that your muscles are completely relaxed, they will administer the ECT treatment. Because you will be asleep, you will experience no pain during the treatment and will not feel the current or the seizure. If you were watching the treatment instead of receiving it, you would see your toes wiggling or other parts of your body moving a little &mdash; but not much else.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      WHAT HAPPENS AFTER THE TREATMENT?",
"     </span>",
"    </p>",
"    <p>",
"     When you wake up after treatment, you may feel confused. This is partially due to the anesthesia and partially due to the treatment. In most people, the confusion passes within an hour. You may also have a headache the day of the treatment. A pain reliever, if necessary, usually helps. Other side effects, such as nausea, typically last only for a few hours.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Memory loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;You may have some memory loss until you complete all of your treatments. This memory loss should gradually reverse itself over the course of several weeks. However, you may never remember many things that happened to you shortly before, during, or soon after your course of treatment.",
"    </p>",
"    <p>",
"     To speed and improve recovery of your memory, use your brain. Read, ask questions, and watch continuing stories on TV. This is the best way for you to help your memory return.",
"    </p>",
"    <p>",
"     Because of the short-lived side effects on your memory, it is important that you postpone any major decisions until a week or two after the ECT course. It is also important that you do not drive during your course of ECT.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      When will my depression lift?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people start to feel somewhat better after 2 to 4 treatments, but many do not get the full benefit of the treatment until later in the treatment course.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      DOES ECT HAVE ANY RISKS?",
"     </span>",
"    </p>",
"    <p>",
"     Yes, like any medical procedure, ECT has some risks. In rare cases, ECT can cause heart rhythm problems, or other potentially serious complications. In patients with pre-existing heart disease, there is an increased risk of these complications. If you have a heart condition, your doctor will take special care to monitor your heart and take other precautions with you, so that the treatment is as safe as possible. For instance, he or she might give you medicines to offset the effects of the ECT, if necessary.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     ECT is an extremely effective and safe treatment for severe depression. It is often more effective than available antidepressant medications. If you have questions about ECT, please discuss them with your doctor.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18218656\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18218664\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37106?source=see_link\">",
"      Patient information: Electroconvulsive therapy (ECT) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18218681\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     This topic currently has no corresponding Beyond the Basics content.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=see_link\">",
"      Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link\">",
"      Medical consultation for electroconvulsive therapy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/21/41305?source=see_link\">",
"      Overview of electroconvulsive therapy (ECT) for adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link\">",
"      Technique for performing electroconvulsive therapy (ECT) in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;",
"     <span class=\"nowrap\">",
"      (www.nlm.nih.gov/medlineplus/healthtopics.html)",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Mental Health",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(www.nimh.nih.gov)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Psychiatric Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.psych.org/\">",
"      www.psych.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?36/50/37664/abstract/1,2\">",
"      1,2",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/50/37664?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37664/abstract/1\">",
"      Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. American Psychiatric Association, Washington, DC 2001.",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f36_50_37664=[""].join("\n");
var outline_f36_50_37664=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           WHAT IS ECT?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HOW DOES ECT WORK?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HOW MANY TIMES WILL I NEED TO BE TREATED?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           WHAT SHOULD I DO TO PREPARE FOR EACH SESSION?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           WHAT HAPPENS DURING THE ECT PROCEDURE?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           WHAT HAPPENS AFTER THE TREATMENT?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           DOES ECT HAVE ANY RISKS?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37665="Colonic diverticula Endosc";
var content_f36_50_37665=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Colonic diverticula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy showing multiple outpouchings of the mucosa through hypertrophied muscular layers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37665=[""].join("\n");
var outline_f36_50_37665=null;
var title_f36_50_37666="Technetium Tc-99m labeled red blood cells: Patient drug information";
var content_f36_50_37666=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Technetium Tc-99m labeled red blood cells: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/60/23490?source=see_link\">",
"     see \"Technetium Tc-99m labeled red blood cells: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13206541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      UltraTag&reg; RBC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F13374095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3560752",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used with a special imaging test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F13374094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3560533",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to technetium Tc 99m-labeled red blood cells or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F13374098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F13374100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F13374097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F13374102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17083 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-555B9DE994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37666=[""].join("\n");
var outline_f36_50_37666=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206541\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374095\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374094\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374098\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374100\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374097\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374102\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/60/23490?source=related_link\">",
"      Technetium Tc-99m labeled red blood cells: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37667="Erysipelas thigh";
var content_f36_50_37667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F56797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F56797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erysipelas involving the groin and thigh",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37667=[""].join("\n");
var outline_f36_50_37667=null;
var title_f36_50_37668="Phenylephrine (ophthalmic): Patient drug information";
var content_f36_50_37668=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Phenylephrine (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/7/23668?source=see_link\">",
"     see \"Phenylephrine (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/13/40147?source=see_link\">",
"     see \"Phenylephrine (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9504770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AK-Dilate&trade;;",
"     </li>",
"     <li>",
"      Altafrin;",
"     </li>",
"     <li>",
"      Mydfrin&reg;;",
"     </li>",
"     <li>",
"      Neofrin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9504797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dionephrine&reg;;",
"     </li>",
"     <li>",
"      Mydfrin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691284",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before an eye exam.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702730",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to phenylephrine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfite allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703545",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: A fast heartbeat, high blood pressure, or narrow angle glaucoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store closely.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12286 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-EBA391572F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37668=[""].join("\n");
var outline_f36_50_37668=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504770\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504797\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025776\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025778\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025777\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025782\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025783\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025785\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025780\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025781\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025786\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025787\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/7/19572?source=related_link\">",
"      Phenylephrine (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/52/21316?source=related_link\">",
"      Phenylephrine (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/10/17572?source=related_link\">",
"      Phenylephrine (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/7/23668?source=related_link\">",
"      Phenylephrine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/13/40147?source=related_link\">",
"      Phenylephrine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/47/6903?source=related_link\">",
"      Phenylephrine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?32/59/33717?source=related_link\">",
"      Phenylephrine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/23/13686?source=related_link\">",
"      Phenylephrine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/53/30547?source=related_link\">",
"      Phenylephrine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/36/20036?source=related_link\">",
"      Phenylephrine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/16/5379?source=related_link\">",
"      Phenylephrine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37669="Pneumocystis pneumonia CT I";
var content_f36_50_37669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74643%7EPULM%2F55021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74643%7EPULM%2F55021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumocystis carinii pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pneumocystis jirovecii pneumonia&nbsp;in a patient with AIDS. Ground glass opacities in a patchy distribution are best seen in the anterior segment of the left upper lobe. An accompanying left lower lobe bacterial pneumonia is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumocystis jirovecii pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 353px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pneumocystis jirovecii pneumonia&nbsp;in a patient on high doses of corticosteroids. Confluent consolidation is interspersed with ground glass opacities and thickening of the interlobular septa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37669=[""].join("\n");
var outline_f36_50_37669=null;
var title_f36_50_37670="Lichenoid drug eruption hand";
var content_f36_50_37670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichenoid drug eruption involving the dorsum of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In contrast to lichen planus, the lesions of lichenoid drug eruption are distributed on the extensor aspects of the extremities. In this patient, confluent violaceous papules are located on the dorsal aspect of the hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37670=[""].join("\n");
var outline_f36_50_37670=null;
var title_f36_50_37671="Frostbite";
var content_f36_50_37671=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Frostbite",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     C Crawford Mechem, MD, FACEP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Ken Zafren, MD, FAAEM, FACEP, FAWM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Daniel F Danzl, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37671/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/50/37671/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frostbite results from the freezing of tissue. It is a disease of morbidity, not mortality. It is most frequently encountered in mountaineers and other cold weather enthusiasts, soldiers, those who work in the cold, the homeless, and individuals stranded outdoors in the winter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the classification, presentation, diagnosis, and management of frostbite. Severe hypothermia and related illnesses are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=see_link\">",
"     \"Accidental hypothermia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frostbite is a severe, localized cold-induced injury. Immersion foot (also referred to as Trench Foot) is a non-freezing cold injury (NFCI) that may also cause tissue loss and long-term sequelae. Milder forms of injury include frostnip and pernio:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Frostnip refers to cold-induced, localized paresthesias that resolve with rewarming. There is no permanent tissue damage.",
"     </li>",
"     <li>",
"      Pernio, or chilblain, is characterized by localized inflammatory lesions that can result from acute or repetitive exposure to damp cold above the freezing point. Lesions are edematous, often reddish or purple, and may be very painful or pruritic. Pernio is most common in young women, but both sexes and all age ranges may be affected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Immersion foot involves injury to the sympathetic nerves and vasculature of the feet. It was first described in 1914 during World War I trench warfare. It results from prolonged exposure of the feet to a combination of dampness and cold. Tight-fitting boots exacerbate the condition. Feet, and occasionally hands, are red, edematous, can be numb or extremely painful, and often covered with hemorrhagic bullae. Tissue loss can occur.",
"      <br/>",
"      <br/>",
"      Improved foot hygiene including better boot design and frequent sock changes resulted in a much lower prevalence among soldiers by 1917. Not just of historical significance, trench foot was a major medical issue during the Falklands War of 1982 and still occurs, especially among the homeless [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tissue destruction of frostbite is due to both immediate cold-induced cell death and the more gradual development of localized inflammatory processes and tissue ischemia. Following exposure to subfreezing temperatures, ice crystals form extracellularly. If freezing is rapid, ice crystals may also form inside cells. Fluid and electrolyte fluxes cause lysis of cell membranes with subsequent cell death. An inflammatory process ensues mediated by thromboxane A2, prostaglandin F2-alpha, bradykinins, and histamine. This leads to tissue ischemia and necrosis. The initial cellular damage and the subsequent inflammatory processes are made worse in the setting of thawing followed by refreezing of the affected area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/3,7\">",
"     3,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of systems to classify frostbite have been developed based on initial clinical presentation, findings on scintigraphy with technetium-99m pertechnetate, and outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/3,8,9\">",
"     3,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The traditional classification system divides frostbite into four degrees of severity based upon the depth of tissue involvement, in similar fashion to the classification of burns:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First-degree frostbite is very superficial and is characterized by a central area of pallor and anesthesia of the skin surrounded by edema.",
"     </li>",
"     <li>",
"      Second-degree frostbite is recognized by large blisters containing clear fluid surrounded by edema and erythema, developing within 24 hours and extending to or nearly to the tips of digits. The blisters may form an eschar, but this later sloughs off, revealing healthy granulation tissue. There is no tissue loss.",
"     </li>",
"     <li>",
"      Third-degree frostbite differs from second-degree in that the injury is deeper and the blisters are smaller, hemorrhagic and more proximal. The skin forms a black eschar in one to several weeks.",
"     </li>",
"     <li>",
"      Fourth-degree frostbite, which extends to muscle and bone, involves complete tissue necrosis. Mummification occurs in 4 to 10 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The traditional system gives clinicians a false sense of accuracy. It has caused many to treat frostbite injuries as if they were burns, with suboptimal results. Depending upon rewarming methods and complications, such as infection or trauma, first and second-degree frostbite can unexpectedly become third or fourth-degree.",
"   </p>",
"   <p>",
"    A more practical classification scheme categorizes frostbite injuries as superficial or deep. Superficial frostbite corresponds to first and second-degree injury. Deep frostbite corresponds to third and fourth-degree injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for developing frostbite and cold-induced injury include anything that increases localized heat loss or decreases heat production. Examples include increased convective heat loss due to exposure to wind or conductive heat loss due to contact with metal or water [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/12\">",
"     12",
"    </a>",
"    ]. Exhaustion, dehydration, malnutrition, or comorbidities such as peripheral vascular disease, diabetes, or mental illness may limit an individual's ability to respond to a cold stress. Alcohol abuse predisposes to frostbite as a result of acute behavioral changes, increased heat loss from vasodilation, and chronic complications of alcohol consumption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other risk factors for developing frostbite include smoking, previous cold injury, and exposure of the hands and arms to vibration, which can elicit a Raynaud phenomenon associated with white fingers in some individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. African-Americans may be at increased risk of frostbite, while women may be at decreased risk, at least for frostbite acquired while traveling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of clothing that provides inadequate insulation or coverage, or is damp, too tight, or permeable to wind, can predispose to frostbite, as can use of protective ointments, such as on the face. Excessive sweating of the hands and feet increases an individual's risk of frostbite to those areas, illustrating the importance of clothing that is able to wick moisture away from the skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While generally considered a disease associated with environmental exposure to cold, frostbite has also been reported following direct exposure to freezing materials. As an example, the application of ice packs to reduce swelling from musculoskeletal injuries can cause frostbite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/20\">",
"     20",
"    </a>",
"    ]. It is important to tell patients to interpose a cloth between the ice pack and their skin, and to limit treatment intervals to 20 minutes with a minute or two break between applications.",
"   </p>",
"   <p>",
"    Case reports describe severe facial, upper airway, and esophageal frostbite from recreational inhalation of halogenated hydrocarbons. Contact with Freon, a fluorinated hydrocarbon used as a refrigerant, has been reported to cause third and fourth-degree frostbite of the hand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Frostbite of the foot has been described resulting from the discharge of a carbon dioxide fire extinguisher on a sprained ankle in an attempt to reduce edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some researchers hypothesize that individual variation in cold-induced vasodilation (CIVD) corresponds to the risk of frostbite. One small, observational study of marines during winter deployment suggests that faster and greater CIVD may decrease risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because there is no formal reporting system for cases of frostbite, data on incidence and prevalence are derived from selected subpopulations, generally consisting of individuals at greater than average risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/15,19,26\">",
"     15,19,26",
"    </a>",
"    ]. Based upon such studies, the areas of the body most susceptible to frostbite appear to be the hands, feet, face (including nose and cheeks), and ears.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Areas most frequently affected by frostbite include the ears, nose, cheeks, chin, fingers, and toes. Frostbite of the cornea has been reported in individuals who keep their eyes open against very strong winds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/6,27\">",
"     6,27",
"    </a>",
"    ]. Patients often complain of cold, numbness, and clumsiness of the affected area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/28\">",
"     28",
"    </a>",
"    ]. Before rewarming, the skin is insensate, white or grayish-yellow in color, and hard or waxy to touch. As noted above, bullae containing clear or bloody fluid may develop after thawing, depending on the depth of the injury. In cases of delayed presentation to medical care, eschar or other signs of tissue necrosis may be observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis is generally made on clinical grounds, based on the context of the injury, signs, and symptoms. Diagnostic studies are helpful in determining the existence of comorbidities, the extent of frostbite injury, and prognosis. Because frostbite is a disease of morbidity, not mortality, more immediate life-threats, such as coexisting hypothermia, must be identified and addressed first. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=see_link\">",
"     \"Accidental hypothermia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radiologic studies can help to determine the extent of tissue involvement, response to therapy, and long-term tissue viability:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain radiographs may show coincidental trauma-related fractures or cold-induced soft tissue swelling. Late radiographic findings include bony destruction and, in children, damage to growth plates [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7\">",
"       7",
"      </a>",
"      ]. Frostbite arthritis often spares the thumbs, most likely because patients wrap them within clenched fists during the exposure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Technetium (Tc)-99 scintigraphy is commonly used to predict long-term viability of affected tissue, with the goal of allowing earlier debridement or amputation of dead or dying areas while preserving viable tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/30\">",
"       30",
"      </a>",
"      ]. Its use may avoid the need for the traditional several-week delay in surgical intervention while awaiting demarcation between viable and nonviable zones. Scintigraphy has also been used to monitor response to a topical therapy protocol by demonstrating the effect of treatment on involved tissue microvasculature [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/8,31\">",
"       8,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some researchers claim magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) may be superior to bone scans in establishing tissue viability. In case reports they have permitted visualization of occluded blood vessels and better demonstrated the line of demarcation between ischemic and nonischemic tissue. However, experience with MRI and MRA in this setting is limited [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7,32\">",
"       7,32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment can be divided into prehospital interventions and definitive care. The approach described below is based on animal studies, observational data, and clinical experience. Management of hypothermia is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=see_link\">",
"     \"Accidental hypothermia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prehospital",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Get the patient to a warm environment as soon as possible. Whenever possible pad or splint the affected area to minimize injury en route.",
"     </li>",
"     <li>",
"      Remove wet clothing.",
"     </li>",
"     <li>",
"      Avoid walking on frostbitten feet; this can increase tissue damage. If walking is necessary for evacuation, do not rewarm the feet before walking.",
"     </li>",
"     <li>",
"      Do not rewarm frostbitten tissue if there is a possibility of refreezing before reaching definitive care. This would result in worse tissue damage.",
"     </li>",
"     <li>",
"      If prehospital warming is attempted, options include placing the affected area in warm (not hot) water or warming it using body heat (eg, placing frostbitten fingers in the axillae).",
"     </li>",
"     <li>",
"      Do not rub frostbitten areas in an attempt to rewarm them; this can cause further tissue damage.",
"     </li>",
"     <li>",
"      Avoid the use of stoves or fires to rewarm frostbitten tissue. Such tissue may be insensate and burns can result [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7,27,33\">",
"       7,27,33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hospital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the patient has reached the hospital, definitive care consists of rapid rewarming, wound care, efforts to enhance tissue viability, and prevention of complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rewarming - Rewarming is most effectively accomplished by immersing the affected area in water heated to 37&ordm; to 39&ordm;C, ideally in a whirlpool. Higher temperatures do not warm the injured area appreciably faster and cause the warming process to be much more painful. Dry heat is difficult to regulate and is not recommended.",
"      <br/>",
"      <br/>",
"      Thawing is usually complete when the tissue is red or purple and soft to the touch. This usually takes 15 to 30 minutes. Rewarming of frostbitten tissue may be painful. Appropriate analgesia, generally opioids, should be administered.",
"     </li>",
"     <li>",
"      Thrombolysis - Because frostbite is associated with vascular thrombosis of the affected tissue, administration of intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      along with either intravenous or intra-arterial tissue plasminogen activator (tPA) has been studied as a potential means of improving outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. A single-center, retrospective review of 32 patients with severe frostbite treated with tPA within 24 hours of injury found the incidence of digital amputation to be 10 percent, compared with 41 percent among patients with comparable injuries not treated with tPA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/36\">",
"       36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Evidence in support of thrombolytic treatment of severe frostbite is retrospective and involves only a small number of cases. Nevertheless, treatment options for patients with severe frostbite are limited and outcomes often poor. Therefore, in patients at high risk for life-altering amputation (eg, multiple digits, proximal amputation), without contraindications to the use of tPA, who present within 24 hours of injury, we suggest treatment with intra-arterial tPA. Whenever possible, treatment should be performed at or in consultation with a center experienced in the use of tPA for frostbite.",
"      <br/>",
"      <br/>",
"      In the study demonstrating benefit from tPA, a bolus of two to four mg was followed by an infusion started 0.5 to 1",
"      <span class=\"nowrap\">",
"       mg/hour",
"      </span>",
"      given via the femoral or brachial artery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/36\">",
"       36",
"      </a>",
"      ]. Repeat angiograms were performed every 8 to 12 hours. Treatment continued until perfusion was restored or a time limit of 48 hours was reached.",
"      <br/>",
"      <br/>",
"      Before administering tPA, clinicians must carefully assess the patient's risk for significant bleeding complications. Do",
"      <strong>",
"       NOT",
"      </strong>",
"      give tPA to patients at risk for such complications, which are described in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/26/6570?source=see_link&amp;anchor=H548320#H548320\">",
"       \"Intravenous fibrinolytic (thrombolytic) therapy in acute ischemic stroke: Therapeutic use\", section on 'Patient selection and eligibility'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/43/1721?source=see_link&amp;anchor=H25#H25\">",
"       \"Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy\", section on 'Contraindications'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Clinicians must discuss the relative risks and benefits of thrombolytic treatment with the patient and obtain informed consent. Treatment with thrombolytics assumes the patient is willing to accept a small risk of potentially catastrophic bleeding in return for a greater likelihood of retaining functional digits or limbs.",
"      <br/>",
"      <br/>",
"      The administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/2/37923?source=see_link\">",
"       papaverine",
"      </a>",
"      , a vasodilator, followed by intra-arterial tPA has been associated with good patient outcomes in case reports [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/37\">",
"       37",
"      </a>",
"      ]. However, a controlled trial of tPA with and without papaverine has yet to be performed.",
"     </li>",
"     <li>",
"      Wound care - Subsequent management includes application of a bulky dressing to the affected area, elevation to reduce edema, and daily hydrotherapy to improve range of motion. Splinting may be required to prevent contracture formation.",
"      <br/>",
"      <br/>",
"      The following practices are important in treating these wounds:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Maintain aseptic technique during wound treatment",
"     </li>",
"     <li>",
"      Apply nonadherent gauze as the first dressing layer",
"     </li>",
"     <li>",
"      Use sterile fluff dressing",
"     </li>",
"     <li>",
"      Insert pledgets (eg, sterile cotton) between digits to prevent tissue maceration during demarcation",
"     </li>",
"     <li>",
"      Avoid occlusive dressings",
"     </li>",
"     <li>",
"      Protect lower extremity wounds with a cradle and upper extremity wounds with sterile sheets",
"     </li>",
"     <li>",
"      Keep wounds open immediately following water bath or whirlpool treatment and allow them to dry before applying any dressing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       Heparin",
"      </a>",
"      - There is no evidence that intravenous heparin alone improves outcomes in frostbite. We do not recommend this treatment.",
"     </li>",
"     <li>",
"      Blisters - There is no clear consensus on management of frostbite-induced blisters. Some authors suggest that because of the high concentrations of inflammatory mediators in the blister fluid, all should be drained. Others take a more conservative approach. A reasonable compromise is to drain, debride, and bandage large nonhemorrhagic bullae that interfere with movement, such as those over joints. Hemorrhagic bullae of comparable size and location are drained by aspiration, but are",
"      <strong>",
"       NOT",
"      </strong>",
"      debrided. Hemorrhagic bullae reflect more significant damage to the microvasculature. Other minor bullae should be left intact [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tetanus is a reported complication of frostbite. Tetanus prophylaxis is recommended [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prophylactic antibiotics are controversial. Post-thaw warm whirlpool treatments may help to reduce bacterial colonization of injured tissue, but infection can develop nevertheless. We suggest giving parenteral antibiotics at the earliest sign of infection. Staphylococci, streptococci, and pseudomonas species should be covered. Topical antibiotics can cause maceration and should be avoided.",
"     </li>",
"     <li>",
"      Topical aloe and oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      may limit inflammation associated with frostbite by inhibiting thromboxane and prostaglandins, although supporting evidence is limited. In the absence of contraindications, it is reasonable to use these treatments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Surgical consultation - Because frostbite may require long-term wound care, including hydrotherapy, repeated tissue debridement, escharotomy, fasciotomy, and possibly delayed amputation, we recommend early surgical consultation, preferably with an orthopedic surgeon with experience managing frostbite [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19125051\">",
"    <span class=\"h2\">",
"     Hyperbaric oxygen and other unproven therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several potential but unproven treatments for frostbite have been reported. Hyperbaric oxygen has been proposed as an adjunctive therapy to improve revascularization and healing of injured tissue. Older studies showed no benefit, but subsequent case reports suggest a possible role and describe improvement in symptoms and the microcirculation of affected tissues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Further study of hyperbaric treatment is needed before it can be recommended. Hyperbaric oxygen therapy is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5448?source=see_link\">",
"     \"Hyperbaric oxygen therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/28/13765?source=see_link\">",
"     Pentoxifylline",
"    </a>",
"    , a drug sometimes used to treat claudication, has been proposed as adjunctive therapy for frostbite because of its favorable effect on blood flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/42\">",
"     42",
"    </a>",
"    ]. Although the benefit of pentoxifylline in claudication is limited, animal studies of frostbite have had positive results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. No controlled studies have been performed in humans. Further data are needed before pentoxifylline can be recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/21/32090?source=see_link&amp;anchor=H19#H19\">",
"     \"Medical management of claudication\", section on 'Pentoxifylline'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    A distal forearm nerve block using 1 percent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    mixed with 1:100,000 epinephrine increases finger temperatures in patients undergoing carpal tunnel release surgery. The underlying mechanism is chemical sympathectomy causing vasodilatation. One report has suggested that such nerve blocks might benefit patients with frostbite of the fingers, but prospective studies have yet to be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/45\">",
"     45",
"    </a>",
"    ]. Previous studies of chemical sympathectomy failed to show benefit.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/53/37716?source=see_link\">",
"     Iloprost",
"    </a>",
"    is a prostacyclin analog not currently available in the United States that is thought to work by a similar mechanism. Iloprost was associated with improved outcomes in one retrospective study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications of frostbite are due primarily to peripheral neurovascular injury with associated abnormalities of sympathetic tone. Vasospasm, especially with reexposure to cold, is common and may be permanent. The severity of complications generally correlates with the severity of the original injury. The sequelae of nonfreezing cold injuries are similar, but often more debilitating than those produced by frostbite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/10,47\">",
"     10,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Short-term complications include infection, gangrene, and autoamputation of the affected area. Autoamputation may take many weeks to occur. Therapeutic amputation is necessary if deep infection develops before the autoamputation of nonviable tissue. &nbsp;",
"   </p>",
"   <p>",
"    Throbbing pain that begins two to three days after rewarming may persist for weeks or months, even after nonviable tissue demarcates. Intermittent paresthesias beginning after one week are thought to be due to ischemic neuritis and may last for months. Burning, electric shock sensations may also occur. Hyperhidrosis is common and may be a cause as well as an effect of frostbite.",
"   </p>",
"   <p>",
"    Cold exposure is contraindicated for six months after minor injury and for at least 12 months after any significant cold injury. Special precautions to protect previously injured tissue may need to be taken for several years if not indefinitely to prevent further damage. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Longer-term complications include hypersensitivity to the cold; patients remain at increased risk for developing frostbite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7,48\">",
"     7,48",
"    </a>",
"    ]. Late and long-term or permanent sequelae include scarring, tissue atrophy, arthritis, bony abnormalities, and peripheral neuropathy, including hyper or hypoesthesia of digits with decreased proprioception and chronic pain. Pediatric patients may develop necrosis of epiphyses, with devastating growth abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of frostbite includes minimizing predisposing factors, paying attention to weather forecasts, dressing appropriately for the weather, and having an emergency plan when venturing to remote regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/13,49\">",
"     13,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alcohol consumption and smoking should be avoided, as should exposure to water or metal surfaces.",
"     </li>",
"     <li>",
"      Adequate calorie intake should be maintained.",
"     </li>",
"     <li>",
"      Predicted high and low temperatures should be noted, as well as forecasted precipitation and wind chill index. In the setting of extreme cold temperature and high winds, frostbite can develop in a matter of minutes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Suggested clothing includes a hat, face protection, eye protection under extreme conditions, mittens (as opposed to gloves), warm and water-resistant shoes, and several layers of loose-fitting clothes. The inner-most layer should be a wicking material, such as polypropylene, that will draw moisture away from the skin. The next layer should be of an insulating material such as fleece or wool. The outer-most layer should provide protection against wind, rain, and snow. Wet clothing should be changed as soon as is feasible [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The practice of applying emollients to exposed skin to prevent frostbite is widespread in many cold regions of the world. However, literature supporting this practice is lacking. In fact, there is some evidence that this may give the user a false sense of security and increase the risk of frostbite. Therefore, we do not suggest the use of emollients as a preventative measure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37671/abstract/51-53\">",
"       51-53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Individuals traveling in remote areas should, prior to departure, inform others of their anticipated route and carry adequate emergency supplies in case they become stranded.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Basics topic(s) (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/53/31569?source=see_link\">",
"       \"Patient information: Frostbite (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risk factors for frostbite or nonfreezing cold injury include anything that increases localized heat loss or decreases heat production. Examples include increased convective heat loss due to exposure to wind or conductive heat loss due to contact with metal or water. Exhaustion, dehydration, malnutrition, alcohol abuse, or comorbidities such as peripheral vascular disease, diabetes, or mental illness also increase risk. The classification of frostbite and other risk factors are discussed in the text. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The areas most frequently affected by frostbite include the ears, nose, cheeks, chin, fingers, and toes. Patients often complain of cold, numbness, and clumsiness of the affected area. The skin may be insensate, white or grayish-yellow in color, and hard or waxy to touch. Bullae containing clear or hemorrhagic fluid may form after thawing. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Technetium (Tc)-99 scintigraphy can be used to predict long-term viability of affected tissue. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prehospital and hospital care of frostbite is described in detail in the text. Rapid rewarming, meticulous sterile wound care, possible thrombolysis, and early orthopedic consultation are key interventions. Rewarming is most effectively accomplished by immersing the affected area in a water bath heated to 37&ordm; to 39&ordm;C. Such water feels warm but not hot to an unaffected hand. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tetanus prophylaxis and early, aggressive treatment of potential infection should be provided. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients at high risk for life-altering amputation (eg, multiple digits, proximal amputation),",
"      <strong>",
"       without contraindications",
"      </strong>",
"      to the use of tPA, who present within 24 hours of injury, we suggest treatment with intra-arterial tPA in consultation with a center experienced in its use for frostbite (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Clinicians must discuss the relative risks and benefits of thrombolytic treatment with the patient and obtain informed consent. Treatment with thrombolytics assumes the patient is willing to accept a small risk of potentially catastrophic bleeding in return for a greater likelihood of retaining functional digits or limbs. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Strategies for prevention of frostbite are discussed in the text. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94242346\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/1\">",
"      Kroeger K, Janssen S, Niebel W. Frostbite in a mountaineer. Vasa 2004; 33:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/2\">",
"      K&uuml;pper T, Steffgen J, Jansing P. Cold exposure during helicopter rescue operations in the Western Alps. Ann Occup Hyg 2003; 47:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/3\">",
"      Petrone P, Kuncir EJ, Asensio JA. Surgical management and strategies in the treatment of hypothermia and cold injury. Emerg Med Clin North Am 2003; 21:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/4\">",
"      Simon TD, Soep JB, Hollister JR. Pernio in pediatrics. Pediatrics 2005; 116:e472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/5\">",
"      Atenstaedt RL. Trench foot: the medical response in the first World War 1914-18. Wilderness Environ Med 2006; 17:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/6\">",
"      Long WB 3rd, Edlich RF, Winters KL, Britt LD. Cold injuries. J Long Term Eff Med Implants 2005; 15:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/7\">",
"      Murphy JV, Banwell PE, Roberts AH, McGrouther DA. Frostbite: pathogenesis and treatment. J Trauma 2000; 48:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/8\">",
"      Bhatnagar A, Sarker BB, Sawroop K, et al. Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study. Eur J Nucl Med Mol Imaging 2002; 29:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/9\">",
"      Cauchy E, Chetaille E, Marchand V, Marsigny B. Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme. Wilderness Environ Med 2001; 12:248.",
"     </a>",
"    </li>",
"    <li>",
"     Mills W. Clinical aspects of freezing cold injuries. In: Medical Aspects of Harsh Environments, Pandolf K, Burr R.  (Eds), Office of the Surgeon General, Falls Church 2001. p.429.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/11\">",
"      Grace TG. Cold exposure injuries and the winter athlete. Clin Orthop Relat Res 1987; :55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/12\">",
"      Geng Q, Holm&eacute;r I, Hartog DE, et al. Temperature limit values for touching cold surfaces with the fingertip. Ann Occup Hyg 2006; 50:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/13\">",
"      Rintam&auml;ki H. Predisposing factors and prevention of frostbite. Int J Circumpolar Health 2000; 59:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/14\">",
"      ORR KD, FAINER DC. Cold injuries in Korea during winter of 1950-51. Medicine (Baltimore) 1952; 31:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/15\">",
"      Ervasti O, Juopperi K, Kettunen P, et al. The occurrence of frostbite and its risk factors in young men. Int J Circumpolar Health 2004; 63:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/16\">",
"      Olsen N. Diagnostic aspects of vibration-induced white finger. Int Arch Occup Environ Health 2002; 75:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/17\">",
"      DeGroot DW, Castellani JW, Williams JO, Amoroso PJ. Epidemiology of U.S. Army cold weather injuries, 1980-1999. Aviat Space Environ Med 2003; 74:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/18\">",
"      Schlagenhauf P, Chen LH, Wilson ME, et al. Sex and gender differences in travel-associated disease. Clin Infect Dis 2010; 50:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/19\">",
"      Lehmuskallio E, Lindholm H, Koskenvuo K, et al. Frostbite of the face and ears: epidemiological study of risk factors in Finnish conscripts. BMJ 1995; 311:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/20\">",
"      Graham CA, Stevenson J. Frozen chips: an unusual cause of severe frostbite injury. Br J Sports Med 2000; 34:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/21\">",
"      Kuspis DA, Krenzelok EP. Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol 1999; 37:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/22\">",
"      Wegener EE, Barraza KR, Das SK. Severe frostbite caused by Freon gas. South Med J 1991; 84:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/23\">",
"      Kurbat RS, Pollack CV Jr. Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 1998; 16:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/24\">",
"      Sever C, Kulahci Y, Uygur F, Sahin C. Frostbite injury of the foot from portable fire extinguisher. Dermatol Online J 2009; 15:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/25\">",
"      Daanen HA, van der Struijs NR. Resistance Index of Frostbite as a predictor of cold injury in arctic operations. Aviat Space Environ Med 2005; 76:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/26\">",
"      Harirchi I, Arvin A, Vash JH, Zafarmand V. Frostbite: incidence and predisposing factors in mountaineers. Br J Sports Med 2005; 39:898.",
"     </a>",
"    </li>",
"    <li>",
"     www.bt.cdc.gov/disasters/winter/faq.asp#frostbite (Accessed on September 20, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/28\">",
"      Reamy BV. Frostbite: review and current concepts. J Am Board Fam Pract 1998; 11:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/29\">",
"      Kahn JE, Lidove O, Laredo JD, Bl&eacute;try O. Frostbite arthritis. Ann Rheum Dis 2005; 64:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/30\">",
"      Cauchy E, Marsigny B, Allamel G, et al. The value of technetium 99 scintigraphy in the prognosis of amputation in severe frostbite injuries of the extremities: A retrospective study of 92 severe frostbite injuries. J Hand Surg Am 2000; 25:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/31\">",
"      Aygit AC, Sarikaya A. Imaging of frostbite injury by technetium-99m-sestamibi scintigraphy: a case report. Foot Ankle Int 2002; 23:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/32\">",
"      Barker JR, Haws MJ, Brown RE, et al. Magnetic resonance imaging of severe frostbite injuries. Ann Plast Surg 1997; 38:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/33\">",
"      Biem J, Koehncke N, Classen D, Dosman J. Out of the cold: management of hypothermia and frostbite. CMAJ 2003; 168:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/34\">",
"      Su CW, Lohman R, Gottlieb LJ. Frostbite of the upper extremity. Hand Clin 2000; 16:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/35\">",
"      Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma 2005; 59:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/36\">",
"      Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg 2007; 142:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/37\">",
"      Saemi AM, Johnson JM, Morris CS. Treatment of bilateral hand frostbite using transcatheter arterial thrombolysis after papaverine infusion. Cardiovasc Intervent Radiol 2009; 32:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/38\">",
"      Chan TY, Smedley FH. Tetanus complicating frostbite. Injury 1990; 21:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/39\">",
"      McCauley RL, Heggers JP, Robson MC. Frostbite. Methods to minimize tissue loss. Postgrad Med 1990; 88:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/40\">",
"      Finderle Z, Cankar K. Delayed treatment of frostbite injury with hyperbaric oxygen therapy: a case report. Aviat Space Environ Med 2002; 73:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/41\">",
"      von Heimburg D, Noah EM, Sieckmann UP, Pallua N. Hyperbaric oxygen treatment in deep frostbite of both hands in a boy. Burns 2001; 27:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/42\">",
"      Hayes DW Jr, Mandracchia VJ, Considine C, Webb GE. Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite. Clin Podiatr Med Surg 2000; 17:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/43\">",
"      Purkayastha SS, Bhaumik G, Chauhan SK, et al. Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin &amp; vitamin C. Indian J Med Res 2002; 116:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/44\">",
"      Miller MB, Koltai PJ. Treatment of experimental frostbite with pentoxifylline and aloe vera cream. Arch Otolaryngol Head Neck Surg 1995; 121:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/45\">",
"      Chandran GJ, Chung B, Lalonde J, Lalonde DH. The hyperthermic effect of a distal volar forearm nerve block: a possible treatment of acute digital frostbite injuries? Plast Reconstr Surg 2010; 126:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/46\">",
"      Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med 2011; 364:189.",
"     </a>",
"    </li>",
"    <li>",
"     Thomas JR, Oakley HN. Nonfreezing cold injury. In: Medial Aspects of Harsh Environments, Pandolf KB, Burr RE.  (Eds), Office of the Surgeon General, Falls Church 2001. p.467.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/48\">",
"      Ervasti O, Hassi J, Rintam&auml;ki H, et al. Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses. Int J Circumpolar Health 2000; 59:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/49\">",
"      Castellani JW, Young AJ, Ducharme MB, et al. American College of Sports Medicine position stand: prevention of cold injuries during exercise. Med Sci Sports Exerc 2006; 38:2012.",
"     </a>",
"    </li>",
"    <li>",
"     www.weather.gov/om/windchill (Accessed on September 20, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/51\">",
"      Lehmuskallio E. Emollients in the prevention of frostbite. Int J Circumpolar Health 2000; 59:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/52\">",
"      Lehmuskallio E. Cold protecting ointments and frostbite. A questionnaire study of 830 conscripts in Finland. Acta Derm Venereol 1999; 79:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37671/abstract/53\">",
"      Lehmuskallio E, Rintam&auml;ki H, Anttonen H. Thermal effects of emollients on facial skin in the cold. Acta Derm Venereol 2000; 80:203.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 179 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-382E3F64B8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37671=[""].join("\n");
var outline_f36_50_37671=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prehospital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hospital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19125051\">",
"      Hyperbaric oxygen and other unproven therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H94242346\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=related_link\">",
"      Accidental hypothermia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/43/1721?source=related_link\">",
"      Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5448?source=related_link\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/26/6570?source=related_link\">",
"      Intravenous fibrinolytic (thrombolytic) therapy in acute ischemic stroke: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/21/32090?source=related_link\">",
"      Medical management of claudication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?30/53/31569?source=related_link\">",
"      Patient information: Frostbite (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37672="Pathogenesis, clinical features, and diagnosis of erythema multiforme";
var content_f36_50_37672=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis, clinical features, and diagnosis of erythema multiforme",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     David A Wetter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37672/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/50/37672/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythema multiforme (EM) is an acute, immune-mediated condition characterized by the appearance of distinctive target-like lesions on the skin. These lesions are often accompanied by erosions or bullae involving the oral, genital,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ocular mucosae. Erythema multiforme major is the term used to describe EM with mucosal involvement; erythema multiforme minor refers to EM without mucosal disease.",
"   </p>",
"   <p>",
"    A variety of factors have been implicated in the pathogenesis of EM. The disorder is most commonly induced by infection, with herpes simplex virus being the most frequent precipitator. The clinical course of EM is usually self-limited, resolving within weeks without significant sequelae. However, in a minority of cases, the disease recurs frequently over the course of years.",
"   </p>",
"   <p>",
"    Similarities in clinical and histopathologic findings have led to controversy over the distinction between EM and Stevens-Johnson syndrome (SJS), an often drug-induced disorder that may present with cutaneous targetoid lesions and mucosal erosions. However, there is suggestive evidence that EM with mucous membrane involvement and SJS are different diseases with distinct causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/1\">",
"     1",
"    </a>",
"    ]. The term erythema multiforme major should",
"    <strong>",
"     not",
"    </strong>",
"    be used to refer to SJS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link&amp;anchor=H25#H25\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\", section on 'Nosologic controversies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical features, evaluation, and diagnosis of acute and recurrent EM will be reviewed here. The treatment of EM and similar issues related to SJS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41334?source=see_link\">",
"     \"Treatment of erythema multiforme\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The annual incidence of EM is unknown, although it is estimated to be far less than 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"     2",
"    </a>",
"    ]. EM most frequently occurs in young adults between the ages of 20 and 40 and exhibits a slight male predominance. Children and older adults can also be affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many factors, including infections, medications, malignancy, autoimmune disease, immunizations, radiation, sarcoidosis, and menstruation have been linked to the development of EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"     2",
"    </a>",
"    ]. Infections (viral, bacterial, or fungal) account for approximately 90 percent of cases, with HSV as the most commonly identified precipitant (",
"    <a class=\"graphic graphic_table graphicRef64893 \" href=\"mobipreview.htm?9/37/9820\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,4-6\">",
"     2,4-6",
"    </a>",
"    ]. Mycoplasma pneumoniae infection is another important cause of EM, particularly in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,7\">",
"     2,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In less than 10 percent of cases, drugs induce EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/4\">",
"     4",
"    </a>",
"    ]. A wide variety of medications have been associated with the eruption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"     2",
"    </a>",
"    ]. The most common precipitators include NSAIDs, sulfonamides, antiepileptics, and antibiotics (",
"    <a class=\"graphic graphic_table graphicRef64893 \" href=\"mobipreview.htm?9/37/9820\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the available data on the pathogenesis of this disorder have been derived from studies investigating HSV-associated EM. The development of EM secondary to HSV infection is thought to involve a cell-mediated immune process directed against viral antigens deposited in lesional skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/8\">",
"     8",
"    </a>",
"    ]. The detection of HSV DNA in skin biopsy specimens from patients with EM supports this theory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/8-13\">",
"     8-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following mechanism has been proposed for the development of mucocutaneous lesions in the setting of HSV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Virus released into the blood during reactivation of HSV infection is phagocytosed by circulating peripheral blood mononuclear cells, particularly Langerhans cells.",
"     </li>",
"     <li>",
"      Langerhans cells containing HSV travel to the epidermis, where they transfer viral DNA fragments to epidermal keratinocytes. The migration of Langerhans cells to the epidermis is facilitated by virus-induced upregulation of E-cadherin expression on Langerhans cells and the presence of adhesion molecules on microvascular endothelial cells.",
"     </li>",
"     <li>",
"      Expression of HSV genes in the skin leads to the recruitment of HSV-specific CD4+ Th1 cells that produce interferon (IFN) gamma in response to viral antigens.",
"     </li>",
"     <li>",
"      The release of IFN-gamma initiates an inflammatory cascade that promotes the lysis of HSV-infected keratinocytes and the recruitment of autoreactive T-cells. These events lead to the epidermal damage and the inflammatory infiltrate that characterize cutaneous lesions of EM.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unclear whether a similar pathway is responsible for the development of EM related to other inciting agents. In drug-induced EM, the presence of tumor necrosis factor (TNF) alpha rather than IFN-gamma correlates with the development of skin lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/15\">",
"     15",
"    </a>",
"    ]. However, EM has occurred in the setting of TNF-alpha inhibitor therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EM does not occur in most people infected with HSV, and does not appear with every recurrence of HSV infection among individuals with a history of HSV-associated EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17\">",
"     17",
"    </a>",
"    ]. The reason for this is unknown. It is postulated that a variety of factors may influence the development of EM, such as the presence of a key peripheral blood mononuclear cell subset, differences in the processing of viral DNA by phagocytic cells, variation in the specific viral proteins expressed in the skin, or the presence of other factors that affect the development of the autoreactive immune response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genetic susceptibility may play a role in the preferential development of EM. In a study of 35 patients with EM and 80 controls, the HLA-DQB1*0301 allele was detected more frequently in patients with erythema multiforme than in the control population (66 versus 31 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/18\">",
"     18",
"    </a>",
"    ]. The strongest association with the allele was found among patients with herpes-associated EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/18\">",
"     18",
"    </a>",
"    ]. Associations with HLA types Aw33, DRw53, B15(62), B35, and DQ3 have also been reported; however, the relationship of Aw33 and DQ3 to EM has been questioned [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cutaneous features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"multiforme\" describes the myriad clinical manifestations that may be observed. Though most lesions appear similar in a particular patient at a given time, the morphology of EM lesions may vary between patients and also may evolve over the course of the disease in a single patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,20\">",
"     2,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appearance &mdash; Target lesions are the hallmark of the disorder, although they may not always be present. Initial lesions may begin as round erythematous papules that evolve into classic target lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/3\">",
"       3",
"      </a>",
"      ]. Typical target lesions consist of three components: a dusky central area or blister, a dark red inflammatory zone surrounded by a pale ring of edema, and an erythematous halo on the extreme periphery of the lesion (",
"      <a class=\"graphic graphic_picture graphicRef68640 \" href=\"mobipreview.htm?9/16/9478\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef79955 \" href=\"mobipreview.htm?18/53/19283\">",
"       picture 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/3,20\">",
"       3,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Atypical target lesions may also occur in patients with EM. These manifest as raised, edematous, palpable lesions with only two zones of color change",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a poorly defined border (",
"    <a class=\"graphic graphic_picture graphicRef79955 \" href=\"mobipreview.htm?18/53/19283\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Distribution &mdash; Cutaneous lesions most commonly appear in a symmetrical distribution on the extensor surfaces of the acral extremities, and subsequently spread in a centripetal manner (",
"      <a class=\"graphic graphic_picture graphicRef62370 graphicRef72055 graphicRef65570 graphicRef80715 graphicRef57894 graphicRef54232 \" href=\"mobipreview.htm?41/56/42890\">",
"       picture 3A-F",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"       2",
"      </a>",
"      ]. The face, neck, palms, soles, flexural surfaces of the extremities,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      trunk may also be involved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. Although cutaneous lesions are usually asymptomatic, some patients may experience itching and burning [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    EM may also occur at sites of physical trauma and sunburn, thus displaying the isomorphic (Koebner) phenomenon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Other features that may be observed in EM include erythema and swelling of the nail folds and clusters of lesions on and around the elbows and knees (",
"    <a class=\"graphic graphic_picture graphicRef76649 \" href=\"mobipreview.htm?0/43/690\">",
"     picture 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mucous membrane involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucous membrane involvement usually occurs in association with cutaneous lesions. Infrequently, EM may present with mucous membrane lesions alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/22\">",
"     22",
"    </a>",
"    ]. Lesions can involve the oral, ocular,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genital mucosa, and commonly manifest as diffuse areas of mucosal erythema, painful erosions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bullae.",
"   </p>",
"   <p>",
"    Oral involvement occurs most commonly, and can affect up to 70 percent of patients with EM (",
"    <a class=\"graphic graphic_picture graphicRef68153 graphicRef58969 \" href=\"mobipreview.htm?18/31/18936\">",
"     picture 5A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17,23,24\">",
"     17,23,24",
"    </a>",
"    ]. Lesions tend to affect the vermilion lip and mucosal surfaces, including the buccal mucosa, labial mucosa, non-attached gingiva, and tongue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Rarely, involvement can extend to the pharynx and upper respiratory tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mucosal lesions in other sites are less common; in one series of 65 patients with recurrent EM, 25 percent had genital lesions and 17 percent had ocular involvement (",
"    <a class=\"graphic graphic_picture graphicRef75314 \" href=\"mobipreview.htm?13/51/14131\">",
"     picture 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Systemic symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prodromal symptoms (eg, fever, malaise, myalgias) are uncommon in mild cases of EM but can be seen in cases with significant mucosal involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"     2",
"    </a>",
"    ]. Cough and respiratory symptoms may be present in patients with EM related to M. pneumoniae infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;EM lesions usually appear over the course of three to five days and resolve within approximately two weeks. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/3\">",
"     3",
"    </a>",
"    ]. Although the skin lesions do not scar, postinflammatory hyperpigmentation may remain for months after resolution, particularly in patients with dark skin.",
"   </p>",
"   <p>",
"    Infrequently, ocular involvement can lead to keratitis, conjunctival scarring, and visual impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Esophagitis and upper airway involvement leading to pneumonia have rarely been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In HSV-associated EM, the eruption usually occurs 2 to 17 days after an episode of herpes simplex (mean interval is eight days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17\">",
"     17",
"    </a>",
"    ]. EM can also be induced by asymptomatic subclinical recurrences of HSV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17,20\">",
"     17,20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Recurrent EM'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory findings are not specific for EM. In severe cases, elevations of the erythrocyte sedimentation rate, white blood cell count, and liver enzymes may be detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2,3,20\">",
"     2,3,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RECURRENT EM",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subset of patients with EM experience frequent episodes over many years leading to substantial morbidity, a condition termed recurrent EM. Studies of patients with this disorder found average rates of recurrence of six episodes per year, with mean durations of disease ranging from 6 to 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17,23\">",
"     17,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to isolated episodes of EM, recurrent EM has been linked to a variety of inciting factors. Recurrent EM can occur in association with HSV infection, and some studies have estimated that 61 to 100 percent of cases are due to HSV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17,22-24,27-29\">",
"     17,22-24,27-29",
"    </a>",
"    ]. However, in one series of 48 patients with recurrent disease, a clear relationship to HSV was detected in only 23 percent of subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23\">",
"     23",
"    </a>",
"    ]. Other conditions reported to occur in association with recurrent EM have included repeated M. pneumoniae infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23,30\">",
"     23,30",
"    </a>",
"    ], hepatitis C [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23,31,32\">",
"     23,31,32",
"    </a>",
"    ], vulvovaginal candidiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23\">",
"     23",
"    </a>",
"    ], menses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17\">",
"     17",
"    </a>",
"    ], complex aphthosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23\">",
"     23",
"    </a>",
"    ], polymorphic light eruption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/33\">",
"     33",
"    </a>",
"    ], and ingestion of benzoic acid, a preservative in food [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cause of recurrent EM may be unclear in up to 60 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23\">",
"     23",
"    </a>",
"    ], and there is evidence that some cases classified as idiopathic EM may be related to subclinical HSV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. One study utilizing polymerase chain reaction (PCR) on lesional skin biopsy specimens from patients with recurrent EM found that HSV DNA was detected in 6 out of 12 specimens from patients with idiopathic recurrent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/11\">",
"     11",
"    </a>",
"    ]. Another study found similar results; HSV DNA was detected in three out of five patients with idiopathic recurrent EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PERSISTENT EM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent erythema multiforme is a rare variant of EM characterized by the uninterrupted occurrence of typical and atypical EM lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/34-37\">",
"     34-37",
"    </a>",
"    ]. Cutaneous lesions are often widespread and papulonecrotic or bullous; mucosal lesions may or may not be present. Laboratory abnormalities including hypocomplementemia and circulating immune complexes also can occur, but are not found in all affected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent EM has been reported in association with viral infections such as HSV, EBV, hepatitis C, and influenza, as well as inflammatory bowel disease and malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/36\">",
"     36",
"    </a>",
"    ]. The disorder may continue for longer than one year without therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin biopsy can assist with the exclusion of other disorders that may present with clinical features that resemble EM. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Pathologic findings in EM typically include basal cell vacuolar degeneration, scattered necrotic keratinocytes, and lymphocyte exocytosis (",
"    <a class=\"graphic graphic_picture graphicRef56873 \" href=\"mobipreview.htm?37/44/38599\">",
"     picture 7",
"    </a>",
"    ). A dense superficial dermal lymphohistiocytic infiltrate surrounding blood vessels and the dermoepidermal junction is also present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Papillary dermal edema and red blood cell extravasation may be evident, particularly in early lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Subepidermal clefting and vesiculation, the results of extensive basal cell vacuolar degeneration, are present in some specimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The site of the biopsy within an EM lesion can influence the histopathologic findings. While specimens from the dusky central portions of lesions may reveal subepidermal separation with necrotic keratinocytes, biopsies from the peripheral portions often show predominantly dermal changes, such as papillary dermal edema, vascular dilation, and a perivascular mononuclear cell infiltrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mucous membrane lesions in EM demonstrate similar histologic features to those observed in cutaneous lesions. Additionally, more prominent spongiosis and intracellular edema and vesiculation may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on direct immunofluorescence microscopy are usually non-specific. One study found granular deposits of C3 and IgM at the dermoepidermal junction and around superficial dermal blood vessels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/38\">",
"     38",
"    </a>",
"    ]. In addition, fibrin was detected around dermal blood vessels and in a band-like distribution at the dermoepidermal junction in regions of necrosis or blister formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history of the eruption and clinical findings provide the most important information for the diagnosis of EM. Patients should be asked about signs or symptoms of HSV, M. pneumoniae, or other infections, as well as new medications and systemic symptoms. Skin biopsy and laboratory studies may help to confirm the diagnosis when necessary and may assist with determining the inciting factor in cases consistent with EM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the diagnosis is in question, a skin biopsy should be performed to exclude other disorders. If the differential diagnosis includes autoimmune bullous diseases such as pemphigus or pemphigoid, direct immunofluorescence studies should be performed on a second biopsy specimen taken from unaffected skin adjacent to a lesion. Blood tests for indirect immunofluorescence may also be useful for the diagnosis of autoimmune blistering disease. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Histopathology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=see_link&amp;anchor=H20007006#H20007006\">",
"     \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of pemphigus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     HSV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSV is the most common cause of erythema multiforme, and the possibility of HSV-induced disease should be considered in all patients. A careful history and clinical exam should be performed to identify signs or symptoms of a recent HSV eruption. If lesions concerning for active HSV infection remain, sampling of lesions for direct fluorescent antibody, viral culture, Tzanck smear, or PCR studies are useful to confirm the presence of the virus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=see_link\">",
"     \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with recurrent disease for whom history and clinical examination do not support a clear relationship to HSV, serologic tests should be performed. Serologic testing for HSV will help to exclude HSV-associated EM when negative; however, antibody titers are not useful for detecting episodes of recurrent disease. If a skin biopsy is performed, molecular testing (PCR or in-situ hybridization) for HSV on skin biopsy specimens can be utilized to confirm a diagnosis of HSV-associated EM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     M. pneumoniae infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who present with respiratory symptoms, serologic tests for M. pneumoniae can help to confirm a diagnosis of M. pneumoniae-related EM. PCR techniques have also been used in the diagnosis of M. pneumoniae infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/5/3162?source=see_link&amp;anchor=H16#H16\">",
"     \"Mycoplasma pneumoniae infection in adults\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=see_link&amp;anchor=H15#H15\">",
"     \"Mycoplasma pneumoniae infection in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe EM in whom oral intake may be compromised should be assessed for fluid and electrolyte abnormalities. As mentioned above, the erythrocyte sedimentation rate, white blood cell count, and hepatic transaminases may be elevated in patients with severe EM. Cutaneous lesions with signs concerning for secondary infection should be cultured and treated as appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The identification of typical target lesions with three color zones is a hallmark for the diagnosis of EM. However, classic target lesions may be few in number, and a variety of disorders may present with mucocutaneous lesions that resemble the other manifestations of EM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/4,41\">",
"     4,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urticaria &mdash; Urticaria presents as erythematous, edematous plaques that lack the central dusky, bullous, or crusted zones that are typical for lesions of EM. Individual lesions are transient, lasting less than 24 hours. Unlike EM, in which all lesions appear within the first 72 hours of the disorder, new lesions of urticaria continuously appear. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21898?source=see_link\">",
"       \"New onset urticaria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Stevens-Johnson syndrome &mdash; Both Stevens-Johnson syndrome and EM may present with mucosal erosions and atypical target lesions on the skin. The atypical target lesions of Stevens-Johnson syndrome tend to be macular, rather than the papular lesions associated with EM. Unlike EM, medication is the most frequent cause of Stevens-Johnson syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"       \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fixed drug eruption &mdash; Fixed drug eruptions are characterized by single or multiple, dusky erythematous plaques with or without central bullae or necrosis. In some cases, the clinical and histologic features of a generalized fixed drug eruption are difficult to differentiate from EM. Fixed drug eruption typically has fewer lesions present at the time of first outbreak [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/4\">",
"       4",
"      </a>",
"      ]. A thorough medication history also may assist with the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link&amp;anchor=H11#H11\">",
"       \"Drug eruptions\", section on 'Fixed drug eruption'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pemphigoid &mdash; Bullous pemphigoid is a chronic autoimmune blistering disorder that can present with urticarial, erythematous plaques and tense bullae, with or without mucosal involvement. Typical target lesions and the dusky erythema associated with epidermal necrosis in EM are extremely rare. A biopsy taken directly from a lesion for routine processing and a second biopsy taken from adjacent skin for direct immunofluorescence studies can distinguish this disorder from EM. Indirect immunofluorescence studies can also aid in the distinction between bullous pemphigoid and EM. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=see_link\">",
"       \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Paraneoplastic pemphigus &mdash; Paraneoplastic pemphigus can present with polymorphous skin lesions (including lesions reminiscent of EM) and mucosal erosions. Skin biopsy, direct immunofluorescence microscopy, and indirect immunofluorescence studies aid in the differentiation of paraneoplastic pemphigus from EM. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/44/18121?source=see_link\">",
"       \"Paraneoplastic pemphigus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sweet syndrome &mdash; Sweet syndrome (also known as acute febrile neutrophilic dermatosis) may present with edematous, erythematous plaques reminiscent of EM. Routine histopathology demonstrating a predominantly neutrophilic infiltrate easily distinguishes Sweet syndrome from EM. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40905?source=see_link\">",
"       \"Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rowell syndrome &mdash; Rowell syndrome describes the occurrence of EM-like lesions in patients with cutaneous lesions of lupus erythematosus. These patients frequently have a positive antinuclear antibody (speckled pattern) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/42,43\">",
"       42,43",
"      </a>",
"      ]. Histopathologic and serologic findings can help differentiate this process from EM.",
"     </li>",
"     <li>",
"      Polymorphous light eruption &mdash; Pediatric cases of HSV-induced EM that clinically and histopathologically resemble the photodistributed erythematous papules, plaques, and bullae of polymorphous light eruption and juvenile spring eruption have been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. A history of herpetic lesions preceding the eruption are clues to the diagnosis of EM. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/62/20455?source=see_link\">",
"       \"Polymorphous light eruption\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Oral EM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of patients with oral EM includes paraneoplastic pemphigus, pemphigus vulgaris, mucous membrane pemphigoid, oral lichen planus, and complex aphthosis, all of which can present with oral erosions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37672/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In contrast to these chronic conditions, the course of EM is typically self-limited. However, the possibility of these other disorders should be considered in patients with frequently recurring disease. Biopsies with direct immunofluorescence studies are useful for establishing the diagnosis. Indirect immunofluorescence studies on serum can also be performed to evaluate for specific autoimmune blistering diseases. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Histopathology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=see_link\">",
"     \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of pemphigus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/3/21553?source=see_link\">",
"       \"Patient information: Erythema multiforme (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Erythema multiforme (EM) is an uncommon, immune-mediated disorder that presents with cutaneous",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mucosal lesions. EM most frequently affects young adults, but may occur at any age. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      EM can be induced by a variety of factors. Infections are the most common causes of EM; herpes simplex virus is the most frequent etiologic agent. Less than 10 percent of cases of EM are associated with medications. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of HSV-induced EM is thought to involve a cell-mediated immune process directed against viral antigens deposited in lesional skin. Genetic susceptibility may also play a role in the development of the disorder. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The target lesion is a characteristic finding in EM, although not present in all patients. Target lesions consist of three concentric zones of color change: a central dusky or blistered area, a dark red inflammatory zone surrounded by a pale ring of edema, and a peripheral erythematous halo. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Cutaneous features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cutaneous lesions frequently begin on the extensor acral extremities, and may spread centripetally to other areas. Lesions are usually asymptomatic, although some patients may note pruritus or a burning sensation. EM may also involve mucosal surfaces, presenting as painful erythematous patches, erosions, or bullae. EM resolves in approximately two weeks. Some patients with EM may experience frequently recurring disease.(See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Recurrent EM'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of acute erythema multiforme typically is based upon the patient's history and clinical findings. When the diagnosis is uncertain, skin biopsies are useful for establishing the diagnosis. Direct immunofluorescence studies are usually indicated to exclude the possibility of autoimmune blistering disease. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HSV infection is the most common cause of erythema multiforme, and the possibility of HSV-induced disease should be considered in all patients. Serologic testing is useful for excluding HSV-associated EM when negative. However, it cannot identify a recurrent episode of HSV infection. Where available, HSV detected in skin biopsy specimens can also be used to confirm HSV-induced disease. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/1\">",
"      Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/2\">",
"      Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983; 8:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/3\">",
"      Huff JC. Erythema multiforme. Dermatol Clin 1985; 3:141.",
"     </a>",
"    </li>",
"    <li>",
"     French, LE, Prins, C. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Dermatology, Bolognia, JL, Jorizzo, JL, Rapini, RP (Eds), Elsevier Limited, United States 2008. p.287.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/5\">",
"      Weston WL, Brice SL, Jester JD, et al. Herpes simplex virus in childhood erythema multiforme. Pediatrics 1992; 89:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/6\">",
"      Weston WL. Herpes-associated erythema multiforme. J Invest Dermatol 2005; 124:xv.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/7\">",
"      Schalock PC, Dinulos JG, Pace N, et al. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006; 23:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/8\">",
"      Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989; 93:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/9\">",
"      Brice SL, Leahy MA, Ong L, et al. Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme. J Cutan Pathol 1994; 21:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/10\">",
"      Miura S, Smith CC, Burnett JW, Aurelian L. Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol 1992; 98:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/11\">",
"      Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology 2003; 207:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/12\">",
"      Darragh TM, Egbert BM, Berger TG, Yen TS. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 1991; 24:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/13\">",
"      Aslanzadeh J, Helm KF, Espy MJ, et al. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol 1992; 126:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/14\">",
"      Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 2005; 124:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/15\">",
"      Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/16\">",
"      Ahdout J, Haley JC, Chiu MW. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis. J Am Acad Dermatol 2010; 62:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/17\">",
"      Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/18\">",
"      Khalil I, Lepage V, Douay C, et al. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. J Invest Dermatol 1991; 97:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/19\">",
"      Schofield JK, Tatnall FM, Brown J, et al. Recurrent erythema multiforme: tissue typing in a large series of patients. Br J Dermatol 1994; 131:532.",
"     </a>",
"    </li>",
"    <li>",
"     Roujeau, JC. Erythema multiforme. In: Fitzpatrick's Dermatology in General Medicine, Wolff, K, Goldsmith, LA, Katz, SI, et al (Eds), McGraw-Hill Companies, Inc, United States 2008. p.343.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/21\">",
"      Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/22\">",
"      Bean SF, Quezada RK. Recurrent oral erythema multiforme. Clinical experience with 11 patients. JAMA 1983; 249:2810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/23\">",
"      Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 2010; 62:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/24\">",
"      Farthing PM, Maragou P, Coates M, et al. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med 1995; 24:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/25\">",
"      Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin 2003; 21:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/26\">",
"      Rogers RS 3rd. Pseudo-Beh&ccedil;et's disease. Dermatol Clin 2003; 21:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/27\">",
"      Huff JC, Weston WL. Recurrent erythema multiforme. Medicine (Baltimore) 1989; 68:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/28\">",
"      Leigh IM, Mowbray JF, Levene GM, Sutherland S. Recurrent and continuous erythema multiforme--a clinical and immunological study. Clin Exp Dermatol 1985; 10:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/29\">",
"      Lewis MA, Lamey PJ, Forsyth A, Gall J. Recurrent erythema multiforme: a possible role of foodstuffs. Br Dent J 1989; 166:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/30\">",
"      Grosber M, Alexandre M, Poszepczynska-Guign&eacute; E, et al. Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections. J Am Acad Dermatol 2007; 56:S118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/31\">",
"      Dumas V, Thieulent N, Souillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Br J Dermatol 2000; 142:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/32\">",
"      Geraminejad P, Walling HW, Voigt MD, Stone MS. Severe erythema multiforme responding to interferon alfa. J Am Acad Dermatol 2006; 54:S18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/33\">",
"      Fraser-Andrews EA, Morris-Jones R, Novakovic L, Hawk JL. Erythema multiforme following polymorphic light eruption: a report of two cases. Clin Exp Dermatol 2005; 30:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/34\">",
"      Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995; 33:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/35\">",
"      J Eur Acad Dermatol Venereol. 2001;15(1):54-8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/36\">",
"      Chen CW, Tsai TF, Chen YF, Hung CM. Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol 2008; 9:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/37\">",
"      Wanner M, Pol-Rodriguez M, Hinds G, et al. Persistent erythema multiforme and CMV infection. J Drugs Dermatol 2007; 6:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/38\">",
"      Howland WW, Golitz LE, Weston WL, Huff JC. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol 1984; 10:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/39\">",
"      Ackerman AB, Penneys NS, Clark WH. Erythema multiforme exudativum: distinctive pathological process. Br J Dermatol 1971; 84:554.",
"     </a>",
"    </li>",
"    <li>",
"     McKee, PH. Lichenoid and interface dermatoses. In: Pathology of the skin with clinical correlations, McKee, PH, Calonje, E, Granter, SR (Eds), Elsevier Limited, Philadelphia, PA 2005. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/41\">",
"      Weston JA, Weston WL. The overdiagnosis of erythema multiforme. Pediatrics 1992; 89:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/42\">",
"      Zeitouni NC, Funaro D, Cloutier RA, et al. Redefining Rowell's syndrome. Br J Dermatol 2000; 142:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/43\">",
"      Lee A, Batra P, Furer V, et al. Rowell syndrome (systemic lupus erythematosus + erythema multiforme). Dermatol Online J 2009; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/44\">",
"      Wolf P, Soyer HP, Fink-Puches R, et al. Recurrent post-herpetic erythema multiforme mimicking polymorphic light and juvenile spring eruption: report of two cases in young boys. Br J Dermatol 1994; 131:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37672/abstract/45\">",
"      P&eacute;rez-Carmona L, Va&ntilde;o-Galvan S, Carrillo-Gij&oacute;n R, Ja&eacute;n-Olasolo P. Photosensitive erythema multiforme presenting as juvenile spring eruption. Photodermatol Photoimmunol Photomed 2010; 26:53.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5559 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-99A7E1262A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37672=[""].join("\n");
var outline_f36_50_37672=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cutaneous features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mucous membrane involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Systemic symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RECURRENT EM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PERSISTENT EM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HSV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      M. pneumoniae infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Oral EM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5559\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5559|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/16/9478\" title=\"picture 1\">",
"      Erythema multiforme target",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/53/19283\" title=\"picture 2\">",
"      Erythema multiforme target2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/14/13540\" title=\"picture 3A\">",
"      Erythema multiforme acral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/1/31763\" title=\"picture 3B\">",
"      Erythema multiforme arm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/36/25155\" title=\"picture 3C\">",
"      Erythema multiforme face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/18/15650\" title=\"picture 3D\">",
"      Erythema multiforme palm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/55/14193\" title=\"picture 3E\">",
"      Erythema multiforme extrem",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/60/42944\" title=\"picture 3F\">",
"      Erythema multiforme leg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/43/690\" title=\"picture 4\">",
"      Erythema multiforme elbow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/62/21474\" title=\"picture 5A\">",
"      Erythema multiforme lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/4/9284\" title=\"picture 5B\">",
"      Erythema multiforme tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/51/14131\" title=\"picture 6\">",
"      Erythema multiforme genital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/44/38599\" title=\"picture 7\">",
"      Erythema multiforme path",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5559|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/37/9820\" title=\"table 1\">",
"      Erythema multiforme causes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/5/3162?source=related_link\">",
"      Mycoplasma pneumoniae infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=related_link\">",
"      Mycoplasma pneumoniae infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/24/21898?source=related_link\">",
"      New onset urticaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/44/18121?source=related_link\">",
"      Paraneoplastic pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/3/21553?source=related_link\">",
"      Patient information: Erythema multiforme (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/62/20455?source=related_link\">",
"      Polymorphous light eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/60/40905?source=related_link\">",
"      Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41334?source=related_link\">",
"      Treatment of erythema multiforme",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37673="Management and prognosis of patients requiring prolonged mechanical ventilation";
var content_f36_50_37673=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management and prognosis of patients requiring prolonged mechanical ventilation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Melissa Miller, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     MeiLan King Han, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     R Sean Morrison, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37673/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/50/37673/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged mechanical ventilation (PMV) is defined by the Centers for Medicare and Medicaid Services in the United States as greater than 21 days of mechanical ventilation for at least six hours per day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/1\">",
"     1",
"    </a>",
"    ], although many studies have used an alternative duration to define PMV. It is estimated that between 4 and 13 percent of mechanically ventilated patients require PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], resulting in between 7250 and 11,400 patients undergoing PMV at any one time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/2\">",
"     2",
"    </a>",
"    ]. PMV is associated with increased health care cost, morbidity, and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to PMV are reviewed here, including predictors, weaning, complications, and outcomes. Issues related to the evaluation and management of patients who are difficult to wean from mechanical ventilation, as well as the selection of such patients for transfer to a long-term acute care facility where prolonged mechanical ventilation usually occurs, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9176?source=see_link\">",
"     \"Management of the difficult-to-wean patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREDICTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prediction of which patients will require PMV is discussed here, whereas prediction of successful liberation from mechanical ventilation is described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21112?source=see_link\">",
"     \"Weaning from mechanical ventilation: Readiness testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no evidence-based predictors that can reliably identify patients who will require PMV. Studies have sought to identify such predictors, but their results are difficult to generalize because they examined varying durations of mechanical ventilation and specific patient populations. In addition, attempts to validate potential predictors have found poor sensitivity and specificity.",
"   </p>",
"   <p>",
"    One of the few studies examining general medical and surgical intensive care unit (ICU) patients prospectively followed 5915 patients that required mechanical ventilation on the first day of their ICU admission. The relative contribution of various patient- and disease-related variables to the duration of mechanical ventilation was identified. The following variables were reported as being associated with an increased duration of mechanical ventilation, with their relative contribution shown in parentheses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ICU admission due to pneumonia, acute respiratory distress syndrome (ARDS), neuromuscular disease, head trauma, or postoperative intracerebral hemorrhage (44.3 percent).",
"     </li>",
"     <li>",
"      Elevated Acute Physiology Score (APS) of the Acute Physiologic and Chronic Health Evaluation III (APACHE III) on the first day in the ICU (25 percent). The average duration of ventilation increased linearly with APS scores up to 75, but then declined with APS scores above 75 due to early mortality.",
"     </li>",
"     <li>",
"      Admission to the ICU from another ICU, another hospital, or the medical ward (6.1 percent). In contrast, admission from the operating room or recovery room was associated with a shorter duration of mechanical ventilation.",
"     </li>",
"     <li>",
"      Abnormal arterial carbon dioxide (PaCO",
"      <sub>",
"       2",
"      </sub>",
"      ), serum blood urea nitrogen (BUN), serum creatinine, arterial pH, white blood cell count (WBC), or body temperature (4.8 percent) on the first day in the ICU.",
"     </li>",
"     <li>",
"      Extended inpatient length of stay prior to ICU admission (4.3 percent).",
"     </li>",
"     <li>",
"      Elevated respiratory rate on the first day in the ICU (3.5 percent).",
"     </li>",
"     <li>",
"      Admission to a large teaching hospital (3.4 percent).",
"     </li>",
"     <li>",
"      Low serum albumin on the first day in the ICU (2.9 percent).",
"     </li>",
"     <li>",
"      History of obstructive or restrictive lung disease (2.4 percent).",
"     </li>",
"     <li>",
"      Decreased ratio of arterial oxygen to fraction of inspired oxygen",
"      <span class=\"nowrap\">",
"       (PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"       )",
"      </span>",
"      on the first day in the ICU (2 percent). The average duration of mechanical ventilation increased as the",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      ratio fell to 150 mmHg and then declined due to early mortality.",
"     </li>",
"     <li>",
"      Advanced age (1.1 percent). Average duration of mechanical ventilation increased with age up to 85 years and then declined due to early mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The development of critical illness polyneuropathy (CIP) appears to be a predictor of PMV. This was illustrated by an observational study of 64 patients deemed ready to wean from mechanical ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/5\">",
"     5",
"    </a>",
"    ]. The patients with confirmed CIP required mechanical ventilation for a longer duration than patients without CIP (median of 34 versus 14 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/5\">",
"     5",
"    </a>",
"    ]. The relationship between CIP and duration of mechanical ventilation persisted after adjustment for potential confounders (odds ratio 15.5, 95% CI, 4.55-52.3).",
"   </p>",
"   <p>",
"    It is likely that peripheral weakness also predicts the duration of mechanical ventilation because it is a marker of respiratory muscle weakness. In an observational study of 116 patients who were mechanically ventilated for seven days or more, the Medical Research Council (MRC) muscle strength score correlated with the maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP) and vital capacity (VC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/60/43976?source=see_link\">",
"     \"Neuromuscular weakness related to critical illness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/18/11560?source=see_link\">",
"     \"Tests of respiratory muscle strength\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The imbalance created by an increased respiratory load and decreased respiratory muscle performance appears to be responsible for most cases of prolonged ventilatory dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased respiratory muscle load was demonstrated by a study of 31 mechanically ventilated patients with COPD who had their respiratory mechanics evaluated before and during a trial of spontaneous breathing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/7\">",
"       7",
"      </a>",
"      ]. Seventeen patients failed the spontaneous breathing trial (SBT) and returned to mechanical ventilation while 14 patients tolerated the trial and were successfully extubated. The group that failed the SBT had larger absolute increases in dynamic lung elastance, intrinsic positive end expiratory pressure (auto-PEEP), and inspiratory resistance during the SBT, findings suggestive of an increased respiratory muscle load.",
"     </li>",
"     <li>",
"      Decreased respiratory muscle performance was illustrated by a study of 31 ventilator dependent patients who had their respiratory mechanics evaluated during spontaneous breathing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/9\">",
"       9",
"      </a>",
"      ]. The patients had an increased respiratory drive (indicated by a decrease in the airway opening pressure at 0.1 s) and decreased respiratory muscle strength (indicated by a diminished maximum transdiaphragmatic pressure), findings suggestive of decreased respiratory muscle performance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been suggested that PMV itself may contribute to decreased respiratory muscle performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/10\">",
"     10",
"    </a>",
"    ], a hypothesis that is largely based upon evidence that short-term mechanical ventilation may induce respiratory muscle and diaphragmatic weakness. The degree to which this observation applies to patients undergoing PMV is unknown. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26119?source=see_link&amp;anchor=H13#H13\">",
"     \"Physiologic and pathophysiologic consequences of mechanical ventilation\", section on 'Diaphragm'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26119?source=see_link&amp;anchor=H14#H14\">",
"     \"Physiologic and pathophysiologic consequences of mechanical ventilation\", section on 'Respiratory muscles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Decreased central respiratory drive (ie, due to medications or CNS disease) is often considered a potential contributor to prolonged ventilatory dependence, but the evidence suggests that this is an infrequent cause of PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], since most patients who fail to wean actually have an increased central respiratory drive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H208898631\">",
"    <span class=\"h1\">",
"     ASSESSING PATIENT GOALS AND PREFERENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who are unable to wean from invasive ventilation within one to three weeks of intubation, the next step is usually consideration of tracheostomy and transfer to a long-term assisted care (LTAC) facility. When approaching these decisions, we meet with the patient to review their current medical status, the likelihood of eventual weaning, and expected quality and duration of life should they remain ventilator dependent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/11\">",
"     11",
"    </a>",
"    ]. If the patient is not able to participate in decision making, we meet with their designated decision-maker, or in the absence of a patient designated decision-maker, with the patient&rsquo;s family. These discussions focus on the patient&rsquo;s goals and preferences for medical care in the context of expected outcomes of PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/12\">",
"     12",
"    </a>",
"    ]. When ICU interventions are unlikely to accomplish the patient's goals, it is appropriate to raise the issue of transitioning to palliative care. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/40/12938?source=see_link\">",
"     \"Communication in the ICU: Holding a family meeting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/17/19735?source=see_link\">",
"     \"Communication of prognosis in palliative care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=see_link\">",
"     \"Ethical issues near the end of life\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32887?source=see_link\">",
"     \"Ethics in the intensive care unit: Withholding and withdrawing life-support\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H208898657\">",
"    <span class=\"h1\">",
"     TRACHEOSTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who choose to continue with PMV will have a tracheostomy placed to facilitate comfort, communication, and transfer to a weaning facility. The timing, techniques, and outcomes of tracheostomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=see_link\">",
"     \"Overview of tracheostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     WEANING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged ventilator dependence signifies either incomplete resolution of the illness that precipitated mechanical ventilation or the development of new problems. More than one factor is often responsible for weaning failure. This section describes the optimization of patients requiring PMV for weaning, as well as strategies for weaning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Optimization for weaning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to weaning a patient who has required PMV, all potential causes of ventilator dependence should be identified and either corrected or optimized. In addition, factors that might not be the cause of the patient's respiratory failure, but could impair the weaning process, should be identified and managed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9176?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of the difficult-to-wean patient\", section on 'Identify and correct the cause'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure or ischemia can be induced by reduction of ventilatory support and cause weaning failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/13-17\">",
"     13-17",
"    </a>",
"    ]. This was illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ninety-three patients underwent continuous ST-segment monitoring while weaning from mechanical ventilation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/16\">",
"       16",
"      </a>",
"      ]. Myocardial ischemia was identified in six patients. Those patients with myocardial ischemia were more likely to fail weaning than those without (4 out of 6 patients versus 32 out of 87 patients).",
"     </li>",
"     <li>",
"      Fifteen mechanically ventilated patients with known cardiac disease failed spontaneous breathing trials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/14\">",
"       14",
"      </a>",
"      ]. During the trials, an increase in the pulmonary artery occlusion pressure (average increase from 8 to 25 mmHg) was noted in every patient. Following diuretic therapy with an average weight loss 0.5 kg, 9 of the 15 patients were successfully liberated from mechanical ventilation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of heart failure and myocardial ischemia are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7018?source=see_link\">",
"     \"Treatment and prognosis of diastolic heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3529?source=see_link\">",
"     \"Overview of the care of patients with stable ischemic heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Metabolic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of electrolyte imbalances can impact weaning from mechanical ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/18-24\">",
"     18-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypophosphatemia, hypomagnesemia, and hypocalcemia have been associated with respiratory muscle weakness. Separate studies have demonstrated marked increase in diaphragmatic strength immediately following repletion, suggesting that the deficiencies impair the contractile properties of the diaphragm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/18-20\">",
"       18-20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severe hypothyroidism and myxedema impair diaphragmatic function and blunt ventilatory responses to hypercapnia and hypoxia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]. They are uncommon (3 percent), but treatable, causes of weaning failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/24\">",
"       24",
"      </a>",
"      ]. In one observational study, nonthyroidal illness syndrome (abnormal thyroid function associated with acute or chronic illness) was an independent risk factor for PMV [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of hypophosphatemia, hypomagnesemia, hypocalcemia, hypothyroidism, and hyperglycemia are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2167?source=see_link\">",
"     \"Diagnosis and treatment of hypophosphatemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/63/11254?source=see_link\">",
"     \"Evaluation and treatment of hypomagnesemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=see_link\">",
"     \"Treatment of hypocalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Sepsis or SIRS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired oxygen uptake is commonly caused by sepsis or systemic inflammatory response syndrome (SIRS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/26\">",
"     26",
"    </a>",
"    ]. As a result, anaerobic metabolism increases and metabolic acidosis develops. The need to compensate for the acidemia increases ventilatory demand and impairs weaning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Psychological fears",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychological factors may be among the most important non-respiratory factors leading to ventilator dependence. Stress can be minimized by frequent communication between the staff, patient, and patient's family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/27\">",
"     27",
"    </a>",
"    ]. Ambulation and environmental stimulation using television, radio, or books improves attitude and long-term outlook [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/28\">",
"     28",
"    </a>",
"    ]. Biofeedback may be helpful in decreasing the weaning time in patients who are having difficulty withdrawing from ventilator support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;During critical illness, protein catabolism leads to decreased respiratory muscle mass, strength, and endurance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/31\">",
"     31",
"    </a>",
"    ]. The purpose of nutrition support is to minimize these effects. There are studies that suggest that some nutrition support may enhance the likelihood of weaning success and other positive outcomes, although this is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13831?source=see_link\">",
"     \"Nutrition support in critically ill patients: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important that the amount of nutrition support be adequate without being excessive:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inadequate nutrition is associated with little to no improvement in clinical outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/32-35\">",
"       32-35",
"      </a>",
"      ], probably because it fails to sufficiently mitigate the loss of respiratory muscle mass, strength, and endurance. Normal hypoxic and hypercapnic ventilatory responses are also impaired [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Conversely, overfeeding with excessive carbohydrates can impair ventilator withdrawal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/32\">",
"       32",
"      </a>",
"      ], presumably by leading to excess carbon dioxide production and an increased ventilatory load on the respiratory muscles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Physical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who require PMV are frequently deconditioned due to prolonged illness and immobility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/37\">",
"     37",
"    </a>",
"    ]. One study randomly assigned 39 patients who required PMV to receive six weeks of physical training or no physical therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/38\">",
"     38",
"    </a>",
"    ]. Compared to baseline, patients who received physical therapy improved their respiratory and extremity muscle strength, functional status, and ventilator-free duration. In contrast, the control group did not improve in any of the outcomes measured.",
"   </p>",
"   <p>",
"    The primary aim of the trial was to evaluate the effect of physical therapy on functional status and not ventilatory status. More data are needed before the role of physical therapy in weaning patients who require PMV can be established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. The physical and psychological benefits of physical therapy have already been established in a wide range of patient care settings; therefore, it is reasonable to expect that these benefits extend to patients who require PMV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications can have a profound impact on a patient's ability to wean from mechanical ventilation. As an example, many drugs suppress central ventilatory drive (eg, central nervous system depressants like opiates, benzodiazepines, or barbiturates) or induce respiratory muscle weakness (eg, paralytics, corticosteroids). A patient's medications should be reviewed prior to weaning. Medications that might impair weaning should be discontinued or titrated to the minimal effective dose, depending on their importance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Weaning strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strategies for the weaning and discontinuation of PMV are summarized here. Strategies for the weaning and discontinuation of mechanical ventilation in patients who received mechanical ventilation for a shorter duration are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14423?source=see_link\">",
"     \"Methods of weaning from mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Guidelines issued by a collective task force organized by the American College of Chest Physicians recommend that weaning be gradual in the patient requiring PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/41\">",
"     41",
"    </a>",
"    ]. The initiation of weaning should be considered when the following criteria are satisfied:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence for reversal of the underlying cause for respiratory failure",
"     </li>",
"     <li>",
"      Adequate oxygenation (eg,",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      ratio &gt;150 to 200 on ventilator settings that include &le;8 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O of PEEP and an FiO",
"      <sub>",
"       2",
"      </sub>",
"      &le;0.5)",
"     </li>",
"     <li>",
"      Adequate pH (eg, &ge;7.25)",
"     </li>",
"     <li>",
"      Hemodynamic stability, defined as the absence of active myocardial ischemia and clinically significant hypotension",
"     </li>",
"     <li>",
"      Ability to initiate an inspiratory effort",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal protocol for weaning in patients who have required PMV is not known. In a randomized trial specific to patients with PMV, patients who received unassisted breathing trials through a tracheostomy collar had a shorter median time to ventilator liberation (15 days [interquartile range (IQR) 8 to 25 days] versus 19 days [IQR 12 to 31 days]), although 6-month and 12-month mortality did not differ [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/42\">",
"     42",
"    </a>",
"    ]. This trial was conducted in a single long-term weaning facility, and further studies at other institutions are needed to determine the generalizability of these findings.",
"   </p>",
"   <p>",
"    Several studies suggest that protocols that stress frequent reassessment have a greater impact on weaning than the method [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/1,43,44\">",
"     1,43,44",
"    </a>",
"    ]. As an example, an observational study evaluated 52 patients requiring PMV who were weaned via a respiratory therapist-driven protocol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/44\">",
"     44",
"    </a>",
"    ]. The protocol advanced patients directly to a one hour spontaneous breathing trial if the rapid shallow breathing index (frequency to tidal volume ratio) was less than 80. Protocol-guided weaning was associated with a shorter median duration of mechanical ventilation compared to historical controls (17 versus 29 days). This suggests that use of a standardized protocol may be more important than the weaning strategy itself. The same investigators later found that a rapid shallow breathing index less than 97 was the most accurate predictor of a successful spontaneous breathing trial in patients with PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21140?source=see_link\">",
"     \"Weaning from mechanical ventilation: The rapid shallow breathing index\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In our clinical practice, once patients can tolerate spontaneous breathing trials, we gradually increase the duration of the daily spontaneous breathing trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/1\">",
"     1",
"    </a>",
"    ]. Criteria used to assess patient tolerance during spontaneous breathing include the respiratory pattern, adequacy of gas exchange, hemodynamic stability, and subjective comfort [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/41\">",
"     41",
"    </a>",
"    ]. Patients who fail spontaneous breathing should be placed on a non-fatiguing, comfortable mode of ventilation and the cause of failure determined and corrected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving PMV suffer similar complications as their counterparts receiving short-term mechanical ventilation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26119?source=see_link\">",
"     \"Physiologic and pathophysiologic consequences of mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies have identified the following as common problems that occur during PMV: infection (eg, bacterial pneumonia, tracheobronchitis, line sepsis, Clostridium difficile colitis, urosepsis), volume overload, tracheal bleeding, ileus, renal failure, pneumothorax, seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Laryngeal edema is also common. In a prospective study of 95 patients undergoing PMV (mean duration 28 days), 37 percent had laryngeal edema (defined as a cuff leak &lt;140 mL) when assessed at the time of tracheostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnosis of pneumonia in patients undergoing PMV is particularly difficult because the airways of these patients are frequently colonized with bacteria. This was illustrated by a study that performed quantitative bronchoalveolar lavage in 14 asymptomatic patients who required PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/50\">",
"     50",
"    </a>",
"    ]. There was growth of at least one organism at &gt;10,000",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    (the generally accepted minimum for diagnosis of ventilator-associated pneumonia) in 29 of the 32 lobes sampled. Thus, the utility of quantitative bronchoscopic culture in patients who require PMV is uncertain and requires further study. Until then, clinicians need to rely more heavily on other indicators of infection.",
"   </p>",
"   <p>",
"    Many patients are transferred from the ICU to a long-term acute care (LTAC) facility for PMV and weaning. Although pneumonia is the most common infectious disease in patients that require PMV, little data exists regarding the epidemiology of ventilator-associated pneumonia in LTAC. Anecdotal evidence suggests that the causative microorganisms are initially the same as those prevalent in the ICU of origin and later the flora prevalent in the LTAC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=see_link\">",
"     \"Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tracheostomy is another source of complications seen in patients receiving PMV. Examples of tracheostomy complications include loss of airway patency due to unplanned decannulation, fistula formation between the trachea and the innominate artery, and obstruction of the tracheal tube can occur due to mucous plugging or the development of granulation tissue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=see_link&amp;anchor=H14#H14\">",
"     \"Overview of tracheostomy\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family members and caregivers tend to be more optimistic than clinicians about the eventual outcomes. This was demonstrated by an observational study of 126 patients requiring PMV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/53\">",
"     53",
"    </a>",
"    ]. The study found that family members and caregivers were more likely than clinicians to expect the patient to be alive (94 versus 43 percent), lack major functional limitations (71 versus 6 percent), and have a good quality of life (83 versus 4 percent) one year later.",
"   </p>",
"   <p>",
"    Estimates of mortality and other clinical outcomes vary considerably for patients undergoing PMV. The variability probably reflects whether the population studied is a general population of patients requiring PMV or a subset of patients selected for their high weaning potential. It may also reflect the transfer practices (from the ICU to a long-term acute care [LTAC] facility) of the hospitals studied, as hospitals that more readily transfer patients from the ICU to an LTAC have been shown to have lower mortality rates and shorter lengths of stay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, overall mortality for these patients is high and, even for the survivors, quality of life is low. It is important that clinicians educate patients and families about these potential outcomes prior to tracheostomy placement and have ongoing discussions with patients regarding overall goals of care. (See",
"    <a class=\"local\" href=\"#H208898631\">",
"     'Assessing patient goals and preferences'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing PMV have a high mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/48,55-59\">",
"     48,55-59",
"    </a>",
"    ]. This was best illustrated by an observational study that followed 1419 mechanically ventilated patients admitted to a ventilator weaning hospital for one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/48\">",
"     48",
"    </a>",
"    ]. One-year mortality was 52 percent. Among these patients, 25 percent died in the weaning hospital and 27 percent died after discharge. Patients were excluded from the study if they were admitted for end-of-life care, terminal weaning, or were deemed incapable of weaning at the time of admission. In a smaller study of 80 patients who were admitted to a respiratory care unit for PMV and survived to discharge, 44 (55 percent) died within one year after discharge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/60\">",
"     60",
"    </a>",
"    ]. Poor skin integrity and chronic irreversible neurologic diseases were associated with increased risk for mortality. Survivors of PMV tend to be those who are younger and spent less time in the ICU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of four variables to predict mortality was evaluated in a prospective cohort study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/62\">",
"     62",
"    </a>",
"    ] and validated in a multicenter trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/63\">",
"     63",
"    </a>",
"    ]. The variables included the need for vasopressors, the need for hemodialysis, the presence of thrombocytopenia, and an age &ge;50 years on the 21st day of mechanical ventilation. The absence of these factors was associated with 15 percent mortality, whereas the presence of three or four factors was associated with a mortality of 97 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Weaning success",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients requiring PMV spend an average of 36 days mechanically ventilated in the ICU and 31 days weaning outside the ICU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/41\">",
"     41",
"    </a>",
"    ]. Some patients require several months to be liberated from mechanical ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/55\">",
"     55",
"    </a>",
"    ]. Unless a patient has respiratory failure due to an irreversible disease process, patients requiring PMV should not be considered permanently ventilator-dependent until at least three months of weaning has failed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective cohort study followed 135 patients admitted to an LTAC facility for PMV and weaning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/64\">",
"     64",
"    </a>",
"    ]. The study found that 73 patients (54 percent) remained dependent on full-time mechanical ventilation, 58 (43 percent) were successfully weaned from mechanical ventilation, and four (3 percent) remained stable with part-time or nocturnal mechanical ventilation. Among the 58 patients who were successfully liberated from mechanical ventilation, 47 (81 percent) were decannulated successfully.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Discharge home",
"    </span>",
"    &nbsp;&mdash;&nbsp;In an observational study of 80 patients requiring PMV (defined in this study as &ge;7 days of mechanical ventilation), the proportion of patients who were home, institutionalized, and deceased at six months were 47, 14, and 39 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/65\">",
"     65",
"    </a>",
"    ]. Three or fewer comorbid conditions and an Acute Physiology Score &le;21 were associated with the best outcomes. In contrast, patients with more comorbid conditions or a slower rate of improvement were least likely to be discharged home within six months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survivors of critical illness have a lower quality-of-life (QOL) than age- and gender-matched controls, particularly patients who require PMV or survive ARDS, trauma, or sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/66\">",
"     66",
"    </a>",
"    ]. However, QOL tends to improve over years.",
"   </p>",
"   <p>",
"    While mortality rates are high, it appears that certain patients are able to regain substantial function. An observational study of 718 patients who required 14 or more days of mechanical ventilation in the ICU revealed that 99 percent of three-year survivors were independent and living at home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/67\">",
"     67",
"    </a>",
"    ]. Only 50 percent reported mild to moderate functional impairment. Another study examined 25 patients discharged from a ventilator rehabilitation unit and demonstrated that PMV had no independent adverse effect on QOL several years later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/68\">",
"     68",
"    </a>",
"    ]. QOL instead appeared to be related to the presence or absence of chronic underlying diseases.",
"   </p>",
"   <p>",
"    Acute respiratory distress syndrome (ARDS) survivors who require PMV have poorer QOL than other ARDS survivors. In a study of 74 patient with ARDS who required PMV (mean duration of ventilation 28 days), neurocognitive sequelae were detected in 77 percent of survivors at discharge and 47 percent of survivors two years later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/69\">",
"     69",
"    </a>",
"    ]. In addition, 25 percent of patients reported moderate to severe depression and anxiety two years after discharge.",
"   </p>",
"   <p>",
"    Approximately 76 percent of patients who survive PMV and tracheostomy indicate that they would have chosen mechanical ventilation if they were able to make the decision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/70\">",
"     70",
"    </a>",
"    ]. But, the responses are influenced by their current health, as well as the financial and emotional burden that their illness had on their family.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9749739\">",
"    <span class=\"h2\">",
"     Psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychiatric disorders are common among patients who are undergoing or previously underwent PMV. In a prospective cohort study of 336 patients transferred to a long-term acute care facility for PMV, 42 percent were diagnosed with depressive disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/71\">",
"     71",
"    </a>",
"    ]. These patients were at higher risk for weaning failure and mortality. In a similar study with 41 patients, 12 percent were diagnosed with post-traumatic stress disorder within the three months following weaning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Resource utilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a growing body of literature examining the costs of caring for patients who require PMV. One cost-effectiveness analysis found that providing PMV costs $55,460 per life-year gained and $82,411 per quality-adjusted life-year gained, compared to withdrawal of ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/73\">",
"     73",
"    </a>",
"    ]. The incremental costs per quality-adjusted life-year gained exceeded $100,000 among those patients who were &ge;68 years old or whose predicted one year mortality was &gt;50 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26087?source=see_link\">",
"     \"A short primer on cost-effectiveness analysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Much of this cost is probably related to the cost of ongoing and recurrent medical care. This was suggested by a prospective cohort study that followed patients who required PMV for one year following discharge from the acute care hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37673/abstract/74\">",
"     74",
"    </a>",
"    ]. Sixty-seven percent of patients required at least one readmission to an acute care hospital, 74 percent of days alive were spent in a health care facility or receiving home health care, and 91 percent of patients had some functional dependency at the end of the study. The mean cost per patient exceeded $300,000.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     TRANSFER FROM ICU",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients requiring PMV were historically cared for in the intensive care unit (ICU). In the 1990s, changes in reimbursement created incentives to transfer patients undergoing PMV from the ICU of acute care hospitals to long-term assisted care (LTAC) facilities. Many patients requiring PMV undergo weaning and discontinuation of mechanical ventilation in an LTAC. The selection of patients for transfer from an ICU to an LTAC is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9176?source=see_link\">",
"     \"Management of the difficult-to-wean patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9731404\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prolonged mechanical ventilation (PMV) is defined by the Centers for Medicare and Medicaid Services in the United States as greater than 21 days of mechanical ventilation for at least six hours per day, although many studies have used an alternative duration to define PMV. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no variables that reliably identify patients who will require PMV. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Predictors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No mode of ventilation has proven superior to others in achieving liberation from mechanical ventilation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Weaning strategies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications of PMV are related to infections or tracheostomy. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mortality is high among patients that require PMV, although a subgroup of patients will return to independent living with satisfactory function. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients requiring PMV should not be considered permanently ventilator dependent until three months of weaning attempts have failed. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Weaning strategies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9731412\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who are facing possible tracheostomy and long-term ventilator dependence, a meeting with the patient is essential to review their goals and preferences in the context of their expected prognosis and quality of life. If the patient is not able to participate in decision making, we meet with their designated decision-maker, or in the absence of a patient designated decision-maker, with the patient&rsquo;s family. (See",
"      <a class=\"local\" href=\"#H208898631\">",
"       'Assessing patient goals and preferences'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that potential causes of ventilator dependence be optimized prior to the initiation of weaning from prolonged mechanical ventilation (PMV), rather than weaning while the causes are being corrected (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Optimization for weaning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that weaning be initiated once the following criteria are satisfied (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Evidence for some reversal of the underlying cause for respiratory failure",
"     </li>",
"     <li>",
"      Adequate oxygenation (eg,",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      ratio &gt;150 to 200 on ventilator settings that include &le;8 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O of PEEP and an Fio",
"      <sub>",
"       2",
"      </sub>",
"      &le;0.5)",
"     </li>",
"     <li>",
"      Adequate pH (eg, &ge;7.25)",
"     </li>",
"     <li>",
"      Hemodynamic stability, defined as the absence of active myocardial ischemia and clinically significant hypotension",
"     </li>",
"     <li>",
"      Capable of initiating an inspiratory effort",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that patients requiring PMV be weaned by gradually increasing the duration of spontaneous breathing (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Weaning strategies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who fail spontaneous breathing should be placed on a non-fatiguing, comfortable mode of ventilation and the cause of failure determined and corrected. We suggest that daily spontaneous breathing resume after the cause of failure has been corrected (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Optimization for weaning'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/1\">",
"      MacIntyre NR, Epstein SK, Carson S, et al. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference. Chest 2005; 128:3937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/2\">",
"      Nevins ML, Epstein SK. Weaning from prolonged mechanical ventilation. Clin Chest Med 2001; 22:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/3\">",
"      Lone NI, Walsh TS. Prolonged mechanical ventilation in critically ill patients: epidemiology, outcomes and modelling the potential cost consequences of establishing a regional weaning unit. Crit Care 2011; 15:R102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/4\">",
"      Seneff MG, Zimmerman JE, Knaus WA, et al. Predicting the duration of mechanical ventilation. The importance of disease and patient characteristics. Chest 1996; 110:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/5\">",
"      Garnacho-Montero J, Amaya-Villar R, Garc&iacute;a-Garmend&iacute;a JL, et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005; 33:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/6\">",
"      De Jonghe B, Bastuji-Garin S, Durand MC, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007; 35:2007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/7\">",
"      Jubran A, Tobin MJ. Pathophysiologic basis of acute respiratory distress in patients who fail a trial of weaning from mechanical ventilation. Am J Respir Crit Care Med 1997; 155:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/8\">",
"      Appendini L, Purro A, Patessio A, et al. Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 1996; 154:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/9\">",
"      Purro A, Appendini L, De Gaetano A, et al. Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. Am J Respir Crit Care Med 2000; 161:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/10\">",
"      Powers SK, Kavazis AN, Levine S. Prolonged mechanical ventilation alters diaphragmatic structure and function. Crit Care Med 2009; 37:S347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/11\">",
"      Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med 2010; 182:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/12\">",
"      Nelson JE, Mercado AF, Camhi SL, et al. Communication about chronic critical illness. Arch Intern Med 2007; 167:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/13\">",
"      Jubran A, Mathru M, Dries D, Tobin MJ. Continuous recordings of mixed venous oxygen saturation during weaning from mechanical ventilation and the ramifications thereof. Am J Respir Crit Care Med 1998; 158:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/14\">",
"      Lemaire F, Teboul JL, Cinotti L, et al. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology 1988; 69:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/15\">",
"      Epstein SK. Etiology of extubation failure and the predictive value of the rapid shallow breathing index. Am J Respir Crit Care Med 1995; 152:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/16\">",
"      Chatila W, Ani S, Guaglianone D, et al. Cardiac ischemia during weaning from mechanical ventilation. Chest 1996; 109:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/17\">",
"      Demoule A, Lefort Y, Lopes ME, Lemaire F. Successful weaning from mechanical ventilation after coronary angioplasty. Br J Anaesth 2004; 93:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/18\">",
"      Aubier M, Viires N, Piquet J, et al. Effects of hypocalcemia on diaphragmatic strength generation. J Appl Physiol 1985; 58:2054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/19\">",
"      Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/20\">",
"      Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis 1984; 129:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/21\">",
"      Zwillich CW, Pierson DJ, Hofeldt FD, et al. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975; 292:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/22\">",
"      Siafakas NM, Salesiotou V, Filaditaki V, et al. Respiratory muscle strength in hypothyroidism. Chest 1992; 102:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/23\">",
"      Behnia M, Clay AS, Farber MO. Management of myxedematous respiratory failure: review of ventilation and weaning principles. Am J Med Sci 2000; 320:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/24\">",
"      Datta D, Scalise P. Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center. Chest 2004; 126:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/25\">",
"      Bello G, Pennisi MA, Montini L, et al. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. Chest 2009; 135:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/26\">",
"      Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 1998; 24:378.",
"     </a>",
"    </li>",
"    <li>",
"     Nett LM, Morganroth M, Petty TL. Weaning from mechanical ventilation: a perspective and review of techniques. In: Critical Care: A Comprehensive Approach, Bone RC (Ed), American College of Chest Physicians Northbrook, IL 1984. p.171.",
"    </li>",
"    <li>",
"     Tobin, MJ, Alex, CG. Discontinuation of mechanical ventilation. In: Principles and Practice of Mechanical Ventilation, Tobin, MJ (Eds), McGraw-Hill, New York 1994. p.1177.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/29\">",
"      LaRiccia PJ, Katz RH, Peters JW, et al. Biofeedback and hypnosis in weaning from mechanical ventilators. Chest 1985; 87:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/30\">",
"      Holliday JE, Hyers TM. The reduction of weaning time from mechanical ventilation using tidal volume and relaxation biofeedback. Am Rev Respir Dis 1990; 141:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/31\">",
"      Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/32\">",
"      Krishnan JA, Parce PB, Martinez A, et al. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 2003; 124:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/33\">",
"      Stapleton RD, Jones N, Heyland DK. Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med 2007; 35:S535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/34\">",
"      Alberda C, Gramlich L, Jones N, et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 2009; 35:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/35\">",
"      Faisy C, Lerolle N, Dachraoui F, et al. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation. Br J Nutr 2009; 101:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/36\">",
"      Doekel RC Jr, Zwillich CW, Scoggin CH, et al. Clinical semi-starvation: depression of hypoxic ventilatory response. N Engl J Med 1976; 295:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/37\">",
"      Moodie LH, Reeve JC, Vermeulen N, Elkins MR. Inspiratory muscle training to facilitate weaning from mechanical ventilation: protocol for a systematic review. BMC Res Notes 2011; 4:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/38\">",
"      Chiang LL, Wang LY, Wu CP, et al. Effects of physical training on functional status in patients with prolonged mechanical ventilation. Phys Ther 2006; 86:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/39\">",
"      Schweickert WD, Kress JP. Implementing early mobilization interventions in mechanically ventilated patients in the ICU. Chest 2011; 140:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/40\">",
"      Choi J, Tasota FJ, Hoffman LA. Mobility interventions to improve outcomes in patients undergoing prolonged mechanical ventilation: a review of the literature. Biol Res Nurs 2008; 10:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/41\">",
"      MacIntyre NR, Cook DJ, Ely EW Jr, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 2001; 120:375S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/42\">",
"      Jubran A, Grant BJ, Duffner LA, et al. Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial. JAMA 2013; 309:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/43\">",
"      Vitacca M, Vianello A, Colombo D, et al. Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 days. Am J Respir Crit Care Med 2001; 164:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/44\">",
"      Scheinhorn DJ, Chao DC, Stearn-Hassenpflug M, Wallace WA. Outcomes in post-ICU mechanical ventilation: a therapist-implemented weaning protocol. Chest 2001; 119:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/45\">",
"      Chao DC, Scheinhorn DJ. Determining the best threshold of rapid shallow breathing index in a therapist-implemented patient-specific weaning protocol. Respir Care 2007; 52:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/46\">",
"      Chatila WM, Criner GJ. Complications of long-term mechanical ventilation. Respir Care Clin N Am 2002; 8:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/47\">",
"      Kalb TH, Lorin S. Infection in the chronically critically ill: unique risk profile in a newly defined population. Crit Care Clin 2002; 18:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/48\">",
"      Scheinhorn DJ, Hassenpflug MS, Votto JJ, et al. Post-ICU mechanical ventilation at 23 long-term care hospitals: a multicenter outcomes study. Chest 2007; 131:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/49\">",
"      Chung YH, Chao TY, Chiu CT, Lin MC. The cuff-leak test is a simple tool to verify severe laryngeal edema in patients undergoing long-term mechanical ventilation. Crit Care Med 2006; 34:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/50\">",
"      Baram D, Hulse G, Palmer LB. Stable patients receiving prolonged mechanical ventilation have a high alveolar burden of bacteria. Chest 2005; 127:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/51\">",
"      Scheinhorn DJ, Chao DC, Stearn-Hassenpflug M. Liberation from prolonged mechanical ventilation. Crit Care Clin 2002; 18:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/52\">",
"      Rumbak MJ. Pneumonia in patients who require prolonged mechanical ventilation. Microbes Infect 2005; 7:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/53\">",
"      Cox CE, Martinu T, Sathy SJ, et al. Expectations and outcomes of prolonged mechanical ventilation. Crit Care Med 2009; 37:2888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/54\">",
"      Hall WB, Willis LE, Medvedev S, Carson SS. The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay. Am J Respir Crit Care Med 2012; 185:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/55\">",
"      Scheinhorn DJ, Chao DC, Stearn-Hassenpflug M, et al. Post-ICU mechanical ventilation: treatment of 1,123 patients at a regional weaning center. Chest 1997; 111:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/56\">",
"      Gracey DR, Hardy DC, Naessens JM, et al. The Mayo Ventilator-Dependent Rehabilitation Unit: a 5-year experience. Mayo Clin Proc 1997; 72:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/57\">",
"      Stoller JK, Xu M, Mascha E, Rice R. Long-term outcomes for patients discharged from a long-term hospital-based weaning unit. Chest 2003; 124:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/58\">",
"      Carson SS, Bach PB, Brzozowski L, Leff A. Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med 1999; 159:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/59\">",
"      Bigatello LM, Stelfox HT, Berra L, et al. Outcome of patients undergoing prolonged mechanical ventilation after critical illness. Crit Care Med 2007; 35:2491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/60\">",
"      Aboussouan LS, Lattin CD, Kline JL. Determinants of long-term mortality after prolonged mechanical ventilation. Lung 2008; 186:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/61\">",
"      Pilcher DV, Bailey MJ, Treacher DF, et al. Outcomes, cost and long term survival of patients referred to a regional weaning centre. Thorax 2005; 60:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/62\">",
"      Carson SS, Garrett J, Hanson LC, et al. A prognostic model for one-year mortality in patients requiring prolonged mechanical ventilation. Crit Care Med 2008; 36:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/63\">",
"      Carson SS, Kahn JM, Hough CL, et al. A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. Crit Care Med 2012; 40:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/64\">",
"      O'Connor HH, Kirby KJ, Terrin N, et al. Decannulation following tracheostomy for prolonged mechanical ventilation. J Intensive Care Med 2009; 24:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/65\">",
"      Kim Y, Hoffman LA, Choi J, et al. Characteristics associated with discharge to home following prolonged mechanical ventilation: a signal detection analysis. Res Nurs Health 2006; 29:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/66\">",
"      Oeyen SG, Vandijck DM, Benoit DD, et al. Quality of life after intensive care: a systematic review of the literature. Crit Care Med 2010; 38:2386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/67\">",
"      Niskanen M, Ruokonen E, Takala J, et al. Quality of life after prolonged intensive care. Crit Care Med 1999; 27:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/68\">",
"      Chatila W, Kreimer DT, Criner GJ. Quality of life in survivors of prolonged mechanical ventilatory support. Crit Care Med 2001; 29:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/69\">",
"      Hopkins RO, Weaver LK, Collingridge D, et al. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/70\">",
"      Guentner K, Hoffman LA, Happ MB, et al. Preferences for mechanical ventilation among survivors of prolonged mechanical ventilation and tracheostomy. Am J Crit Care 2006; 15:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/71\">",
"      Jubran A, Lawm G, Kelly J, et al. Depressive disorders during weaning from prolonged mechanical ventilation. Intensive Care Med 2010; 36:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/72\">",
"      Jubran A, Lawm G, Duffner LA, et al. Post-traumatic stress disorder after weaning from prolonged mechanical ventilation. Intensive Care Med 2010; 36:2030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/73\">",
"      Cox CE, Carson SS, Govert JA, et al. An economic evaluation of prolonged mechanical ventilation. Crit Care Med 2007; 35:1918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37673/abstract/74\">",
"      Unroe M, Kahn JM, Carson SS, et al. One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: a cohort study. Ann Intern Med 2010; 153:167.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1638 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37673=[""].join("\n");
var outline_f36_50_37673=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREDICTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H208898631\">",
"      ASSESSING PATIENT GOALS AND PREFERENCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H208898657\">",
"      TRACHEOSTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      WEANING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Optimization for weaning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Metabolic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Sepsis or SIRS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Psychological fears",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Nutrition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Physical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Weaning strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Weaning success",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Discharge home",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Quality of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9749739\">",
"      Psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Resource utilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      TRANSFER FROM ICU",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9731404\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9731412\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26087?source=related_link\">",
"      A short primer on cost-effectiveness analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/40/12938?source=related_link\">",
"      Communication in the ICU: Holding a family meeting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/17/19735?source=related_link\">",
"      Communication of prognosis in palliative care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2167?source=related_link\">",
"      Diagnosis and treatment of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=related_link\">",
"      Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=related_link\">",
"      Ethical issues near the end of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32887?source=related_link\">",
"      Ethics in the intensive care unit: Withholding and withdrawing life-support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/63/11254?source=related_link\">",
"      Evaluation and treatment of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9176?source=related_link\">",
"      Management of the difficult-to-wean patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14423?source=related_link\">",
"      Methods of weaning from mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/60/43976?source=related_link\">",
"      Neuromuscular weakness related to critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13831?source=related_link\">",
"      Nutrition support in critically ill patients: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3529?source=related_link\">",
"      Overview of the care of patients with stable ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=related_link\">",
"      Overview of tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26119?source=related_link\">",
"      Physiologic and pathophysiologic consequences of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/18/11560?source=related_link\">",
"      Tests of respiratory muscle strength",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7018?source=related_link\">",
"      Treatment and prognosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=related_link\">",
"      Treatment of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21112?source=related_link\">",
"      Weaning from mechanical ventilation: Readiness testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21140?source=related_link\">",
"      Weaning from mechanical ventilation: The rapid shallow breathing index",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37674="Comorbidities and complications of obesity in children and adolescents";
var content_f36_50_37674=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Comorbidities and complications of obesity in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/50/37674/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/50/37674/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity has become one of the most important public health problems in the United States (",
"    <a class=\"graphic graphic_figure graphicRef65047 \" href=\"mobipreview.htm?19/56/20366\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. As the prevalence of obesity increases so does the prevalence of the comorbidities associated with obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/4\">",
"     4",
"    </a>",
"    ]. For this reason it is imperative that health care providers identify overweight and obese children so that counseling and treatment can be provided.",
"   </p>",
"   <p>",
"    The comorbidities of obesity in childhood and adolescence include abnormalities in the endocrine, cardiovascular, gastrointestinal, pulmonary, orthopedic, neurologic, dermatologic, and psychosocial systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/5\">",
"     5",
"    </a>",
"    ]. Certain comorbidities, such as type 2 diabetes mellitus and steatohepatitis, that used to be considered \"adult diseases\" are now regularly seen in obese children. Moreover, obesity during adolescence increases the risk for disease and premature death during adulthood, independent of obesity during adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. As an example, in a longitudinal study, females who had been overweight during childhood had an increased risk of death from breast cancer and from all causes in adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/8\">",
"     8",
"    </a>",
"    ]. Males who had been overweight during childhood had an increased risk of death from ischemic heart disease.",
"   </p>",
"   <p>",
"    The comorbidities of obesity in children and adolescents will be discussed here. The definition, epidemiology, etiology, clinical evaluation of obesity in children and adolescents and the health hazards of obesity in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link\">",
"     \"Clinical evaluation of the obese child and adolescent\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18378?source=see_link\">",
"     \"Management of childhood obesity in the primary care setting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the discussion that follows, the term \"obesity\" refers to children with body mass index (BMI) &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age and sex and the term \"overweight\" refers to children with BMI between the 85",
"    <sup>",
"     th",
"    </sup>",
"    and 95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age and sex, unless otherwise noted. Calculation of body mass index and definitions of obesity are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link&amp;anchor=H2#H2\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ENDOCRINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endocrine comorbidities of obesity in children and adolescents include impaired glucose tolerance, diabetes mellitus, hyperandrogenism in females, and abnormalities in growth and puberty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Impaired glucose tolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired glucose tolerance, which predicts the development of diabetes, is a common complication of childhood and adolescent obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The reported prevalence of impaired glucose tolerance and type 2 diabetes in obese children varies considerably, presumably because of different degrees of obesity, racial and ethnic variation, and age range of the sampled population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of more than 6000 students in the sixth grade (average age 11.8 years), nearly 20 percent were overweight and 30 percent were obese [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. Impaired fasting glucose (fasting blood glucose &ge;100",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      was present in 15.5 percent of overweight children, 20.2 percent of obese children, and 22.5 percent of severely obese children. &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      In one study of 167 children and adolescents with BMI &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age and sex who were referred to an obesity clinic, 25 percent of children and 21 percent of adolescents had evidence of impaired glucose tolerance (as determined by an oral glucose tolerance test) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/14\">",
"       14",
"      </a>",
"      ]. After controlling for BMI, underlying insulin resistance was the best predictor of impaired glucose tolerance.",
"     </li>",
"     <li>",
"      In a study of 468 obese children and adolescents with elevated fasting insulin, the prevalence of impaired glucose tolerance was 12 percent, and type 2 diabetes was 2 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In other populations of obese children and adolescents, the prevalence of impaired glucose tolerance ranges from 7 to 13.5 percent, and the prevalence of type 2 diabetes was less than 1 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because insulin resistance is a good predictor of impaired glucose tolerance, it would be clinically useful to quantify insulin resistance in overweight and obese children and adolescents. However, there is no consensus on how to accurately evaluate children for insulin resistance. In research settings the standard technique is the hyperinsulinemic euglycemic clamp, but this technique is too invasive for clinical purposes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Insulin resistance is a state in which a given concentration of insulin is associated with subnormal glucose response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/19\">",
"     19",
"    </a>",
"    ]. A number of surrogate measures have been described, including the homeostasis model assessment of insulin resistance (HOMA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/20\">",
"     20",
"    </a>",
"    ], the fasting glucose-to-insulin ratio (FGIR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/21-23\">",
"     21-23",
"    </a>",
"    ], and the quantitative insulin sensitivity check index (QUICKI) (",
"    <a class=\"graphic graphic_table graphicRef71901 \" href=\"mobipreview.htm?30/24/31116\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/24\">",
"     24",
"    </a>",
"    ]. The validity of these measures as surrogates for insulin resistance in obese children and adolescents has been assessed using various confirmatory tests (oral glucose tolerance test, frequent sampling intravenous glucose tolerance test, and clamp testing) with variable results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/18,25-29\">",
"     18,25-29",
"    </a>",
"    ]. Other indices of insulin sensitivity, termed an oral disposition index, are derived from data collected during a standard oral glucose tolerance test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/30\">",
"     30",
"    </a>",
"    ]. The definition and clinical manifestations of insulin resistance are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28567?source=see_link\">",
"     \"Insulin resistance: Definition and clinical spectrum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation for impaired glucose tolerance and insulin resistance in obese children and adolescents involves measurement of fasting glucose",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    measurement of Hemoglobin A1C (HbA1c). A fasting plasma glucose of 100 to 125",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or HbA1C 5.7 to 6.4 percent suggests increased risk for developing type 2 diabetes (sometimes termed &ldquo;prediabetes&rdquo; (",
"    <a class=\"graphic graphic_table graphicRef82479 \" href=\"mobipreview.htm?1/61/2011\">",
"     table 2",
"    </a>",
"    )) and should be further evaluated with an oral glucose tolerance test. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical evaluation of the obese child and adolescent\", section on 'Laboratory studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4506?source=see_link\">",
"     \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 diabetes mellitus (T2DM, noninsulin dependent diabetes) is another comorbidity of obesity in children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. In the study described above, 4 percent of adolescents with BMI &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age and sex had asymptomatic T2DM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/14\">",
"     14",
"    </a>",
"    ]. Early diagnosis is imperative because aggressive treatment can slow the development of complications including progressive neuropathy, retinopathy, nephropathy, and atherosclerotic cardiovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/34\">",
"     34",
"    </a>",
"    ]. Moreover, individuals who present with T2DM during adolescence appear to have more rapid progression of diabetes-related complications as compared with those who present later in life. As an example, among adolescent patients with newly diagnosed T2DM, a large percentage had comorbidities (13.0 percent had microalbuminuria, 80.5 percent had dyslipidemia, and 13.6 percent had hypertension) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large study of young men in Israel showed an association between BMI during adolescence and T2DM during adulthood, as expected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/36\">",
"     36",
"    </a>",
"    ]. Of note, this association was seen even within the range of BMI that is considered normal. Interestingly, the association disappeared after adjusting for BMI during adulthood, suggesting that T2DM is primarily associated with obesity at or near the time of diagnosis, rather than the effects of chronic obesity since childhood. Similarly, a large longitudinal study found that individuals who were overweight or obese during childhood but who were not obese as adults had similar risk for T2DM as individuals who were never obese [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/37\">",
"     37",
"    </a>",
"    ]. By contrast, individuals with persistent obesity from childhood through adulthood had a significantly increased risk of T2DM in adulthood (RR 5.4; 95% CI 3.4-8.5). &nbsp;",
"   </p>",
"   <p>",
"    Screening of overweight or obese children for type 2 diabetes is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4506?source=see_link&amp;anchor=H21#H21\">",
"     \"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"metabolic syndrome\" is a term used to describe the clustering of metabolic risk factors for type 2 diabetes and atherosclerotic cardiovascular disease in adults: abdominal obesity, hyperglycemia, dyslipidemia, and hypertension. Clustering of cardiovascular risks also occurs in children and adolescents, particularly those who are overweight or obese [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/38\">",
"     38",
"    </a>",
"    ]. Several studies estimate that approximately 10 percent of US adolescents have metabolic syndrome, as defined by modifications of adult criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. However, because puberty is associated with changes in several of the traits that characterize metabolic syndrome, there is considerable instability to the diagnosis. In one study, about half of the adolescents initially classified as having metabolic syndrome lost the diagnosis during a three-year observation period, while others acquired the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/42\">",
"     42",
"    </a>",
"    ]. The long-term implications of the metabolic syndrome in children and adolescents are unknown.",
"   </p>",
"   <p>",
"    Several different schemes have been used to define the metabolic syndrome in adolescents (",
"    <a class=\"graphic graphic_table graphicRef66120 \" href=\"mobipreview.htm?19/20/19788\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. These and other aspects of the metabolic syndrome are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link&amp;anchor=H25#H25\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\", section on 'Children and adolescents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hyperandrogenism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescent girls with obesity are at increased risk of hyperandrogenism and early onset polycystic ovary syndrome (PCOS). PCOS can include a variety of clinical abnormalities, including hirsutism, menstrual irregularities, acanthosis nigricans, acne, and seborrhea. In some patients the diagnosis may be difficult to establish during adolescence. The clinical manifestations, diagnosis, and management of PCOS in adolescents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/13/39130?source=see_link\">",
"     \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/46/24297?source=see_link\">",
"     \"Treatment of polycystic ovary syndrome in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The association of obesity with PCOS is partially responsible for the association between obesity and reduced fertility in adult women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/11/29882?source=see_link&amp;anchor=H7#H7\">",
"     \"The impact of obesity on fertility and pregnancy\", section on 'Subfertility'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Growth and puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity in children and adolescents may be accompanied by accelerated linear growth and bone age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/45\">",
"     45",
"    </a>",
"    ]. It is uncertain whether this accelerated growth results in stature different than that which is genetically programmed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10073?source=see_link&amp;anchor=H19#H19\">",
"     \"The child with tall stature or abnormally rapid growth\", section on 'Exogenous obesity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overweight has been associated with early onset of sexual maturation in girls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. However, this relationship is inconsistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/48\">",
"     48",
"    </a>",
"    ]. The relationship between obesity and pubertal onset in boys is also inconsistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/46,49\">",
"     46,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1434?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal puberty\", section on 'Earlier onset of puberty'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity in children and adolescents is associated with a number of cardiovascular changes that are linked to increased cardiovascular risk in adulthood. Two of these, hypertension and dyslipidemia, are components of the metabolic syndrome. A minority of obese children and adolescents have no evidence of cardiovascular risk factors (termed &ldquo;metabolically healthy obesity&rdquo;). These individuals also show no signs of early atherosclerotic disease (as measured by carotid intima-media thickness), and tend to remain metabolically healthy in adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link&amp;anchor=H25#H25\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\", section on 'Children and adolescents'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of hypertension is increased in overweight and obese children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/51\">",
"     51",
"    </a>",
"    ]. Those who have BMI &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age and sex have approximately a three-fold higher risk of hypertension than those with BMI &lt;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age and sex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/52\">",
"     52",
"    </a>",
"    ]. When hypertension is assessed using ambulatory blood pressure monitoring, approximately 50 percent of obese children have hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. When casual office blood pressure measurements are used, substantially fewer cases of hypertension are detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/55\">",
"     55",
"    </a>",
"    ]. This discrepancy, termed \"masked\" hypertension, is particularly common in children with obesity, and has clinically important consequences. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/21/25943?source=see_link&amp;anchor=H8#H8\">",
"     \"Ambulatory blood pressure monitoring in children\", section on 'Masked hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increased BMI also is associated with increased left ventricular mass in hypertensive and non-hypertensive children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/51,56-60\">",
"     51,56-60",
"    </a>",
"    ]. The presence of hypertension during childhood predicts hypertension and metabolic syndrome during adulthood, even after adjustment for BMI during childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/61\">",
"     61",
"    </a>",
"    ]. Conversely, the presence of obesity during childhood predicts hypertension during adulthood, even after adjustment for BMI during adulthood (ie, there is a persistent effect of childhood obesity on the risk for hypertension even if the individual loses weight by adulthood) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/37\">",
"     37",
"    </a>",
"    ]. The evaluation and management of hypertension in children and adolescents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/45/17113?source=see_link\">",
"     \"Definition and diagnosis of hypertension in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27626?source=see_link\">",
"     \"Treatment of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dyslipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyslipidemia occurs among overweight and obese children and adolescents, particularly those with a central fat distribution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62-66\">",
"     62-66",
"    </a>",
"    ] and increased adiposity (as measured by triceps skin-fold thickness &ge;85",
"    <sup>",
"     th",
"    </sup>",
"    percentile) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/63\">",
"     63",
"    </a>",
"    ]. The typical pattern is one of elevated concentration of serum low-density lipoprotein (LDL)-cholesterol and triglycerides and decreased concentration of high-density-lipoprotein (HDL)-cholesterol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/51,64-66\">",
"     51,64-66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/17/281?source=see_link\">",
"     \"Definition and screening for dyslipidemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of hyperlipidemia in obese children and adolescents includes measurement of a fasting lipid panel (total cholesterol, triglycerides, and HDL-cholesterol) (",
"    <a class=\"graphic graphic_table graphicRef68183 \" href=\"mobipreview.htm?42/51/43836\">",
"     table 4",
"    </a>",
"    ). Treatment for dyslipidemia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical evaluation of the obese child and adolescent\", section on 'Laboratory studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/63/12282?source=see_link\">",
"     \"Management of pediatric dyslipidemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other CV risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood obesity also predisposes to a number of other risk factors for atherosclerosis. These include endothelial dysfunction, carotid intima-media thickening, the development of early aortic and coronary arterial fatty streaks and fibrous plaques, decreased arterial distensibility, and increased left atrial diameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/54,67-76\">",
"     54,67-76",
"    </a>",
"    ]. These observations lend additional support to the idea that atherosclerotic processes begin at an early age and are associated with obesity, inflammation, hypertension, and abnormal lipid profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. In addition, insulin resistance is an independent risk factor for premature carotid atherosclerosis after adjustment for a variety of other cardiovascular risk factors, including hypertension and dyslipidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study demonstrated that cardiovascular risk factors are elevated in overweight youth (BMI 85",
"    <sup>",
"     th",
"    </sup>",
"    to 95",
"    <sup>",
"     th",
"    </sup>",
"    percentile), with further abnormalities in those with obesity (BMI &ge;95",
"    <sup>",
"     th",
"    </sup>",
"    percentile), suggesting that even modest degrees of excess adiposity contribute to cardiovascular risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/80\">",
"     80",
"    </a>",
"    ]. This study used a twin pair design and included a several measures that have been shown to predict cardiovascular risk, including nocturnal blood pressure, left ventricular mass index, and overnight sodium excretion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adult coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The studies outlined above describe the effects of childhood obesity on hypertension and dyslipidemia, which are intermediate cardiovascular outcomes. However, increasing evidence demonstrates an association between obesity during childhood and cardiovascular disease during adulthood:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A population-wide study demonstrated a dramatic effect of childhood BMI on the critical outcome of cardiovascular events [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/81\">",
"       81",
"      </a>",
"      ]. Higher BMI during childhood was associated with an increased risk for fatal and nonfatal cardiovascular events during adulthood in both males and females. The risk increased linearly with BMI at each age, increased with increasing age of the child, and was even stronger when adjusted for birthweight. Of note, some of the observed effects may have been mediated by the association between childhood obesity and adult obesity, because the study did not adjust for the effect of adult BMI.",
"     </li>",
"     <li>",
"      A study of more than 35,000 young men in Israel found that BMI at 17 years of age was associated with angiography-proven coronary heart disease during adulthood, and the association persisted even after adjusting for adult BMI [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/36\">",
"       36",
"      </a>",
"      ]. Of note, this association was seen even within the range of BMIs considered to be normal in adolescents. These observations suggest that the processes causing coronary heart disease begin during adolescence.",
"     </li>",
"     <li>",
"      Data from four large longitudinal studies including 6328 subjects was analyzed to determine how changes in obesity status affect cardiovascular risk factors during adulthood [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/37\">",
"       37",
"      </a>",
"      ]. Individuals who were overweight or obese during childhood and remained obese as adults have significantly increased risks for type 2 diabetes, hypertension, dyslipidemia, and carotid-artery atherosclerosis as adults as compared with individuals who were never obese. By contrast, individuals who were overweight or obese during childhood but who were not obese as adults had similar cardiovascular risks as compared with individuals who were never obese.",
"     </li>",
"     <li>",
"      A predictive model estimated that the prevalence of coronary heart disease in the United States will increase 5 to 16 percent by 2035, with more than 100,000 excess cases of coronary heart disease attributable to the increase in childhood obesity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/82\">",
"       82",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nonalcoholic fatty liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is associated with a clinical spectrum of liver abnormalities collectively known as nonalcoholic fatty liver disease (NAFLD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83,84\">",
"     83,84",
"    </a>",
"    ], the most common cause of liver disease in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. The abnormalities include steatosis (increased liver fat without inflammation) and nonalcoholic steatohepatitis (NASH, increased liver fat with inflammation) (",
"    <a class=\"graphic graphic_picture graphicRef59170 \" href=\"mobipreview.htm?30/5/30806\">",
"     picture 1",
"    </a>",
"    ). NASH may lead to fibrosis, cirrhosis, and ultimately liver failure if it is not treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of NAFLD in overweight and obese individuals is not fully understood, but insulin resistance appears to be an important component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. The pathogenesis of NAFLD is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16073?source=see_link\">",
"     \"Pathogenesis of nonalcoholic fatty liver disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38105?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are important clinical associations between NAFLD and elements of the metabolic syndrome, including insulin resistance, dyslipidemia, and hypertension, independent of the degree of obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/90\">",
"     90",
"    </a>",
"    ]. Therefore, children with NAFLD should be carefully evaluated for each of these comorbidities and have global counseling about nutrition, physical activity, and tobacco use to help prevent the development of cardiovascular disease and type 2 diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link\">",
"     \"Clinical evaluation of the obese child and adolescent\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With the increased prevalence of childhood obesity, NAFLD is increasingly seen in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/91-93\">",
"     91-93",
"    </a>",
"    ]. The prevalence depends upon the population (ie, referral, community, ethnic group) and the definition of NAFLD used in the study (eg, height of aminotransferase elevation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ultrasonographic findings), as illustrated by the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an autopsy study of 742 children and adolescents, the prevalence of fatty liver was 9.6 percent overall, and 38 percent in obese children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/94\">",
"       94",
"      </a>",
"      ]. Histologic evidence of steatohepatitis was seen in 23 percent of the subjects with fatty liver, or 3 percent of the population overall. Of note, fatty liver was strongly associated with race, independent of obesity: Hispanic youths had a fivefold increase in risk for fatty liver as compared with black youths, after adjustment for BMI. White subjects had intermediate levels of risk. Because this study used histological measures of fatty liver in an unselected population, it is the best representation of the true prevalence of fatty liver disease among US children and adolescents.",
"     </li>",
"     <li>",
"      In the third National Health and Examination Survey (NHANES III), the prevalence of elevated ALT (&gt;30",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"      [0.50",
"      <span class=\"nowrap\">",
"       microkat/L])",
"      </span>",
"      among adolescents with BMI &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age and sex was 10 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/91\">",
"       91",
"      </a>",
"      ]. The prevalence of ALT &gt;60",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"      (1.00",
"      <span class=\"nowrap\">",
"       microkat/L,",
"      </span>",
"      two times normal) among adolescents with BMI &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      percentile in this nonreferral population was only 1 percent. Of note, the prevalence of elevated ALT (&gt;30",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"      [0.50",
"      <span class=\"nowrap\">",
"       microkat/L])",
"      </span>",
"      among adolescents with BMI &ge;95th percentile increased to 52 percent among those who reported that they ingested alcohol at least four times per month.",
"     </li>",
"     <li>",
"      The prevalence of ultrasonic findings consistent with fatty liver was 22.5 percent in Japanese children (aged 4 to 12 years) with BMI &ge;20 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/95\">",
"       95",
"      </a>",
"      ]. In a study of Chinese children that used a higher cutoff for obesity (mean BMI 30.3), the prevalence of ultrasonic findings consistent with hepatic steatosis was 77 percent, whereas the prevalence of ultrasonographic hepatic steatosis combined with elevated ALT was 24 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/96\">",
"       96",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with NAFLD are asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83\">",
"     83",
"    </a>",
"    ]. However, they may have right upper quadrant pain, hepatomegaly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/97,98\">",
"     97,98",
"    </a>",
"    ], or nonspecific symptoms such as abdominal discomfort, weakness, fatigue or malaise. They rarely have signs of liver disease: palmar erythema, spider angiomata, muscular wasting, jaundice, or encephalopathy. Laboratory abnormalities include elevations in liver transaminases (alanine aminotransferase [ALT], and aspartate aminotransferase [AST]), alkaline phosphatase, and gamma glutamyl transpeptidase (GGT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83,99-102\">",
"     83,99-102",
"    </a>",
"    ]. These abnormalities resolve with weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/99,103\">",
"     99,103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Imaging may confirm the presence of fatty liver, indicated by increased echogenicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/99,104,105\">",
"     99,104,105",
"    </a>",
"    ]. However, the severity of liver involvement does not correlate with radiographic features, clinical features, or the degree of elevation of liver transaminases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/98,105-107\">",
"     98,105-107",
"    </a>",
"    ]. Because of low sensitivity and specificity, the clinical utility of ultrasonography for the diagnosis of fatty liver disease is questionable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/108\">",
"     108",
"    </a>",
"    ]. However, we and many other providers use ultrasonography to confirm the presence of fatty liver, and to look for features that demand a more intensive evaluation. As examples, the presence of splenomegaly or liver nodularity suggest more advanced liver disease, and call for a thorough evaluation, including liver biopsy.",
"   </p>",
"   <p>",
"    The indications for liver biopsy for suspected NAFLD have not been established in either children or adults, and remain controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/102\">",
"     102",
"    </a>",
"    ]. Liver biopsy is the only way to reliably distinguish between simple steatosis, steatohepatitis, and fibrosis, and can also be helpful in excluding other causes of elevated serum aminotransferases. On the other hand, because there is currently no specific treatment for NAFLD other than weight management, the results of a liver biopsy are not likely to provide clinical benefit. Therefore, the benefits of performing a liver biopsy may not outweigh the costs and risks, unless there are specific features that suggest more severe or progressive liver disease, or that raise concerns about an alternate cause of the liver disease which requires evaluation by liver biopsy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38105?source=see_link&amp;anchor=H34933599#H34933599\">",
"     \"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults\", section on 'Role of liver biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In our practice, we use the following approach in patients with obesity and elevated serum aminotransferases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If ALT is greater than twice the upper limit of normal, we screen for viral hepatitis (anti Hepatitis C antibodies, and anti Hepatitis Bs antigen), Wilson disease (ceruloplasmin) and alpha 1 antitrypsin deficiency (serum alpha 1 antitrypsin level, and also \"pi\" typing or phenotype) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/102\">",
"       102",
"      </a>",
"      ]. Autoimmune hepatitis can be screened for with autoimmune antibodies (anti-nuclear antibodies [ANA], anti-liver-kidney-muscle antibodies [anti-LKM], and anti-mitochondrial antibodies [AMA]), and a total immunoglobulin G (IgG) level, and by inquiring about a family history of autoimmune disease. Of note, positive serum autoimmune antibodies are seen in about 20 percent of children and adults with NAFLD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/109\">",
"       109",
"      </a>",
"      ]. Therefore, low-positive titers (eg, ANA 1:40) do not exclude the diagnosis of NAFLD, but patients with high-positive titers should be further evaluated for the possibility of autoimmune hepatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110\">",
"       110",
"      </a>",
"      ]. If these tests are abnormal or equivocal, we follow up with more specific tests. We also inquire about alcohol use and investigate the possibility of hepatotoxic drugs (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/54/27497?source=see_link\">",
"       valproate",
"      </a>",
"      or tetracyclines). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14088?source=see_link\">",
"       \"Tests used in the diagnosis of Wilson disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35528?source=see_link\">",
"       \"Clinical manifestations and diagnosis of autoimmune hepatitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"       \"Approach to the patient with abnormal liver biochemical and function tests\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend and support weight loss measures, emphasizing physical activity, and counsel against alcohol use.",
"     </li>",
"     <li>",
"      If the ALT remains more than twice the upper limit of normal for six or more months (whether or not the patient has lost weight), we recommend a liver biopsy, to establish the diagnosis and determine the severity of the fatty liver disease, if present. As compared to adolescents and adults, children with NAFLD often display unique histopathological features as, including portal inflammation and portal fibrosis in the absence of ballooning; this histologic pattern has been called &ldquo;type 2&rdquo; NAFLD, while the pattern typically seen in adults has been called &ldquo;type 1&rdquo; NAFLD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110-112\">",
"       110-112",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If the patient declines liver biopsy, we continue to counsel and support weight loss, and we check aminotransferase levels every six months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the aminotransferase elevation is substantially more than twice the upper limit of normal, or if conjugated bilirubin, neurological symptoms, splenomegaly, or any other indications of significant liver disease are present, more intensive investigation is warranted. Patients with early onset of liver disease or other atypical features also should be evaluated for monogenic disorders that present as fatty liver in very young children, such as inborn errors of fatty acid metabolism, peroxisomal disorders, lysosomal storage disorders, or Wilson disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110\">",
"     110",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight management is the only established treatment for NAFLD; small nonrandomized studies in children have shown improvement in liver histology or aminotransferase activity after weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/99,102,113-115\">",
"     99,102,113-115",
"    </a>",
"    ]. Emphasis on physical activity is appropriate because of its utility in improving insulin sensitivity, which appears to be an important pathway for the development of NAFLD. In one study, physical activity improved NAFLD (as measured by ALT elevations), independent of weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/116\">",
"     116",
"    </a>",
"    ]. Guidelines from the American Gastroenterological Association (AGA) suggest lifestyle modification targeting weight loss as the first-line therapy for obese children with NAFLD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110\">",
"     110",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Pharmacologic approaches under investigation include the use of vitamin E,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/59/13238?source=see_link\">",
"     metformin",
"    </a>",
"    and thiazolidinediones (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/28/43463?source=see_link\">",
"     pioglitazone",
"    </a>",
"    ). In small trials, none of these have shown a convincing advantage over lifestyle intervention alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. In a placebo-controlled randomized trial that included 178 children and adolescents with biopsy-proven steatohepatitis, there was no benefit from either vitamin E or metformin on the primary outcome of serum aminotransferase levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/119\">",
"     119",
"    </a>",
"    ]. However, the proportion of children with histologic resolution of steatohepatitis after 96 weeks of treatment was 58 percent (p &lt;0.01) for those treated with vitamin E, and 41 percent (p = 0.23) for those treated with metformin, compared with 21 percent for those treated with placebo. Some of this improvement may have been due to weight loss, because all patients were given advice on diet and exercise throughout the study, and the mean BMI z-score decreased slightly in each group. Supported by the results of this randomized trial, the AGA guideline concludes that vitamin E (800 Int. Units daily) leads to histological improvement in NAFLD in children, but that there is insufficient information to develop specific recommendations for its use in clinical practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110\">",
"     110",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=see_link\">",
"     \"Natural history and management of nonalcoholic fatty liver disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cholelithiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is the most common cause of gallstones in children without predisposing conditions (eg, hemolytic anemia, history of parenteral nutrition) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/120-122\">",
"     120-122",
"    </a>",
"    ]. The risk for gallstones increases with BMI and is greater for girls than boys. As an example, one study reported sevenfold greater risk for gallstones among girls with severe obesity as compared with normal-weight girls (adjusted odds ratio 7.71) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/123\">",
"     123",
"    </a>",
"    ]. The risk was further increased for girls who used oral contraceptives. Hispanic ethnicity is an independent risk factor for non-hemolytic gallstone disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/124\">",
"     124",
"    </a>",
"    ]. One study examined the prevalence of gallstones in 493 asymptomatic children and adolescents between 8 and 18 years of age, with obesity defined as a BMI &ge;2 standard deviation scores (approximately 97",
"    <sup>",
"     th",
"    </sup>",
"    percentile). Ultrasound screening detected gallstones in 10 of the children (2 percent; eight girls and two boys), all of whom were postpubertal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs and symptoms of gallstones in children and adolescents are nonspecific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/122,126\">",
"     122,126",
"    </a>",
"    ]. They include epigastric pain, jaundice, right upper quadrant pain, nausea, vomiting, and fatty food intolerance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/120,121,126\">",
"     120,121,126",
"    </a>",
"    ]. Because early recognition is necessary for successful management, gallbladder disease should be considered in the differential diagnosis of persistent abdominal pain in overweight or obese adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83\">",
"     83",
"    </a>",
"    ]. Ultrasonography is the test of choice for diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PULMONARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary comorbidities of obesity in children and adolescents include obstructive sleep apnea (OSA) and the obesity hypoventilation syndrome (OHS). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15286?source=see_link\">",
"     \"Sleep related breathing disorders in adults: Definitions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Obstructive sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea (OSA) describes complete obstruction of the upper airway during sleep and cessation of air movement despite ongoing respiratory effort; partial airway obstruction is termed obstructive hypoventilation. OSA is typically but not always associated with persistent snoring. Obesity is an important predisposing factor; the prevalence of OSA is increased in obese children and adolescents as compared to those with healthy weights. In a study of 64 children and adolescents with obesity, 8 percent had moderate to severe OSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/127\">",
"     127",
"    </a>",
"    ]. The pathogenesis and evaluation of OSA in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/36/9801?source=see_link\">",
"     \"Mechanisms and predisposing factors for sleep related breathing disorders in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between sleep and obesity is complex. There is some evidence that shortened sleep duration or sleep fragmentation promotes obesity, and also that obstructive sleep apnea is associated with decreased insulin sensitivity in adolescents, independent of adiposity. These associations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link&amp;anchor=H10#H10\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Sleep'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Obesity hypoventilation syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obesity hypoventilation syndrome is defined by extreme obesity and alveolar hypoventilation during wakefulness. This disorder is rare but life-threatening and requires prompt diagnosis and therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38661?source=see_link\">",
"     \"Clinical manifestations and diagnosis of obesity hypoventilation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More commonly, patients with obesity also may have hypoventilation during sleep in the absence of airway obstruction, perhaps due to the restrictive ventilatory defect caused by obesity. In the study of 64 children cited above, 17 percent had episodes of hypoventilation, often with severe oxygen desaturation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/127\">",
"     127",
"    </a>",
"    ]. Abdominal distribution of fat mass was associated with this finding.",
"   </p>",
"   <p>",
"    Children and adolescents with obesity and sleep disordered breathing should be referred for specialty care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83,128\">",
"     83,128",
"    </a>",
"    ]. They require an aggressive weight loss program since weight loss can improve ventilation and general health. In addition, they may require CPAP until weight loss is sufficient to restore adequate ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     ORTHOPEDIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orthopedic comorbidities of obesity include slipped capital femoral epiphysis (SCFE) and tibia vara (Blount disease). In addition, obese children have an increased prevalence of fractures, genu valgum, musculoskeletal pain (eg, back, leg, knee, ankle, and foot), impaired mobility, and lower extremity malalignment than nonobese children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/129-132\">",
"     129-132",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/3/6199?source=see_link\">",
"     \"Approach to the child with knock-knees\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/55/27511?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the child with bow-legs\", section on 'Blount disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Slipped capital femoral epiphysis (SCFE)",
"    </span>",
"    &nbsp;&mdash;&nbsp;SCFE is characterized by a displacement of the capital femoral epiphysis from the femoral neck through the physeal plate (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82320 \" href=\"mobipreview.htm?39/1/39967\">",
"     image 1",
"    </a>",
"    ). It typically occurs in early adolescence. Obesity is a significant risk factor. The classic presentation is that of an obese adolescent with a complaint of nonradiating, dull, aching pain in the hip, groin, thigh, or knee, and no history of preceding trauma. Diagnosis is confirmed by radiographs. Patients with SCFE should be referred to an orthopedic surgeon for management and an obesity specialist for an appropriate weight-loss program to prevent occurrence of contralateral SCFE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/128\">",
"     128",
"    </a>",
"    ]. The epidemiology, presentation, evaluation, and management of SCFE are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23209?source=see_link\">",
"     \"Slipped capital femoral epiphysis (SCFE)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Tibia vara (Blount disease)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibia vara (Blount disease) is characterized by progressive bowed legs and tibial torsion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/133\">",
"     133",
"    </a>",
"    ]. It results from inhibited growth of the medial proximal tibial growth plate due to excessive abnormal weight bearing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/134,135\">",
"     134,135",
"    </a>",
"    ]. Tibia vara is associated with obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/133,135-139\">",
"     133,135-139",
"    </a>",
"    ] and is more common among Black than non-Black individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/134,136,138,140\">",
"     134,136,138,140",
"    </a>",
"    ]. In one report, the prevalence of tibia vara among 80 Black boys (aged 13 to 19 years) who weighed &ge;210 pounds was 2.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/140\">",
"     140",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features of tibia vara include complaints of knee pain or instability and bowlegs that gradually increase in severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/91,141\">",
"     91,141",
"    </a>",
"    ]. Severe adiposity may obscure the physical findings and delay the diagnosis. Radiographs are necessary for diagnosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57787 \" href=\"mobipreview.htm?2/9/2193\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/55/27511?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the child with bow-legs\", section on 'Blount disease'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16070249\">",
"    <span class=\"h2\">",
"     Fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obese children are more susceptible to fractures than normal weight children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/131\">",
"     131",
"    </a>",
"    ]. Unlike adults, children with obesity generally have reduced bone mass when adjusted for body size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/142-144\">",
"     142-144",
"    </a>",
"    ]. The relative contributions of stress from body weight during falls, vitamin D deficiency, reduced bone mass from lack of exercise, and other biomechanical effects of obesity on bone have not been established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/145\">",
"     145",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     NEUROLOGIC",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Idiopathic intracranial hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of idiopathic intracranial hypertension (pseudotumor cerebri) is increased in children and adolescents with obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/146,147\">",
"     146,147",
"    </a>",
"    ]. The risk increases with the severity of obesity (odds ratio 16.14 for severe obesity as compared with normal-weight children) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/147\">",
"     147",
"    </a>",
"    ]. Although as many as one-half of children who present with idiopathic intracranial hypertension are obese, the onset of symptoms does not appear to correlate with weight gain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/148\">",
"     148",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children and adolescents with idiopathic intracranial hypertension typically present with headache. Associated complaints may include nausea, vomiting, retroocular eye pain, transient visual obscurations, visual loss, and diplopia. Papilledema is the characteristic examination finding (",
"    <a class=\"graphic graphic_picture graphicRef54781 graphicRef59423 graphicRef72175 \" href=\"mobipreview.htm?4/45/4825\">",
"     picture 2A-C",
"    </a>",
"    ). Idiopathic intracranial hypertension can cause severe visual impairment or blindness. Thus, weight loss is an important component of treatment for patients with obesity and idiopathic intracranial hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation and management of children and adolescents with idiopathic intracranial hypertension is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17417?source=see_link\">",
"     \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     DERMATOLOGIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatologic comorbidities of obesity include intertrigo, furunculosis, and hidradenitis suppurativa. Hidradenitis suppurativa is characterized by inflammatory nodules or deep fluctuant cysts in the intertriginous skin of the axillae and groin (",
"    <a class=\"graphic graphic_picture graphicRef77990 \" href=\"mobipreview.htm?37/25/38289\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/59/30648?source=see_link\">",
"     \"Candidal intertrigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43831?source=see_link\">",
"     \"Skin abscesses, furuncles, and carbuncles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/7/6265?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acanthosis nigricans (",
"    <a class=\"graphic graphic_picture graphicRef53776 \" href=\"mobipreview.htm?3/7/3198\">",
"     picture 4",
"    </a>",
"    ) is a common skin abnormality in individuals with obesity, and is associated with insulin resistance. Striae distensae (stretch marks) are also common; they are caused by mechanical factors (skin distension), possibly acting in concert with hormonal factors such as relatively high levels of adrenocorticosteroids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/149\">",
"     149",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PSYCHOSOCIAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosocial consequences of childhood obesity are widespread [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62,150\">",
"     62,150",
"    </a>",
"    ]. These include alienation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/151,152\">",
"     151,152",
"    </a>",
"    ], distorted peer relationships, poor self esteem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/153,154\">",
"     153,154",
"    </a>",
"    ], distorted body image [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/155\">",
"     155",
"    </a>",
"    ], anxiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/156\">",
"     156",
"    </a>",
"    ], and depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/157-161\">",
"     157-161",
"    </a>",
"    ]. The risk of psychosocial morbidity increases with increasing age and is greater among girls than boys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/150,153,162-164\">",
"     150,153,162-164",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In community-based and referral populations, obese children and adolescents and their parents report decreased health-related quality of life (physical, emotional, social, and school functioning) compared to healthy non-overweight children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/161,165-168\">",
"     161,165-168",
"    </a>",
"    ]. In the referral population, health-related quality of life among severely obese children and adolescents was similar to that reported by children and adolescents with cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/165\">",
"     165",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the early school years (age 6 to 10 years), overweight and obese children may become targets of discrimination by their peers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62,102,169\">",
"     62,102,169",
"    </a>",
"    ]. In one study from the 1960s of male schoolchildren from Indiana, obesity was associated with negative characteristics (eg, laziness, lying, cheating, ugliness, dirtiness, and stupidity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/170\">",
"     170",
"    </a>",
"    ]. In another study, schoolchildren preferred children with a variety of handicaps to obese children as their friends [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62,171\">",
"     62,171",
"    </a>",
"    ]. In a more recent study from southwest England, boys and girls who were obese at 7.5 years of age were more likely to be victims of bullying at 8.5 years of age than average weight children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/172\">",
"     172",
"    </a>",
"    ]. In addition, boys who were obese at 7.5 years were more likely to be overt bullies at 8.5 years than average weight boys. Despite these issues, many overweight or obese young children appear to maintain a positive self-image and self-esteem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/154,173,174\">",
"     154,173,174",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adolescents with obesity also experience bias and bullying from their peers; many, particularly girls, develop a negative self-image that persists into adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/102,155\">",
"     102,155",
"    </a>",
"    ]. Data from the National Longitudinal Survey of Youth indicate that women, but not men, who were obese in late adolescence and early adulthood completed fewer years of advanced education, and had decreased family income, lower rates of marriage, and higher rates of poverty compared to their non-obese peers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/175\">",
"     175",
"    </a>",
"    ]. Similar data were reported from a British cohort [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/50/37674/abstract/176\">",
"     176",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/30/23010?source=see_link\">",
"       \"Patient information: My child is overweight (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/53/3923?source=see_link\">",
"       \"Patient information: Health risks of obesity (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5950605\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951239\">",
"    <span class=\"h2\">",
"     Endocrine",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The reported prevalence of impaired glucose tolerance among obese children and adolescents ranges from 7 to 25 percent, and the prevalence of type 2 diabetes ranges from 0.5 to 4 percent. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Endocrine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fasting plasma glucose between 100 and 125",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or HbA1C between 5.7 and 6.4 percent suggests impaired glucose tolerance, and should be further evaluated with an oral glucose tolerance test. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Impaired glucose tolerance'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical evaluation of the obese child and adolescent\", section on 'Laboratory studies'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      The metabolic syndrome describes the clustering of abdominal obesity, hyperglycemia, dyslipidemia, and hypertension, which are risk factors for type 2 diabetes and atherosclerotic cardiovascular disease. Several different schemes have been used to define the metabolic syndrome in adolescents (",
"      <a class=\"graphic graphic_table graphicRef66120 \" href=\"mobipreview.htm?19/20/19788\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Metabolic syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescent girls with obesity are at increased risk of hyperandrogenism and early onset polycystic ovary syndrome (PCOS). PCOS can include a variety of clinical abnormalities, including hirsutism, menstrual irregularities, acanthosis nigricans, acne, and seborrhea. In some patients the diagnosis may be difficult to establish during adolescence. Obesity during adulthood is also associated with reduced fertility. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Hyperandrogenism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951247\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypertension is probably the most common comorbidity associated with obesity. Children with obesity are three times more likely to have hypertension than nonobese children. Ambulatory blood pressure monitoring detects hypertension in about 50 percent of children and adolescents with obesity. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      More than 50 percent of obese children have lipid abnormalities as measured by a fasting lipid profile. The typical pattern is one of elevated concentration of serum low-density lipoprotein (LDL)-cholesterol and triglycerides and decreased concentration of high-density-lipoprotein (HDL)-cholesterol. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dyslipidemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Childhood obesity also predisposes to a number of other risk factors for atherosclerosis. These include endothelial dysfunction, carotid intima-media thickening, the development of early aortic and coronary arterial fatty streaks and fibrous plaques, decreased arterial distensibility, and increased left atrial diameter. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Other CV risks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obesity during childhood and adolescence is associated with an increased risk for major cardiovascular events during adulthood, independent of adult obesity status. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Adult coronary heart disease'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951265\">",
"    <span class=\"h2\">",
"     Gastrointestinal",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      About 40 percent of obese children have fatty liver, with a prevalence that varies by ethnicity independent of obesity status. Approximately 10 percent of obese children and adolescents have mildly elevated serum aminotransferase concentrations, which are usually caused by nonalcoholic fatty liver disease (NAFLD). Vitamin E (800 int. units daily) leads to histological improvement in NAFLD in children, but there is insufficient information to develop specific recommendations for its use in clinical practice. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Nonalcoholic fatty liver disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asymptomatic gallstones can be detected in approximately 2 percent of obese adolescents; most of whom are females. If symptoms develop, they tend to include epigastric pain, jaundice, right upper quadrant pain, nausea, vomiting, and fatty food intolerance. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Cholelithiasis'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951273\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      About 10 percent of children and adolescents with obesity have clinically significant sleep apnea, and the risk is higher among children with severe obesity",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      consistent snoring. The diagnosis is made with polysomnography. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Obstructive sleep apnea'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=see_link\">",
"       \"Evaluation of suspected obstructive sleep apnea in children\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951291\">",
"    <span class=\"h2\">",
"     Orthopedic",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Orthopedic comorbidities of obesity include slipped capital femoral epiphysis (SCFE) and tibia vara (Blount disease). In addition, obese children have an increased prevalence of fractures, genu valgum, musculoskeletal pain (eg, back, leg, knee, ankle, and foot), impaired mobility, and lower extremity malalignment than nonobese children. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Orthopedic'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5951337\">",
"    <span class=\"h2\">",
"     Psychosocial",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychosocial consequences of childhood obesity are common, and include alienation, distorted peer relationships, poor self esteem, distorted body image, anxiety, and depression. The risk of psychosocial morbidity increases with increasing age and is greater among girls than boys. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Psychosocial'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/1\">",
"      Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/2\">",
"      Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001; 286:2845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/3\">",
"      Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord 2004; 28:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/4\">",
"      Dietz WH, Robinson TN. Clinical practice. Overweight children and adolescents. N Engl J Med 2005; 352:2100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/5\">",
"      Unger R, Kreeger L, Christoffel KK. Childhood obesity. Medical and familial correlates and age of onset. Clin Pediatr (Phila) 1990; 29:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/6\">",
"      van Dam RM, Willett WC, Manson JE, Hu FB. The relationship between overweight in adolescence and premature death in women. Ann Intern Med 2006; 145:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/7\">",
"      Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/8\">",
"      Must A, Phillips SM, Naumova EN. Occurrence and timing of childhood overweight and mortality: findings from the Third Harvard Growth Study. J Pediatr 2012; 160:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/9\">",
"      Bj&oslash;rge T, Engeland A, Tverdal A, Smith GD. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008; 168:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/10\">",
"      Williams DE, Cadwell BL, Cheng YJ, et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005; 116:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/11\">",
"      Sabin MA, Ford AL, Holly JM, et al. Characterisation of morbidity in a UK, hospital based, obesity clinic. Arch Dis Child 2006; 91:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/12\">",
"      HEALTHY Study Group, Kaufman FR, Hirst K, et al. Risk factors for type 2 diabetes in a sixth- grade multiracial cohort: the HEALTHY study. Diabetes Care 2009; 32:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/13\">",
"      Marcus MD, Baranowski T, DeBar LL, et al. Severe obesity and selected risk factors in a sixth grade multiracial cohort: the HEALTHY study. J Adolesc Health 2010; 47:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/14\">",
"      Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/15\">",
"      Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics 2009; 124:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/16\">",
"      Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes (Lond) 2005; 29:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/17\">",
"      Maffeis C, Pinelli L, Brambilla P, et al. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 2010; 18:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/18\">",
"      Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115:e500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/19\">",
"      Moller DE, Flier JS. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med 1991; 325:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/20\">",
"      Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/21\">",
"      Silfen ME, Manibo AM, McMahon DJ, et al. Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure. J Clin Endocrinol Metab 2001; 86:2863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/22\">",
"      Vuguin P, Saenger P, Dimartino-Nardi J. Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. J Clin Endocrinol Metab 2001; 86:4618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/23\">",
"      Dimartino-Nardi J. Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls. Acta Paediatr Suppl 1999; 88:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/24\">",
"      Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/25\">",
"      Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004; 27:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/26\">",
"      Brandou F, Brun JF, Mercier J. Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 2005; 90:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/27\">",
"      Uwaifo GI, Fallon EM, Chin J, et al. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002; 25:2081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/28\">",
"      Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004; 144:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/29\">",
"      Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294:E15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/30\">",
"      Sjaarda LG, Bacha F, Lee S, et al. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr 2012; 161:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/31\">",
"      Moln&aacute;r D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 2004; 28 Suppl 3:S70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/32\">",
"      Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996; 128:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/33\">",
"      Goran MI, Davis J, Kelly L, et al. Low prevalence of pediatric type 2 diabetes: where's the epidemic? J Pediatr 2008; 152:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/34\">",
"      Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005; 116:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/35\">",
"      Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab 2011; 96:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/36\">",
"      Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 2011; 364:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/37\">",
"      Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011; 365:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/38\">",
"      Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/39\">",
"      Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/40\">",
"      Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/41\">",
"      Lambert M, Paradis G, O'Loughlin J, et al. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord 2004; 28:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/42\">",
"      Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007; 115:2316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/43\">",
"      Chi CH, Wang Y, Wilson DM, Robinson TN. Definition of metabolic syndrome in preadolescent girls. J Pediatr 2006; 148:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/44\">",
"      Zimmet P, Alberti G, Kaufman F, et al. The metabolic syndrome in children and adolescents. Lancet 2007; 369:2059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/45\">",
"      Garn SM, Clark DC. Nutrition, growth, development, and maturation: findings from the ten-state nutrition survey of 1968-1970. Pediatrics 1975; 56:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/46\">",
"      Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002; 110:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/47\">",
"      Kaplowitz PB, Slora EJ, Wasserman RC, et al. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 2001; 108:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/48\">",
"      Laron Z. Is obesity associated with early sexual maturation? Pediatrics 2004; 113:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/49\">",
"      Herman-Giddens ME, Steffes J, Harris D, et al. Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network. Pediatrics 2012; 130:e1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/50\">",
"      Li S, Chen W, Srinivasan SR, et al. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am J Epidemiol 2012; 176 Suppl 7:S142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/51\">",
"      Friedemann C, Heneghan C, Mahtani K, et al. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 2012; 345:e4759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/52\">",
"      Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002; 40:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/53\">",
"      Maggio AB, Aggoun Y, Marchand LM, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr 2008; 152:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/54\">",
"      Stabouli S, Kotsis V, Papamichael C, et al. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005; 147:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/55\">",
"      Aguilar A, Ostrow V, De Luca F, Suarez E. Elevated ambulatory blood pressure in a multi-ethnic population of obese children and adolescents. J Pediatr 2010; 156:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/56\">",
"      Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/57\">",
"      Urbina EM, Gidding SS, Bao W, et al. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 1995; 91:2400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/58\">",
"      Urbina EM, Gidding SS, Bao W, et al. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study. Am Heart J 1999; 138:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/59\">",
"      Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006; 47:2267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/60\">",
"      Crowley DI, Khoury PR, Urbina EM, et al. Cardiovascular impact of the pediatric obesity epidemic: higher left ventricular mass is related to higher body mass index. J Pediatr 2011; 158:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/61\">",
"      Sun SS, Grave GD, Siervogel RM, et al. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 2007; 119:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/62\">",
"      Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/63\">",
"      Williams DP, Going SB, Lohman TG, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992; 82:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/64\">",
"      Harel Z, Riggs S, Vaz R, et al. Isolated low HDL cholesterol emerges as the most common lipid abnormality among obese adolescents. Clin Pediatr (Phila) 2010; 49:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/65\">",
"      Morrison JA, Sprecher DL, Barton BA, et al. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 1999; 135:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/66\">",
"      Caprio S, Hyman LD, McCarthy S, et al. Fat distribution and cardiovascular risk factors in obese adolescent girls: importance of the intraabdominal fat depot. Am J Clin Nutr 1996; 64:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/67\">",
"      Freedman DS, Dietz WH, Tang R, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004; 28:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/68\">",
"      Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/69\">",
"      Zhu W, Huang X, He J, et al. Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr 2005; 164:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/70\">",
"      Woo KS, Chook P, Yu CW, et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 2004; 28:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/71\">",
"      Whincup PH, Gilg JA, Donald AE, et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 2005; 112:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/72\">",
"      Iannuzzi A, Licenziati MR, Acampora C, et al. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care 2004; 27:2506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/73\">",
"      Yu JJ, Yeom HH, Chung S, et al. Left atrial diameters in overweight children with normal blood pressure. J Pediatr 2006; 148:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/74\">",
"      Meyer AA, Kundt G, Steiner M, et al. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics 2006; 117:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/75\">",
"      Groner JA, Joshi M, Bauer JA. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics 2006; 118:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/76\">",
"      Mittelman SD, Gilsanz P, Mo AO, et al. Adiposity predicts carotid intima-media thickness in healthy children and adolescents. J Pediatr 2010; 156:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/77\">",
"      Skinner AC, Steiner MJ, Henderson FW, Perrin EM. Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics 2010; 125:e801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/78\">",
"      Osiniri I, Sitjar C, Soriano-Rodr&iacute;guez P, et al. Carotid intima-media thickness at 7 years of age: relationship to C-reactive protein rather than adiposity. J Pediatr 2012; 160:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/79\">",
"      Atabek ME, Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res 2007; 61:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/80\">",
"      Zhu H, Yan W, Ge D, et al. Relationships of cardiovascular phenotypes with healthy weight, at risk of overweight, and overweight in US youths. Pediatrics 2008; 121:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/81\">",
"      Baker JL, Olsen LW, S&oslash;rensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357:2329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/82\">",
"      Bibbins-Domingo K, Coxson P, Pletcher MJ, et al. Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007; 357:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/83\">",
"      Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005; 90:1871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/84\">",
"      Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/85\">",
"      Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004; 8:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/86\">",
"      Huang JS, Barlow SE, Quiros-Tejeira RE, et al. Childhood obesity for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr 2013; 56:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/87\">",
"      Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/88\">",
"      Mandato C, Lucariello S, Licenziati MR, et al. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr 2005; 147:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/89\">",
"      Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/90\">",
"      Schwimmer JB, Pardee PE, Lavine JE, et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008; 118:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/91\">",
"      Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000; 136:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/92\">",
"      Schwimmer JB, McGreal N, Deutsch R, et al. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115:e561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/93\">",
"      Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic Fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013; 162:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/94\">",
"      Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/95\">",
"      Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40:2002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/96\">",
"      Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/97\">",
"      Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/98\">",
"      Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/99\">",
"      Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/100\">",
"      Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997; 86:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/101\">",
"      Kinugasa A, Tsunamoto K, Furukawa N, et al. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/102\">",
"      Huang JS, Barlow SE, Quiros-Tejeira RE, et al. Consensus Statement: Childhood Obesity for Pediatric Gastroenterologists. J Pediatr Gastroenterol Nutr 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/103\">",
"      Vajro P, Fontanella A, Perna C, et al. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/104\">",
"      Radetti G, Kleon W, Stuefer J, Pittschieler K. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr 2006; 95:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/105\">",
"      Shannon A, Alkhouri N, Carter-Kent C, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 2011; 53:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/106\">",
"      Baker S, Barlow S, Cochran W, et al. Overweight children and adolescents: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/107\">",
"      McNair A. Non-alcoholic steatohepatitis (NASH): why biopsy? Gut 2002; 51:898; author reply 898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/108\">",
"      Bohte AE, Koot BG, van der Baan-Slootweg OH, et al. US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 2012; 262:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/109\">",
"      Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2004; 99:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/110\">",
"      Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/111\">",
"      Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/112\">",
"      Suzuki A, Abdelmalek MF, Schwimmer JB, et al. Association between puberty and features of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/113\">",
"      Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005; 100:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/114\">",
"      Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 2009; 94:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/115\">",
"      Pozzato C, Verduci E, Scaglioni S, et al. Liver fat change in obese children after a 1-year nutrition-behavior intervention. J Pediatr Gastroenterol Nutr 2010; 51:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/116\">",
"      Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006; 44:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/117\">",
"      Nobili V, Manco M, Ciampalini P, et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 2008; 30:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/118\">",
"      Nobili V, Manco M, Devito R, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008; 48:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/119\">",
"      Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011; 305:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/120\">",
"      Friesen CA, Roberts CC. Cholelithiasis. Clinical characteristics in children. Case analysis and literature review. Clin Pediatr (Phila) 1989; 28:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/121\">",
"      Holcomb GW Jr, O'Neill JA Jr, Holcomb GW 3rd. Cholecystitis, cholelithiasis and common duct stenosis in children and adolescents. Ann Surg 1980; 191:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/122\">",
"      Goodman DB. Cholelithiasis in persons under 25 years old. Clinicopathologic review of 96 cases. JAMA 1976; 236:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/123\">",
"      Koebnick C, Smith N, Black MH, et al. Pediatric obesity and gallstone disease. J Pediatr Gastroenterol Nutr 2012; 55:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/124\">",
"      Mehta S, Lopez ME, Chumpitazi BP, et al. Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. Pediatrics 2012; 129:e82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/125\">",
"      Kaechele V, Wabitsch M, Thiere D, et al. Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr 2006; 42:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/126\">",
"      Reif S, Sloven DG, Lebenthal E. Gallstones in children. Characterization by age, etiology, and outcome. Am J Dis Child 1991; 145:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/127\">",
"      Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child 2007; 92:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/128\">",
"      Krebs NF, Himes JH, Jacobson D, et al. Assessment of child and adolescent overweight and obesity. Pediatrics 2007; 120 Suppl 4:S193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/129\">",
"      Taylor ED, Theim KR, Mirch MC, et al. Orthopedic complications of overweight in children and adolescents. Pediatrics 2006; 117:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/130\">",
"      Stovitz SD, Pardee PE, Vazquez G, et al. Musculoskeletal pain in obese children and adolescents. Acta Paediatr 2008; 97:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/131\">",
"      Chan G, Chen CT. Musculoskeletal effects of obesity. Curr Opin Pediatr 2009; 21:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/132\">",
"      Pomerantz WJ, Timm NL, Gittelman MA. Injury patterns in obese versus nonobese children presenting to a pediatric emergency department. Pediatrics 2010; 125:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/133\">",
"      Dietz WH Jr, Gross WL, Kirkpatrick JA Jr. Blount disease (tibia vara): another skeletal disorder associated with childhood obesity. J Pediatr 1982; 101:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/134\">",
"      Henderson RC. Tibia vara: a complication of adolescent obesity. J Pediatr 1992; 121:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/135\">",
"      Blount WP. Tibia vara, osteochondrosis deformans tibiae. J Bone Joint Surg 1937; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/136\">",
"      Thompson GH, Carter JR. Late-onset tibia vara (Blount's disease). Current concepts. Clin Orthop Relat Res 1990; :24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/137\">",
"      Davids JR, Huskamp M, Bagley AM. A dynamic biomechanical analysis of the etiology of adolescent tibia vara. J Pediatr Orthop 1996; 16:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/138\">",
"      Loder RT, Schaffer JJ, Bardenstein MB. Late-onset tibia vara. J Pediatr Orthop 1991; 11:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/139\">",
"      Sabharwal S, Zhao C, McClemens E. Correlation of body mass index and radiographic deformities in children with Blount disease. J Bone Joint Surg Am 2007; 89:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/140\">",
"      Henderson RC, Kemp GJ, Hayes PR. Prevalence of late-onset tibia vara. J Pediatr Orthop 1993; 13:255.",
"     </a>",
"    </li>",
"    <li>",
"     Tachdjian MO. The knee and leg. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Appleton and Lange, Stamford, CT 1997. p.107.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/142\">",
"      Goulding A, Jones IE, Taylor RW, et al. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001; 139:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/143\">",
"      Dimitri P, Wales JK, Bishop N. Fat and bone in children: differential effects of obesity on bone size and mass according to fracture history. J Bone Miner Res 2010; 25:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/144\">",
"      Wetzsteon RJ, Petit MA, Macdonald HM, et al. Bone structure and volumetric BMD in overweight children: a longitudinal study. J Bone Miner Res 2008; 23:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/145\">",
"      Lenders CM, Feldman HA, Von Scheven E, et al. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr 2009; 90:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/146\">",
"      Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997; 124:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/147\">",
"      Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr 2012; 161:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/148\">",
"      Weisberg LA, Chutorian AM. Pseudotumor cerebri of childhood. Am J Dis Child 1977; 131:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/149\">",
"      SIMKIN B, ARCE R. Steroid excretion in obese patients with colored abdominal striae. N Engl J Med 1962; 266:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/150\">",
"      Reilly JJ, Methven E, McDowell ZC, et al. Health consequences of obesity. Arch Dis Child 2003; 88:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/151\">",
"      Strauss RS, Pollack HA. Social marginalization of overweight children. Arch Pediatr Adolesc Med 2003; 157:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/152\">",
"      Eisenberg ME, Neumark-Sztainer D, Story M. Associations of weight-based teasing and emotional well-being among adolescents. Arch Pediatr Adolesc Med 2003; 157:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/153\">",
"      Strauss RS. Childhood obesity and self-esteem. Pediatrics 2000; 105:e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/154\">",
"      French SA, Story M, Perry CL. Self-esteem and obesity in children and adolescents: a literature review. Obes Res 1995; 3:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/155\">",
"      Stunkard A, Burt V. Obesity and the body image. II. Age at onset of disturbances in the body image. Am J Psychiatry 1967; 123:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/156\">",
"      Becker ES, Margraf J, T&uuml;rke V, et al. Obesity and mental illness in a representative sample of young women. Int J Obes Relat Metab Disord 2001; 25 Suppl 1:S5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/157\">",
"      Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002; 110:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/158\">",
"      Zametkin AJ, Zoon CK, Klein HW, Munson S. Psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2004; 43:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/159\">",
"      Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics 2001; 107:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/160\">",
"      Sj&ouml;berg RL, Nilsson KW, Leppert J. Obesity, shame, and depression in school-aged children: a population-based study. Pediatrics 2005; 116:e389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/161\">",
"      Zeller MH, Roehrig HR, Modi AC, et al. Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics 2006; 117:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/162\">",
"      Erickson SJ, Robinson TN, Haydel KF, Killen JD. Are overweight children unhappy?: Body mass index, depressive symptoms, and overweight concerns in elementary school children. Arch Pediatr Adolesc Med 2000; 154:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/163\">",
"      Falkner NH, Neumark-Sztainer D, Story M, et al. Social, educational, and psychological correlates of weight status in adolescents. Obes Res 2001; 9:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/164\">",
"      Lawlor DA, Mamun AA, O'Callaghan MJ, et al. Is being overweight associated with behavioural problems in childhood and adolescence? Findings from the Mater-University study of pregnancy and its outcomes. Arch Dis Child 2005; 90:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/165\">",
"      Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003; 289:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/166\">",
"      Williams J, Wake M, Hesketh K, et al. Health-related quality of life of overweight and obese children. JAMA 2005; 293:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/167\">",
"      Fallon EM, Tanofsky-Kraff M, Norman AC, et al. Health-related quality of life in overweight and nonoverweight black and white adolescents. J Pediatr 2005; 147:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/168\">",
"      Sawyer MG, Harchak T, Wake M, Lynch J. Four-year prospective study of BMI and mental health problems in young children. Pediatrics 2011; 128:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/169\">",
"      Puhl RM, Peterson JL, Luedicke J. Weight-based victimization: bullying experiences of weight loss treatment-seeking youth. Pediatrics 2013; 131:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/170\">",
"      Staffieri JR. A study of social stereotype of body image in children. J Pers Soc Psychol 1967; 7:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/171\">",
"      Richardson SA, Goodman N, Hastorf AH, et al. Cultural uniformity in reaction to physical disabilities. Am Soc Rev 1961; 26:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/172\">",
"      Griffiths LJ, Wolke D, Page AS, et al. Obesity and bullying: different effects for boys and girls. Arch Dis Child 2006; 91:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/173\">",
"      Kaplan KM, Wadden TA. Childhood obesity and self-esteem. J Pediatr 1986; 109:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/174\">",
"      Sallade J. A comparison of the psychological adjustment of obese vs. non-obese children. J Psychosom Res 1973; 17:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/175\">",
"      Gortmaker SL, Must A, Perrin JM, et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993; 329:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/50/37674/abstract/176\">",
"      Sargent JD, Blanchflower DG. Obesity and stature in adolescence and earnings in young adulthood. Analysis of a British birth cohort. Arch Pediatr Adolesc Med 1994; 148:681.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5869 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-87E6A227E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37674=[""].join("\n");
var outline_f36_50_37674=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5950605\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ENDOCRINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Impaired glucose tolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Growth and puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CARDIOVASCULAR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other CV risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adult coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      GASTROINTESTINAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nonalcoholic fatty liver disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cholelithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PULMONARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Obesity hypoventilation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      ORTHOPEDIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Slipped capital femoral epiphysis (SCFE)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Tibia vara (Blount disease)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16070249\">",
"      Fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      NEUROLOGIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Idiopathic intracranial hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      DERMATOLOGIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PSYCHOSOCIAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5950605\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951239\">",
"      Endocrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951247\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951265\">",
"      Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951273\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951291\">",
"      Orthopedic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5951337\">",
"      Psychosocial",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5869\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5869|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?39/1/39967\" title=\"diagnostic image 1\">",
"      SCFE progression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?2/9/2193\" title=\"diagnostic image 2\">",
"      Blount disease radiograph",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5869|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/56/20366\" title=\"figure 1\">",
"      Prevalence obesity children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5869|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/5/30806\" title=\"picture 1\">",
"      NASH liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/48/32512\" title=\"picture 2A\">",
"      Normal optic disc 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/57/36753\" title=\"picture 2B\">",
"      Optic disc Frisen grade 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/15/19697\" title=\"picture 2C\">",
"      Optic disc Frisen grade 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/25/38289\" title=\"picture 3\">",
"      Hidradenitis suppurativa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/7/3198\" title=\"picture 4\">",
"      Acanthosis nigricans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5869|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/24/31116\" title=\"table 1\">",
"      Surrogates insulin resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/61/2011\" title=\"table 2\">",
"      Categories of increased risk for diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/20/19788\" title=\"table 3\">",
"      Metabolic syndrome definitions in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/51/43836\" title=\"table 4\">",
"      NHLBI pediatric definition of lipid levels",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/21/25943?source=related_link\">",
"      Ambulatory blood pressure monitoring in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/55/27511?source=related_link\">",
"      Approach to the child with bow-legs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/3/6199?source=related_link\">",
"      Approach to the child with knock-knees",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/59/30648?source=related_link\">",
"      Candidal intertrigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=related_link\">",
"      Clinical evaluation of the obese child and adolescent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/13/39130?source=related_link\">",
"      Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35528?source=related_link\">",
"      Clinical manifestations and diagnosis of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38661?source=related_link\">",
"      Clinical manifestations and diagnosis of obesity hypoventilation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/45/17113?source=related_link\">",
"      Definition and diagnosis of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/17/281?source=related_link\">",
"      Definition and screening for dyslipidemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38105?source=related_link\">",
"      Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/25/4506?source=related_link\">",
"      Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17417?source=related_link\">",
"      Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28567?source=related_link\">",
"      Insulin resistance: Definition and clinical spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18378?source=related_link\">",
"      Management of childhood obesity in the primary care setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/63/12282?source=related_link\">",
"      Management of pediatric dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/36/9801?source=related_link\">",
"      Mechanisms and predisposing factors for sleep related breathing disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23882?source=related_link\">",
"      Natural history and management of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16073?source=related_link\">",
"      Pathogenesis of nonalcoholic fatty liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/7/6265?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/53/3923?source=related_link\">",
"      Patient information: Health risks of obesity (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/30/23010?source=related_link\">",
"      Patient information: My child is overweight (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15286?source=related_link\">",
"      Sleep related breathing disorders in adults: Definitions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23209?source=related_link\">",
"      Slipped capital femoral epiphysis (SCFE)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14088?source=related_link\">",
"      Tests used in the diagnosis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10073?source=related_link\">",
"      The child with tall stature or abnormally rapid growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/11/29882?source=related_link\">",
"      The impact of obesity on fertility and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27626?source=related_link\">",
"      Treatment of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/46/24297?source=related_link\">",
"      Treatment of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_50_37675="Symptoms and signs of PE";
var content_f36_50_37675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptoms and signs of acute pulmonary embolism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Symptom",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dyspnea",
"       </td>",
"       <td>",
"        73 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleuritic chest pain",
"       </td>",
"       <td>",
"        66 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cough",
"       </td>",
"       <td>",
"        37 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemoptysis",
"       </td>",
"       <td>",
"        13 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Sign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tachypnea",
"       </td>",
"       <td>",
"        70 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rales",
"       </td>",
"       <td>",
"        51 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tachycardia",
"       </td>",
"       <td>",
"        30 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fourth heart sound",
"       </td>",
"       <td>",
"        24 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Accentuated pulmonic component of second heart sound",
"       </td>",
"       <td>",
"        23 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Circulatory collapse",
"       </td>",
"       <td>",
"        8 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Stein, PD, et al. Chest 1991; 100:598.",
"     <br>",
"      Data from Stein, PD, et al. Am J Cardiol 1991; 68:1723.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37675=[""].join("\n");
var outline_f36_50_37675=null;
var title_f36_50_37676="Description of genital ulcer I";
var content_f36_50_37676=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of sexually transmitted genital ulcers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary syphilis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genital herpes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Chancroid",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lymphogranuloma venereum",
"       </td>",
"       <td class=\"subtitle1\">",
"        Donovanosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Etiology",
"       </td>",
"       <td>",
"        Treponema pallidum",
"       </td>",
"       <td>",
"        Herpes simplex",
"       </td>",
"       <td>",
"        Haemophilus ducreyi",
"       </td>",
"       <td>",
"        Chlamydia trachomatis",
"       </td>",
"       <td>",
"        Calymmatobacterium granulomatis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Incubation period",
"       </td>",
"       <td>",
"        9 - 90 days; average 2 - 4 weeks",
"       </td>",
"       <td>",
"        2 - 7 days",
"       </td>",
"       <td>",
"        Range 1 - 35 days; average 3 - 7 days",
"       </td>",
"       <td>",
"        3 days - 3 weeks; average 10 - 14 days",
"       </td>",
"       <td>",
"        Precise data unavailable; probably a few days to several months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Number of lesions",
"       </td>",
"       <td>",
"        Usually single lesion, but multiple lesions may occur",
"       </td>",
"       <td>",
"        Multiple; may coalesce; more lesions appear in primary episodes than in recurrences",
"       </td>",
"       <td>",
"        Usually 1 -3, but multiple lesions may occur",
"       </td>",
"       <td>",
"        Usually single",
"       </td>",
"       <td>",
"        Single or multiple",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Appearance of genital ulcers",
"       </td>",
"       <td>",
"        Sharply demarcated round or oval ulcer with slightly elevated edges; may be irregular or symmetrical (\"kissing chancre\").",
"       </td>",
"       <td>",
"        Small superficial grouped",
"vesicles and/or erosions; lesions may coalesce, forming bullae or large",
"areas of ulceration; lesions have irregular borders.",
"       </td>",
"       <td>",
"        Deep, sharply demarcated ulcer; irregular ragged undermined edge; ranges in diameter from a few ml to 2 cm.",
"       </td>",
"       <td>",
"        Papule, pustule, vesicle, or ulcer; discrete and transient; frequently overlooked.",
"       </td>",
"       <td>",
"        Sharply defined irregular ulcerations or hypertrophic, verrucous, necrotic, or cicatrical granulomas.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Base",
"       </td>",
"       <td>",
"        Red, smooth and shiny, or crusted; serous exudate occurs when squeezed.",
"       </td>",
"       <td>",
"        Bright, red, and smooth.",
"       </td>",
"       <td>",
"        Rough, uneven, yellow to gray in color.",
"       </td>",
"       <td>",
"        Variable.",
"       </td>",
"       <td>",
"        Usually friable, rough, beefy granulations; can be necrotic, verrucous, or cicatrical.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Induration",
"       </td>",
"       <td>",
"        Firm; does not change shape with pressure.",
"       </td>",
"       <td>",
"        None.",
"       </td>",
"       <td>",
"        Soft; changes shape with pressure.",
"       </td>",
"       <td>",
"        None.",
"       </td>",
"       <td>",
"        Firm granulation tissue.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Martin DH, Mroczkowski TF: Sexually Transmitted Diseases. In: The Skin and Infection: A Color Atlas and Text. C. V. Sanders and LT Nesbitt, eds. Baltimore, Maryland: Williams &amp; Wilkins, 1995, p. 95.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37676=[""].join("\n");
var outline_f36_50_37676=null;
var title_f36_50_37677="Drug induced skin vasculitis";
var content_f36_50_37677=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F60323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F60323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Drug-induced cutaneous vasculitis with palpable purpura",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 142px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACOANgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDkpLj7OyHG92OFz39f8apXl1KZXSN/MlcCRRvHXjgA8Z96oSajtCLGnmz47LwD7j0NaUKW84WaKGNpEHKc4JPb6ZrxXDl1Z9VTknsdDpNw9xqDu8MYmj+TAcEuSOc+hFXNRukQJDszkjLofukdjzWSq/Z7ZXjULLMNzEZBzjgepqlbXt1ny5ESNmbBuXOTkjuD+VYqPNqdHYnOrzSXe2JG+zk5O4DZjPr696h1QFnsJVlGTk4jbK4+vOeM/wCcUNarvLQSPd2wZQyBsYIPPSn6lHOwjhtSv2ZsFR5ZUgDqPrVaX0Nb6GTd2iW0klyZN2esgP3TyBjnpnFYd7HM/ltJCYsHHHcH/DmtjXEk3SquWKJgL0BUHOSB+VQSr5trDdhlRFZl2Y655zz610U20k2clWHMrHVeCNXa4tVguXy0Q25I5AHQ/SuwBBGQcivGdK1KbStTjmZHRVwJY8HBUn/61etaVeQ3tqskBUqR/Ca61sfPV6fs526F2iinKhJ/xoMhACfepFVjTlQCn0AGKKWiiwBRS8UdKYCc0DJ6Up5FKFJGcUDGc5pTSmjigBtNYt2FPNJSERbmI7Yxmm5bnmp8DsKa2MkZFAWK5JJ5opSADgHNFVG3UD5/srtLrbMN2cAYHUe/1rrNEIeUyFyEwMbh/nFeU6XftaPnJ2N1Fd9omqIEUklsYIYHqKivTdtD0cJiL6M7lLkTXkKRlwyoSVIBHsc1o3Vg17a7JeOQd0WDx34rnY7zDKynf6Jjsfeti31SNA0e2YOMbTg8/iK8yUXHVHrRlcgh02x0u4EDXk0ZbMqRngNkcnPrmp79zDHA7t5hdSjMn3Qpxz60v2uD7WWlty84A2EAncD/ABD6ZNUp4JdRlPzRmAHEhI2hWGcld3cjtT+LVmyvuNBQ2NxFCoXZGeQ2WA9QT7/nmsHU70NMFdAfJYBF24DEg5Ddu+at3kQVc2bO0Eo3IoOCwycj2H60kD2r3KzTxogU5CZ3dBgA8dSf5VtBKOu45Rcl7pnbGdDMfnVl2lWHT5s4H4A/rVa11K809Q0JKw5IAz92txXtL6QwsjxpCx3HzOFBOfmPp7+9RXumxSGaCFk2Mx/dofQjkH8+K0jU5XaSOLE4ZVFdCQeIr9z/AKw1aTXtQPSTisC1jELNGH3AEgZPNaCjgCtmeG1Z2ZqjXb7/AJ6Uv9vX3/PT9TWVj1o2nsDS1CyNb+377+/xSf8ACQX3/PT9TWYI2PbH1pWjCj71K7Cxpf2/fY/1n86D4gvsf6z+dZX4Un6UXA1/+EgvwP8AWfqaQ+IL4/8ALT8s1k0Urgav9vX2f9Z/OkOvX3TzeayjRkUBY1Dr17/z1pp169/57VlFlHbmkyAckH2pjsjSbXr7tKfzqNtdvj/y1OPrWc2PpTDQxWRonWr4/wDLY/nRWaeBzRSCyPJsnFaGm372zqN5C9j6VnUoODmvROaMnF3R6Vp92XizI+GXBXPGfpW5b6hKkKiSJ3ZnH3CSOTj0zXmehao1u3lSOQuRtOfu/wCRXbWt5JiMlla1PBXPJx/X/CuGtRPcwuIU15nUx+dcaSksBbzUmAZSCAV3cg/hUtw2pRKpaNLgM2JDj5UHYY/Hr/jWLZXU5nkhncOCpw4IAz2Jx06c1s20hZ2M9wrqPmHlvkDjpwc/pXJyuLO/muiO6jug8YMPlTbj8xxwuOnHtnvWLJGIiVMYiaM59Sxz+Fdg8UK3cjOIhCVUK+/fuHfI/Lmue1G3jMjiIqxVzyBgge/rW1Jp9BSm3bUbZ3CWtjEsUEe6XJJC7i2MHB9utU2kkmcZMcEsWXYrHj5sjj361cjTypIyAox82RnP/wBbiiHE80rSW+1Q3ybR1Hpj+tXypaiveyKFlA8sczTyLuZ8EgcDv17Ditm2SIKFkQq4AJBqtPbfaWFxD8vkttYEgbvy75781YkkMoUxtJ8oAxtHXnP4cUc9zjr4XmV1uSSCMdFqscZOOlJ5oYn5iOejcGkJ5++AKDy2uV2YtNbpzjNLuH94U19rH7wxRYCJwA1OXGBkClAXOSwpDtxgHHanYVyNsZOOlFOIX+9TTt/vfpSsF0FJgU1tp70h2/3qLDugdT2/Go2Bz1z9Kc23P3jTeD1enYLjfxoI980p29mppYDvTsFwIophkX1oqbMTZ5QeKSr11bFWOKplSK707nM1YQV02h6gJY1gmOHX7rd8VzQFSRu0Tq6HDA5BpSVzSlNwd0erLPY3VmvmPIsztnHrjjp27Vb047VDwEO44ZzkhgfX071zWhTrNbJMoJVwVI9CP6/zrpz5SKZopkkB6xsMMOo9q4pRUHZ7HuUqrqxvEltlbaqtEQR8o2juO2K0rW2E90zhVSdcEg89QOOfpVN71gGeQbWXG38uQarxao5kVbRU3jIG7gDp1zVJSloRKXL7x0a6dHPMkW4xSTuE34ByeOf0FF/pEtikkThmkBIRlOM5H9elUbfXbtWVWiZpNvMkYB2NnryeR/nmt611y4it7bfaGV3J+b7zOcj5sDgCueXPB3R1QmpxszmJYBZsIxmN3O4JnLMexz+tVBC8TSJGJPnUblDY/wA//XrsdXt4niWad4mkIz+6wPUD34/X8q5C6ikMiujZUjJI47nj60Rlzam6s9AuIwZImVkdFTkg4x7VUMqliOgzx6Vaa22RlBkYb+L0qpJCqJvDYz37j61pF6WOPE4ZTd0ibYewz9KQoR1rNinmiYmPgYyQRxV631KKUFZRsYdSOVpyjJbHnSpcu47aaNpq2Cr8jBHrS4BHTisXJk8qKLKx6YpNjY6irjIuRxTCg7A0c7DkRU8k0CI1cEfrTWXBo52VyorGE47UwR5OKtkCjaM570c7DkRT8naAAMAU1oc1eKg00jmjnYOCXQzzBjoaKtumeRRVKT7i5TjLqz3dB+FYl3ZlSeK7Ex5H3eDVS6stwOFrpjOxzuNziXQoeabWze2RUnisx4SDXQpJmbVjqPA8vmedbHqn7xTjt0I/UV2sVsrQPlDvzk5bgfXH1rgfBJWPWQXcINh69+RxXq0fnhC2+PazbT8pBOPXB6c9DWNSz3OzCymvhM+4s5toV9pjVcIcjjOeOayLSxu47omRzGn+0xUfpmupjSRwMyyMpHIIXn/OaY8SRq+4MYxn5j2AHcn1NQm1qjtsnoyv8gkV4hGGXBCqckY7k8ZzVqwlYzkBwCTkAMF7gkk9fyptpFbsA0bgFjgKpzn646dqvWu4ExiP5Q2SCMgHPap5ru7Go8isSGZvKLStvAwN4P3eoABxWZHZSJI7AByXLHGcH8z1q9Ikjb0cnywcKuBx3+pNSlisCodxBbd8gzj6Dv8AWk46aG1OrZlS6t440b5TtzjIycH0rMmVo1BbBRl+72z9Poa15y3zLkhQRkkcg/5NVpoAYm2u23JAbHf04rJKx1qaZzl8gG1tnLHJI/Os+RTncvDE7fQGt2eBy2wIO3Ht7fjVTyPLkZGjyOxwOO+K6I6I5ZwTZTgd7bDxykEkfIASK0INSVXKXI2ejfwn/CqjQuHDQhsMeF6Z+lPVnYeTcRqYwe/f2z/jUzSerMJYZPbQ1wVkXKkFSMgilxWMn2iwZAqbUc4CHlTzxg1oWt/DOxTOyTONrHBP09a53DqjnqUpQdmWSKTaOc1IV4oK96gzsyEoM5pu3PSp9vpSbDnjikPUgKkUlWNnFRmM9sUXGREUU/y26GimiXYwaXaW4xmn7e1SCPB68V0GNjMu7MSLkLzXOX1ntYkCu52g8Vkanaj5uKuE2iXG5z/hlJP7ZjVFQtg8OMivTLKZoxMitGWYckjOP88VyPg7THn1iSVF4jXH1JP+FehrpdwuAoVHI/uk5qqs47M7MFTlukR224uC8kgPqOMmtGS1jm83cqlWTBY5zWTPZTR4SV2jI+YBRjjNSo6hiRKcpztzndUp3R1ypu9y3BZW0WSW+8wOSc9OlWJWgUM7Zd2OB8o4981SWUMMFVOBk7f0FSPsRVabMas4UbjwTTJat8Q+aUBujojDnA6gegqrBcZk3BiUDAbj/D7CrhMMsgR9rbeNwYE59KbPtTKeWflyAq8fmaq66jUW/hRGGQyOzu3zAgE9M/T196oIkoZozLiIfMJOhzn9aZczyEkKvPovt6UgjmBWOXdtIyFBqbot05LVkirFG2d+1RyAO+fanNbJOcwjHZQR096glVWuAm4kqcA+vX+lSo+DGc+WxOGHrSe5tFxa90ZLbIzRFzudVIyx56mq6wkKJZFVtuATg9+/8hWuiIgy3O4g4agRxOkjMVRmPygdD7CspysdVKKerMK/TzJYAoTA+7FkqYz2/Ws69t/LZt0Yz3KYO0/411UtuZHO5Pl655PQds/54qK405JWVyu1TgYIwB9f896yU+U1nTjURzUep3VsiidBKD0JOCPx71MmsMZNnlKfYE1t3mjQyEDZhlAA255+prAvLNrdQXjw4HBxnP8AjWlOdOfQ8qvgpQ1jsX01KFiAUlQn+8vvirsbrKPkbIrmL0IyqZY1VzjkHHA9BVnTpQY12TtleOSckdquVGLXunJ7KS3OhCetNZcVRtb26Enl3EG7/bQ/0NaClZUDIQVPQ1zyi4vUzalHcjIopzAetFCE9TCA4ApQOvNFOUc8Vuc6AVW1BcoDV5V45qC+UCKknqUL4Rl8kTYHLSf0ru7N3kifYWJPKgHn3rzPRbxLbU/Ll+6/T616GsuBEUJUAYDCprxbPTwFRKNiSa1uJp1Y85yAp4KjNQnTUV2VlJIB6NWsTK8AKklj/FnqPSr0G0gGRB8oxjHBqIuyPQdS2qOa/s1llYq5wBwvtx/jUrLshDzRYHOwjofr71ukxyM7F1DIcDHGB6Vi6hPM9wkaqsiZwo7j3rRTexzzipO7GmZXkjkgUkMOuOn09KrvI6xSDLKT6moysizbjkKp5wMVn6heJDEd8jYXsxzVJtkucI9SWa4jjZNxOVUY44Hr+tQNqcak5IcNn73JrnJ9SXcTLJhD0Gc1VXU4PNVsD5fetFBnNLExvvc6h9YUSbljRAVKjIyc02C6GAt0QXZvlY89e1c9LqC3M28EDt8uAD+FRR3XzlWZgwORg4qlEqOIjay0O7hCqMSN+7ccsEJx/k4qUSM3krLEoQHCtu5YelcvY648IMaE4A7jOa0re+W6cuwYSOeBnAz+VYzg76nXSrprQ6hFiaQrl3TO1sLwp989+nNWoLCGZEdV3fPn733QR0PrWa9yZLWOKOTYRwWI4b61djkEe4cKrYOQ3euZ7HUpX1RoTWW0qpO0E45Uc565/wAaxNT0p5VG0nhiR7GrI1zLSK672RsADkH3pn9stIz7UUE8DPSo5Lao0UpLc5K/0x4/lcSMxxhm6/Tj3osdJVGYmIovCqFAPPJ7V2KXttLty8Zxyw2n1qSB7Dy28s9WPvWnPNKxk/ZvVo4C7NxpE8cyIsij5XR/Q961bexmhupXTBjmwwjGSF47Vd1u0jmYMSQp9e9Fvq8+l2qxxSRvGmMbl547ZrVvnjZbnn16LT93VFWVChwwwfQ0U+W8OoO10VCCToufSisl5nC9HYwdvTFSLzxjmlAxn0pyqD1FbbnOOVcE1U1EgR81dFUtSX5M+1C3G9ji9UmKy7kJDKcg11vhzxCb2BYpZNsqgZHvmuL1cHzG471RhYrzkg9iK7ORSiZQqypSuj3e21Vo0jVj83Y9ea0pNT+UrGQfU56V4JHqF3GMJcSgem7NTrrWoL0uXFYuh2OtY3uj2W81CKCP5jgn35+tY93r9lbFnD5bHU9QK8sm1G7lJMlxIfxqAyM/3mJPuaSod2N42+yO21Hxe8hcQMzA8egrmbvULm7YmaQn2HSqGcHinAgDOeTWkYKOxzVKkp7khJJopgbJp2adzGw4HFLvYHIJ/Om0madwuWVuJFOQ5q5baxNCuOuOntWXRQ7PctVJR2Z1EHiZ12b8nufrWhH4lhKohfD8Yrh80Vm6cWdUMfVieif2vERlplLY7Vn3HiCON2USYGOgFcZmgnNJU4ouWYVGtDoLnxFMYikBIYn7/pTrLxPdQ8S4b3UYNc5mlz71fKjm+sTve513/CSz3bhFIAHA3Vs2MaTovnuZOc4xgV50kjI2R1rotE1OXcATkCspw0900WIlPRs7UADgAYoqvaTeagz1orls0BnhvSnr9ajBPIp4FaGaJFwevSmXMIlTHpThU0ZJUU7lM4TXbJgzHFc7ja2K9Q1GxSdSD1Iri9W0jyGLK49a6qVRPRmFSHVGOvSlpShQ4JBNAGcCtTJBRVq3snmOAyit3T/DgkKtJKPwqZTUdy1Fs56GCSRsKpz9K2bLw9cXHUFR7iuz0/QoLcA8EitiONIx8oxxXNOv2NVC25xkPg8kAvLg/SpH8HDbkTH8q7NTkCmkgnHOM1l7aRXKjh5fCEoHyy/pVGfw1dxZ24b6CvRnBxkHmk2DGfamq8g5EeUT2FzAfnib8qqMGViGUg167JbRyfKyg+vFULrQLS4PK4JrRV11RPs+x5cTjml3du9dzceE7djlJCprOl8KFclZxx7VoqsWLkZy5PA+tAJ7cmuhXwu2eZ1x9DWpY+F4VPzyZ70OpFByM40q2PukmjBHUEV6ZFolokf3M4px0KykGWjrP26H7I8yVGY4AJ/Ct7RLCXeGKkfhXZRaJaIAVjAq0tukanYAMVMq91oVGnbcrWMJijwetFWGOBk9qKyLbP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dense palpable purpura on the lower extremity of a patient with drug-induced cutaneous vasculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Leonard Calabrese, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37677=[""].join("\n");
var outline_f36_50_37677=null;
var title_f36_50_37678="Influenza testing in institutional or closed settings";
var content_f36_50_37678=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Guide to use of influenza virus diagnostic tests in investigating outbreaks in institutional or other closed settings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 271px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examples of institutional or closed settings include long-term care facilities, nursing homes, schools, correctional facilities, hospitals, and ships.",
"    <div class=\"footnotes\">",
"     * In settings where persons at high-risk of influenza complications reside, a single case of suspected influenza is sufficient for triggering influenza testing and consideration of implementation of empiric control measures, including active surveillance for new illness cases.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Eg, influenza-like-illness (fever with either cough or sore throat), fever with other respiratory symptoms, etc. Note that some persons may have atypical presentations (eg, elderly, very young infants, immunosuppressed, and patients with certain chronic medical conditions). Fever is not always present. Other symptoms associated with influenza include myalgias, headache, fatigue. Complications include exacerbation of underlying chronic disease (eg, congestive cardiac failure, asthma), pneumonia, bacterial co-infection, bronchiolitis, croup, encephalopathy, seizures, myositis, and others.",
"      <br>",
"       &Delta; Eg, use of antivirals empirically for treatment or for chemoprophylaxis of influenza, changes in infection control practices (isolation or cohorting of ill, quarantine of exposed), changes in admission or staffing policies, or changes in social distancing recommendations, etc.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Persons &gt;65 years or &lt;2 years; pregnant women; persons with chronic lung disease (including asthma), heart disease, renal, metabolic, hematologic and neurologic disease; immunosuppression; and morbid obesity.",
"        <br>",
"         &sect; In an outbreak setting, because of the low sensitivity of rapid influenza diagnostic tests, use of the tests on specimens from more than one ill person is recommended. The presence of any influenza positives among persons with clinically compatible illnesses is supportive of influenza as the probable cause of the outbreak. Confirmation of rapid test results by more specific influenza testing is indicated.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     United States Centers for Disease Control and Prevention. Guidance for clinicians on the use of rapid influenza diagnostic tests.&nbsp;",
"     <a href=\"file://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm\" target=\"_blank\">",
"      file://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm",
"     </a>",
"     (Accessed on April 4, 2012).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_50_37678=[""].join("\n");
var outline_f36_50_37678=null;
var title_f36_50_37679="Contents: Maternal medical problems";
var content_f36_50_37679=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Maternal medical problems",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Maternal medical problems",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/42/6826\">",
"           Cervical cancer in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/50/7977\">",
"           Overview of fertility and pregnancy in cancer survivors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dermatologic conditions",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29657\">",
"           Dermatoses of pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/4/41030\">",
"           Management of psoriasis in pregnant women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/36/12871\">",
"           Hyperthyroidism during pregnancy: Clinical manifestations, diagnosis, and causes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/48/42760\">",
"           Hyperthyroidism during pregnancy: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/47/14073\">",
"           Hypothyroidism during pregnancy: Clinical manifestations, diagnosis, and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/19/20794\">",
"           Medical management of type 1 and type 2 diabetes mellitus in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/13/4313\">",
"           Obstetrical management of pregnancies complicated by gestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/62/35818\">",
"           Obstetrical management of pregnancy complicated by pregestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/51/16186\">",
"           Overview of thyroid disease in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/27/36281\">",
"           Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/31/42487\">",
"           Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/16/2312\">",
"           Screening for diabetes mellitus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/34/42536\">",
"           Acute appendicitis in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/14/25834\">",
"           Fertility, pregnancy, and nursing in inflammatory bowel disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/38/41575\">",
"           Alcohol intake and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/44/36554\">",
"           Approach to abdominal pain and the acute abdomen in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5850\">",
"           Buprenorphine substitution therapy in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/29/28120\">",
"           Diagnostic imaging procedures during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/29/4570\">",
"           Methadone maintenance therapy during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/12/6346\">",
"           Overview of illicit drug use in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/52/3914\">",
"           Recognition and management of allergic disease during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/53/27482\">",
"           Smoking and pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Heart disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29097\">",
"           Acquired heart disease and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30950\">",
"           Acute coronary syndromes in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/32/1543\">",
"           Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/22/20840\">",
"           Management of cardiopulmonary arrest in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/34/1577\">",
"           Management of heart failure in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/53/1882\">",
"           Management of pregnant women with prosthetic heart valves",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/0/20487\">",
"           Pregnancy after cardiac transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/50/20262\">",
"           Pregnancy and Marfan syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/25/27032\">",
"           Pregnancy in women with a bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/7/29818\">",
"           Pregnancy in women with congenital heart disease: General principles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/21/35159\">",
"           Pregnancy in women with congenital heart disease: Specific lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/48/29447\">",
"           Pregnancy in women with mitral stenosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematologic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/46/18153\">",
"           Anticoagulation during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/27/39353\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/46/14055\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/5/26714\">",
"           Inherited thrombophilias in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/0/44041\">",
"           Management of pregnant women with antiphospholipid antibodies or the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/2/41000\">",
"           Obstetrical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/56/38793\">",
"           Thrombocytopenia in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/32/1543\">",
"           Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infectious disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/15/13561\">",
"           Acute uncomplicated cystitis and pyelonephritis in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/30/24037\">",
"           Antiretroviral medications in pregnancy: Entry and integrase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/60/16328\">",
"           Antiretroviral medications in pregnancy: Non-nucleoside reverse transcriptase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42841\">",
"           Antiretroviral medications in pregnancy: Nucleoside reverse transcriptase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/24/18825\">",
"           Antiretroviral medications in pregnancy: Protease inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/19/42295\">",
"           Approach to the adult with asymptomatic bacteriuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/21/12634\">",
"           Cytomegalovirus infection in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/14/33001\">",
"           Genital herpes simplex virus infection and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/3/43062\">",
"           Group B streptococcal infection in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/25/35224\">",
"           Influenza and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/33/16921\">",
"           Overview of malaria in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/29/40408\">",
"           Parvovirus B19 infection during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/63/4089\">",
"           Placental infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/60/6087\">",
"           Rubella in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/61/4057\">",
"           Syphilis in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/39/22137\">",
"           Toxoplasmosis and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/13/20695\">",
"           Treatment and prevention of malaria in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29096\">",
"           Tuberculosis in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/28/33225\">",
"           Varicella-zoster virus infection in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Liver disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/37/26198\">",
"           Approach to liver disease occurring during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/41/13976\">",
"           ERCP in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/61/3033\">",
"           Hepatitis B and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/24/14726\">",
"           Intercurrent hepatobiliary disease during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/15/22777\">",
"           Pregnancy in women with pre-existing chronic liver disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/56/24458\">",
"           Cerebrovascular disorders complicating pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/63/5114\">",
"           Headache in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/9/20634\">",
"           Neurologic disorders complicating pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/61/43994\">",
"           Pharmacology of antiepileptic drugs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/6/22633\">",
"           Risks associated with epilepsy and pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Psychiatric issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/2/29735\">",
"           Depression in pregnant women: Clinical features and consequences",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/0/28682\">",
"           Depression in pregnant women: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/38/7781\">",
"           Eating disorders in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/29/19927\">",
"           Pseudocyesis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/27/39353\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/46/14055\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/33/39446\">",
"           Dyspnea during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/34/29226\">",
"           Management of asthma during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/45/19159\">",
"           Physiology and clinical course of asthma in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/31/36344\">",
"           Treatment of respiratory infections in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29096\">",
"           Tuberculosis in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/40/39561\">",
"           Obstructive sleep apnea in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/44/33479\">",
"           Acute kidney injury (acute renal failure) in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/63/23544\">",
"           Evaluation of proteinuria in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/28/38340\">",
"           Nephrolithiasis during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/19/21816\">",
"           Pregnancy in women with diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/62/11241\">",
"           Pregnancy in women with underlying renal disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rheumatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/53/40791\">",
"           Rheumatoid arthritis and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/28/34244\">",
"           Systemic sclerosis (scleroderma) and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/12/23754\">",
"           Treatment of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/59/38842\">",
"           Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-ACE696A653-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f36_50_37679=[""].join("\n");
var outline_f36_50_37679=null;
